Immunovia presenterar vid Vator Securities Unicorn Summit

LUND, Sverige - Immunovia AB är ett av sju utvalda bolag som ska presentera under eftermiddagen. För presentationen, som börjar klockan 14.30 står Mats Grahn, VD på Immunovia. Mats Grahn ska bland annat tala om kommersialiseringen och prospektiva studier av Immunovias test för tidig detektion av pankreascancer. Dessutom kommer den nya satsningen på tester för den autoimmuna sjukdomen SLE, som pressreleasades i början av januari, att beröras. Vator Securities har ända sedan starten 2009 framgångsrikt bistått bolag, entreprenöreroch investerare inom Life Science-sektorn med finansiell rådgivning. Visionen är att ledaarbetet med att skapa ett svenskt supercluster där kunniga investerare finner snabbtväxande bolag med potential att bli nästa svenska Unicorn (bolag med över 1 miljard dollari marknadsvärde) inom Life Science. Mer information om anmälan kommer snart finnas tillgänglig på Vator Securities hemsida: http://www.vatorsecurities.se För mer information, vänligen kontaktaMats Grahn, VD, ImmunoviaTfn: + 46 (0)70 532 02 30E-post: mats.grahn@immunovia.com Om ImmunoviaImmunovia AB grundades 2007 av forskare från Institutionen för immunteknologi vid Lunds universitet och CREATE Health, strategiskt centrum för translationell cancerforskning i Lund, Sverige. Immunovias strategi är att analysera den uppsjö av information som finns i blodet och översätta den till kliniskt användbara verktyg för att diagnostisera komplexa sjukdomar så som cancer, tidigare och mer exakt än vad som tidigare varit möjligt. Immunovias centrala teknologiplattform, IMMray™, baseras på analys av mikroarrayer av biomarkörantikroppar. Företaget utför nu kliniska valideringsstudier för kommersialisering av IMMray™ PanCan-d, som kan bli det första blodbaserade testet för tidig diagnos av pankreascancer. I början av 2016, initierade företaget ett program med fokus på diagnos, prognos och terapimonitorering av autoimmuna sjukdomar. Det första testet från detta program, IMMray™ SLE-d, som är en biomarkörsignatur framtagen för differentialdiagnos av lupus utvärderas och valideras nu. (Källa: www.immunovia.com) Immunovias aktier (IMMNOV) är noterade på Nasdaq Stockholm First North med Wildeco som bolagets Certified Adviser. För mer information, vänligen besök www.immunovia.com.  Om Vator SecuritiesVator Securities är en finansiell rådgivare som står under Finansinspektionens tillsyn och är medlem i Näringslivsrådet på Kungliga Ingenjörsvetenskapsakademin (IVA). Vator Securities har sitt säte i Stockholm. Vator Securities corporate finance-avdelning erbjuder finansiell rådgivning till snabbväxande bolag. Vator Securities erbjuder även kapitalförvaltning till kunder med en finansiell portfölj som i regel överstiger 5 miljoner kronor.        ### 

Tågkompaniet and Nobina sign agreements for bus-for-rail services

“Nobina has demonstrated expertise and skill in scheduling and implementing bus-for-rail services in a customer-oriented and efficient manner. Thus, when selecting a partner, the choice fell on Nobina. We look forward to, together with Nobina, offer traffic services that exceeds our customers’ expectations when the trains are unable to run,” says Mats Gustafsson CEO of Tågkompaniet. Nobina possesses long experience of successfully operating bus-for-rail services. Nobina’s bus-for-rail offering comprises a carefully designed service in which, among other things, Nobina’s central 24/7 traffic management resources are used in order to provide Tågkompaniet with the best possible assistance in terms of both scheduled bus-for-rail services as well as rapid intervention in the case of rail traffic disruptions. In addition to traffic management, Nobina will cooperate with subcontractors in those areas in which Nobina currently does not operate. “We look forward to collaborating with Tågkompaniet. Nobina operates bus traffic over large parts of Sweden – a factor which makes us well-equipped for finding solutions promptly and efficiently in all situations. With our bus-for-rail services solution, together with Tågkompaniet we will ensure the provision of the entire journey for the passenger – irrespective of whether ordinary daytime travel is involved or whether it’s a matter of dimensioning bus-for-rail services in the case of disruption,” says Jan Bosaeus, Managing Director at Nobina Sverige AB. Tågkompaniet, which provide services on behalf of PTAs, operates 56,000 train departures and carries out approximately 5 million journeys per year. As a supplier of bus-for-rail service solutions on behalf of a number of customers in the Nordic countries, Nobina is, thanks to its experience and major scale, able to offer locally customised, comprehensive solutions with 24/7 support. The information comprises such as Nobina AB (publ) is obliged to publicly disclose pursuant to the EU Market Abuse Regulation and the Securities Market Act. Through the above contact person, the information was submitted for publication at 12.50 CET on 13 February 2017.

Stena Line enters partnership with Mercy Ships

Mercy Ships owns and operates the largest civilian hospital-ship in the world to deliver free, world-class health care services to the poorest of the poor together with capacity building and sustainable development to nations in the developing world. Since 1978 Mercy Ships has helped more than 2.5 million people. The ship’s crew is made up of more than 400 volunteers from up to 40 nations. Surgeons, nurses, technical, marine and many other professionals, an average of a 1000 volunteers yearly, pay their own expenses to aid those in need of safe surgical expertise and healthcare. “We have found a partner with the right qualifications and commitment who, like us, sees the advantages and flexibility in having the sea and ships as workplace. Care is part of our soul which means that our sustainability work includes more than just environmental initiatives. Our partnership with Mercy Ships now becomes an important part of that work and it gives us an exciting opportunity to involve our staff, customers and partners in making a difference.” says Niclas Mårtensson, CEO at Stena Line. “Mercy Ships is a unique organization and we very pleased to see the great support from Stena Line. They have taken our mission to their heart and it is great to see their willingness to partner with us to support the work we do”, stated Pascal Andréasson, Head of Marketing for Mercy Ships Sweden. At the end of January, Stena Line’s CEO Niclas Mårtensson visited the Africa Mercy, currently docked in Cotonou Benin, to see for himself the work done on-board. The Mercy Ship is a former Scandinavian rail ferry which was converted to a hospital ship with five operating theatres and spends ten months at a time in African port cities.  The impressions at the visit were many and Niclas Mårtensson says: “I see the great need to support Africa, where Mercy Ships with their volunteers, their commitment and knowledge, make an enormous difference. During the stay on-board the vessel in West-Africa, where I met patients and saw the operation of the organisation, I realized that this is a life-changing contribution. To see and experience this is a very important experience for me.” Stena Line’s vessels and social channels will be able to reach some 10 million people every year with information about Mercy Ships. During the spring of 2017 Stena Line will cooperate with Mercy Ships Sweden to bring awareness of the charity’s commendable cause on their vessels in all of Europe. Stena Line is also presently working to set up a programme for sponsoring staff/crew who would like to join as volunteers on Mercy Ships vessels.

“I use it”: LIQUI MOLY launches nationwide advertising campaign

February 2017 – “I use it” is the slogan of the advertising campaign being launched by oil and additive specialist LIQUI MOLY in the USA and Canada. The focus is on garage owners and their experience of LIQUI MOLY. “We show real people with something real to say”, says Sebastian Zelger, responsible for LIQUI MOLY’s North American trade.LIQUI MOLY is deliberately doing without celebrities as testimonials. “We want to provide a platform for these everyday heroes,” says Zelger. “They’re all people who work with our products on a day-to-day basis, which is why we’re calling the campaign ‘I use it’.”Users include Josh Collver of the European Service Center in Dallas, TX. He talks about a BMW Z4 M that was brought into the garage with problems: „This BMW came to us with low oil pressure faults and had obviously not been maintained. After a thorough engine flush with LIQUI MOLY products and fresh Smooth Running High Tech 5W-40, there were no more pressure faults or stumbling. We have full confidence that with these products, the customer has avoided the need for an engine replacement!” See www.iuseit.us for details of Josh Collver and the other testimonials.LIQUI MOLY developed the advertising concept itself without using an agency. This reflects the oil manufacturer’s philosophy of doing as much as possible in-house. The campaign will run for the whole of 2017 – digitally as well as in magazines, trade journals and consumer media, both in the USA and in Canada. LIQUI MOLY is also involving its customers in the campaign to further extend coverage. The company has significantly increased its advertising budget for this project. Sebastian Zelger: “This is our biggest advertising investment in North America to date.”

TerraNet AB to present at Vator Securities Unicorn Summit on March 7, 2017

TerraNet AB's ("TerraNet") CEO, Pär-Olof Johannesson, and Chairman of the Board, Christian Lagerling, will be presenting at Vator Securities Unicorn Summit in Stockholm on March 7, 2017. Following its commercial breakthrough in 2016, TerraNet will provide an update on upcoming corporate activities as well as its proximal connectivity software platform which ensures consistent application performance, quality and user experience whether a user is online or offline.Vator Securities Unicorn Summit is a capital markets day with some of the most interesting and innovative companies in Sweden. Beyond company presentations, participants are offered a unique opportunity to network with industry peers and investors.More information and registration will soon be available at www.vatorsecurities.seContacts:TerraNet ABPär-Olof Johannesson, CEOLena Hägvall, EA to CEOEmail: lena.hagvall@terranet.sePhone: + 46 70 332 32 62Christian Lagerling, Chairman of the Boardchristian.lagerling@terranet.se Notes to editors:TerraNet Proximal Connectivity Software PlatformTerraNet’s patented software algorithms enable streaming of data, including bandwidth intensive HD media, directly between mobile units independently of cellular or other hotspot network connectivity. The company’s proximal connectivity software platform uses Wi-Fi as a carrier although the solution can also be adopted for other radio technologies such as Bluetooth and LTE.Based on this technology, TerraNet has developed unique solutions for its customers which include leading global microchip, mobile operator and multimedia distribution companies as well as OEM suppliers into the automotive and manufacturing industries.In July 2015, the leading industry standardization body Wi-Fi Alliance adopted the protocol for ’discovery and synchronization’, which TerraNet initially authored and pioneered, effectively creating overnight industry wide acceptance of proximal connectivity.This standardization is the foundation of the TerraNet platform and has significantly increased the interest for the company including strong commercial progress in late 2015 and 2016 including new customers within IoT, Telecom and Mobile OEMs.For more information please visit www.terranet.se20170213 Press Release – Unicorn Summit

Kährs Group: Year-end Report 2016

Fourth quarter · Net sales totalled SEK 736 million (667), an increase of 10 per cent compared with the same period in 2015. FX adjusted sales growth was 9 per cent, excluding a currency impact (net) of SEK 11 million · Operating profit before depreciation, amortisation and non-recurring items (adjusted EBITDA) was SEK 76 million (83), corresponding to an operating margin of 10.3 per cent (12.4) · Operating profit before non-recurring items (adjusted EBIT) for the fourth quarter decreased by 7 per cent to SEK 54 million (58), corresponding to 7.3 per cent (8.7) · Consolidated result for the quarter was SEK -30 million (18) and the decline was mainly related to non-recurring items of SEK 78 million (38). These were primarily related to a reserve for a legal dispute in the US as well as a capital loss related to the sale of an associated company January - December 2016 · Net sales for the full period January-December amounted to SEK 2,894 million (2,724), an increase of SEK 170 million or 6 per cent compared with the previous year. FX adjusted sales growth was 7 per cent · Operating profit before depreciation, amortisation and non-recurring items (adjusted EBITDA) for the period was SEK 320 million (314), corresponding to an operating margin of 11.1 per cent (11.5). · Operating profit excluding non-recurring items (adjusted EBIT) for the period was SEK 227 million (217), corresponding to an operating margin of 7.8 per cent (8.0). The FX adjusted improvement in profit was SEK 10 million or 5 per cent · Consolidated profit for the period was SEK 59 million (62). Non-recurring items in 2016 totalled SEK 94 million (45)  President and CEO Christer Persson comments:”Kährs Group’s stable sales growth continued, with an increase of 10 per cent in the fourth quarter. Strong underlying sales in the core markets Sweden, Germany, the UK and the US, contributed to the development. Also for the full year we saw a good development with increased sales and improved operating profit of 6 and 5 per cent respectively. I am positive about the Group’s ability to continue improving sales and profitability also in 2017. We will achieve our continued growth by launching new products, enhancing the brand experience, increasing our presence in the projects market and leveraging the potential of the digital ecosystem.”   For further information, please contact:Christer Persson, President and CEO, tel: +46 70 271 20 14Torbjörn Clementz, CFO, tel: +46 70 869 07 88   About Kährs Holding AB (publ) Kährs Holding AB (publ) is a world-leading flooring manufacturer in hardwood and resilient flooring with a number of strong brands in its product portfolio, including Kährs, Karelia and Upofloor. The Company's innovations have shaped the industry throughout history and Kährs Group is dedicated to providing the market with innovative new flooring solutions. Kährs Group, which delivers products to more than 70 countries, is the market leader in Sweden, Finland, Norway and Russia and holds a strong position in other key markets, such as the UK and Germany. The Group has approximately 1,600 employees and annual sales of EUR 300 million. www.kahrsgroup.com

Nel ASA: Awarded contract for hydrogen production and 3 fueling stations for Iceland

(Oslo, February 13th, 2017) Nel Hydrogen Solutions, a division of Nel ASA (Nel, OSE: NEL) has been awarded a contract by Icelandic Hydrogen for three H2Station® hydrogen fueling stations and a NEL C-series electrolyser. “We are delighted to open up this new market for hydrogen powered vehicles together with a leading player like Skeljungur. With this collaboration we continue our successful and proven joint venture approach already applied in markets like Denmark and Norway,” says Jon André Løkke, CEO of Nel ASA. Initially Icelandic Hydrogen will establish three hydrogen fueling stations connected to central renewable hydrogen electrolysis production, and aiming at a continuous long-term expansion of the network along with FCEV deployments to meet a growing hydrogen fuel demand. Icelandic Hydrogen is a newly established joint venture (“JV”) between the major Icelandic oil retail company Skeljungur HF (owning 90%) and Nel ASA (owning 10%), the purpose of the JV is to establish a network of hydrogen fueling stations and renewable hydrogen production in Iceland.  Skeljungur is a stock exchange listed, major oil retail company operating in Iceland and the Faroe Islands, with more than 75 service stations throughout the countries and more than 200 employees. Skeljungur will provide the JV with locations for hydrogen fueling and retail operational expertise. Nel will provide both hydrogen production and fueling equipment as well as operational experience from more 30 hydrogen fueling station installations across Europe. “We choose Nel as a partner for this project based on their vast experience in supporting hydrogen fueling networks as well as their leading cutting-edge technology solutions. With 100% renewable and domestic based electricity supply, we aim to make hydrogen a lower cost option for the end consumer compared to gasoline – this will also help to reduce national fuel imports.  This contract is a part of a plan to introduce multi-fuel ecofriendly stations in Iceland,” says Valgeir M. Baldursson, CEO of Skeljungur HF. The contract has a total value of more than EUR 4 million. The target is to start shipping equipment towards the end of 2017 and install during 2018. Almost 80% of the population in Iceland will be within reach of one of the three hydrogen fueling stations, making it the highest share for any country in the world. Skeljungur, Nel, Icelandic New Energy and leading automotive manufactures will call for a press conference and a workshop at the end of first quarter 2017 regarding the commercial introduction of hydrogen in Iceland, station roll-out and fuel cell cars. This effort is supported by the European Fuel Cells and Hydrogen Joint Undertaking as part of the major H2ME-2 demonstration project – www.h2me.eu., with participation of leading automotive car manufacturers as they are preparing market introduction of FCEVs to Iceland in the coming years. ENDS For additional information, please contact: Jon André Løkke, CEO, +47 9074 4949 Bjørn Simonsen, VP Market Development and Public Relations, +47 971 79 821 About Nel Hydrogen | www.nelhydrogen.com       Nel Hydrogen is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today.

The first Sjöberg Prize, totalling 1 million US dollars, is awarded for discoveries that have led to new and effective cancer treatments

The Sjöberg Prize is an annual international prize in cancer research that is now being awarded for the first time. The prize is financed by the Sjöberg Foundation, and the Royal Swedish Academy of Sciences is responsible for selecting the Laureates. The foundation was founded in 2016 by the late businessman Bengt Sjöberg, who donated 2 billion Swedish krona, one of the biggest donations in Swedish history. “We are delighted that we can encourage future cancer research by awarding this prize to two such outstanding researchers. Their discoveries have led to improved cancer treatment for thousands of people and we are proud to be awarding them the first Sjöberg Prize. Their high-quality research represents the Sjöberg Foundation’s idea and purpose of inspiring and aiding new efforts in the work to fight cancer,” says the donor’s brother, Ingemar Sjöberg, Chairman of the Sjöberg Foundation. The prize totals 1 million US dollars and is shared equally between the Laureates. It is divided into a personal award of 100,000 US dollars and a grant for future research of 900,000 US dollars. This year, the research being rewarded has opened up two entirely new ways of treating cancer. James Allison investigated how the white blood cells known as T cells are activated, and how a specific “brake” signal could be prevented. He realised that when this brake is removed, the immune system can use its full potential to attack tumour cells. These discoveries have resulted in the cancer pharmaceuticals that are called immune checkpoint inhibitors and which are of decisive significance in treating melanoma. They are also used in treating other forms of cancer and numerous clinical trials are underway. “I am honored and humbled to be a recipient of the first Sjöberg Prize, and feel that it acknowledges the effort of all those who worked to translate fundamental understanding of immunological processes into treatment strategies that are saving the lives of many cancer patients,” says James Allison. James P. Allison was born in 1948 in Alice, Texas, USA. He is professor and Vivian L. Smith Distinguished Chair in Immunology at The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Tony Hunter studied how normal cells become tumour cells, demonstrating that a special process was necessary: tyrosine phosphorylation. His discovery led to the development of a new type of cancer pharmaceutical, tyrosine kinase inhibitors. These have revolutionised the treatment of chronic myeloid leukaemia (KML) and are also of great benefit in other forms of cancer.  “I am deeply honoured to have been recognized by the inaugural Sjöberg Prize. It is very gratifying that our work on a simple chicken tumour virus has ultimately led to new and effective therapies for human cancer, with 26 tyrosine kinase inhibitor drugs currently approved for clinical use,” says Tony Hunter. Tony Hunter was born in 1943 in Ashford, Kent in the United Kingdom. He is an American Cancer Society Professor and Renato Dulbecco Chair, and Deputy Director of the Salk Institute Cancer Center at the Salk Institute for Biological Studies, La Jolla, California, USA.   The award ceremony will be during the Royal Swedish Academy of Sciences’ Annual Meeting on 31 March 2017 in the presence of His Majesty the King and Her Majesty the Queen of Sweden. The laureates will hold open lectures at Karolinska Institutet on 30 March. Further information, press photos and illustrations for editorial use are available at: http://kva.se/sjobergprize CONTACT ExpertsBengt Westermark, Chairman of the prize committeeProfessor of Tumor Biology+46 70 818 18 44bengt.westermark@igp.uu.se Rune Toftgård, Secretary of the prize committeeProfessor of Environmental Toxicology+46 8 673 95 60rune.toftgard@kva.se The Sjöberg FoundationIngemar Sjöberg, Chairman of the Sjöberg Foundation+46 70 799 14 79info@sjobergstiftelsen.se

SWECO AB (publ) Year-end report 2016

October – December 2016           · Net sales increased to SEK 4,421 million (4,350), acquired growth was 1 per cent · EBITA excluding extraordinary items increased to SEK 478 million (390), margin 10.8 per cent (9.0) · EBITA increased to SEK 395 million (200), margin 8.9 per cent (4.6) · EBIT increased to SEK 378 million (179), margin 8.6 per cent (4.1) · Profit after tax increased to SEK 276 million (86), corresponding to SEK 2.30 per share (0.75) January – December 2016           · Net sales increased to SEK 16,531 million (11,389), acquired growth was 42 per cent · EBITA excluding extraordinary items increased to SEK 1,482 million (991), margin 9.0 per cent (8.7) · EBITA increased to SEK 1,336 million (740), margin 8.1 per cent (6.5) · EBIT increased to SEK 1,249 million (681), margin 7.6 per cent (6.0) · Net debt decreased to SEK 1,558 million (1,688) · Net debt/EBITDA decreased to 1.0 times (1.8). Net debt/EBITDA pro forma and excluding extraordinary items was 0.9 times (1.2) · Profit after tax increased to SEK 931 million (439), corresponding to SEK 7.78 per share (4.36) · The Board of Directors proposes a dividend distribution of SEK 4.30 per share (3.50) Comments from President and CEO Tomas Carlsson: Sweco is ending a record year with its strongest quarter to date. EBITA excluding extraordinary items is up 35 per cent for the full year and 23 per cent for the quarter, compared with last year’s pro forma. The improvement is mainly due to synergies from the Grontmij integration. Synergies are estimated to be 20 per cent higher and realised in half the time relative to initial estimates, while extraordinary items are expected to be 11 per cent lower. Close to 90 per cent of the synergies and essentially all extraordinary items were realised by the end of the quarter. With the integration largely completed, this is the last report in which we will comment on the Grontmij integration in detail. Our focus forward is on Sweco’s further development. With a strong financial position and as the market-leading architecture and engineering consultancy in Europe, Sweco is well positioned for continued value-creating growth. Our strategy for the future is to repeat our history. Sweco’s operational model remains focused on customers, internal efficiency and having the best people in our business. We will continue to expand our Northern European footprint, through acquisitions and organic growth. Overall, the market for Sweco’s services is good. The Swedish market is strong. The markets in Norway, Denmark, Western Europe and Central Europe are generally good. The markets in Finland and the Netherlands remain challenging.

Kindred Group plc - Year end report January – December 2016 (unaudited)

“Another very strong quarter with EBITDA up 48 per cent and EPS up 54 per cent despite betting duties increasing by 67 per cent.” “High volumes of activity and strong growth across all products have continued in the fourth quarter bringing a new all-time high in Gross winnings revenue of GBP 152.8 million, up 37 per cent on last year (+ 16 per cent in constant currency). Despite some favorites winning in December, the sportsbook margin after Free Bets was in line with prior year” “EBITDA grew by 48 per cent in GBP to 38.9 million. It represents an all-time high and continues to prove the scalability of our business model and our ability to face and absorb the impact of regulatory changes. Betting duties increased by 67 per cent compared to the same period last year.” “Of the Group’s Gross winnings revenue 35 per cent was from locally regulated markets. Gross winnings revenue from the mobile channel grew by 74 per cent and accounted for 71 per cent of total Gross winnings revenue in the fourth quarter.” “The strong performance of the Group resulted in an increase in free cash flow of 57 per cent in the fourth quarter. The Board is proposing a cash dividend of GBP 0.310, a growth of 32 per cent compared to the previous year.” “In the period up to 12 February 2017, average daily Gross winnings revenue in GBP was 36 per cent higher compared to the same period in 2016. Adjusting for the impact of exchange rate changes, the growth was 21 per cent,” says Henrik Tjärnström, CEO of Kindred Group. Today, Tuesday 14 February 2017, Kindred Group’s CEO Henrik Tjärnström will host a presentation in English at FinancialHearings, Tändstickspalatset, Västra Trädgårdsgatan 15, in Stockholm at 9.00 CET. Please go to www.financialhearings.com/event/6517 to sign in. The presentation is also webcast live on www.kindredplc.com. For those who would like to participate in the telephone conference in connection with the presentation, the telephone number is UK: +44 20 3008 9804 or in the USA: +1 855 831 5946. The Kindred Group companies hold local gambling licences in UK, France, Belgium, Denmark, Germany (Schleswig-Holstein), Italy, Australia, Ireland, Romania and Estonia. The Kindred Group also holds international gambling licences in Malta and Gibraltar. The Kindred Group pays betting duties in all markets in accordance with applicable local laws

Sale of shares in Nordax Group AB (publ)

Vision Capital Partners VII LP (Guernsey LP) and Vision Capital Partners VII A LP (Guernsey LP) (together “Vision Capital”), have sold 15,058,347 shares in Nordax Group AB (publ) (“Nordax”) through an accelerated bookbuilding to Swedish and international investors at a price of SEK 51.00 per share (the “Placing”). Following settlement of the Placing, Vision Capital will no longer hold any shares in Nordax. Carnegie Investment Bank AB and Morgan Stanley & Co. International plc have acted as joint bookrunners in connection with the Placing. Vision Capital,14 February 2017 IMPORTANT NOTICE  THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL, OR SOLICITATION OF AN OFFER TO BUY, ANY SECURITIES IN THE UNITED STATES. THE SECURITIES REFERRED TO HEREIN HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") AND MAY NOT BE SOLD IN THE UNITED STATES ABSENT REGISTRATION WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT. THERE WILL NOT BE A PUBLIC OFFERING OF THE SHARES IN THE UNITED STATES. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES OR INVESTMENTS FOR SALE OR A SOLICITATION OF AN OFFER TO BUY SECURITIES OR INVESTMENTS IN ANY JURISDICTION WHERE SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL. NO ACTION HAS BEEN TAKEN THAT WOULD PERMIT AN OFFERING OF THE SECURITIES OR POSSESSION OR DISTRIBUTION OF THIS ANNOUNCEMENT IN ANY JURISDICTION WHERE ACTION FOR THAT PURPOSE IS REQUIRED. PERSONS INTO WHOSE POSSESSION THIS ANNOUNCEMENT COMES ARE REQUIRED TO INFORM THEMSELVES ABOUT AND TO OBSERVE ANY SUCH RESTRICTIONS. ANY FAILURE TO COMPLY WITH THESE RESTRICTIONS MAY CONSTITUTE A VIOLATION OF THE SECURITIES LAWS OF ANY SUCH JURISDICTION. IN MEMBER STATES OF THE EUROPEAN ECONOMIC AREA ("EEA") (EACH, A "RELEVANT MEMBER STATE"), THIS ANNOUNCEMENT AND ANY OFFER IF MADE SUBSEQUENTLY IS DIRECTED EXCLUSIVELY AT PERSONS WHO ARE "QUALIFIED INVESTORS" WITHIN THE MEANING OF THE PROSPECTUS DIRECTIVE ("QUALIFIED INVESTORS"). FOR THESE PURPOSES, THE EXPRESSION "PROSPECTUS DIRECTIVE" MEANS DIRECTIVE 2003/71/EC (AND AMENDMENTS THERETO, INCLUDING THE 2010 PD AMENDING DIRECTIVE, TO THE EXTENT IMPLEMENTED IN A RELEVANT MEMBER STATE), AND INCLUDES ANY RELEVANT IMPLEMENTING MEASURE IN THE RELEVANT MEMBER STATE AND THE EXPRESSION "2010 PD AMENDING DIRECTIVE" MEANS DIRECTIVE 2010/73/EU. IN THE UNITED KINGDOM THIS ANNOUNCEMENT IS DIRECTED EXCLUSIVELY AT QUALIFIED INVESTORS (I) WHO HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS FALLING WITHIN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (THE "ORDER") OR (II) WHO FALL WITHIN ARTICLE 49(2)(A) TO (D) OF THE ORDER, AND (III) TO WHOM IT MAY OTHERWISE LAWFULLY BE COMMUNICATED. IN CONNECTION WITH THE PLACING, THE JOINT BOOKRUNNERS AND ANY OF THEIR AFFILIATES ACTING AS AN INVESTOR FOR ITS OWN ACCOUNT MAY TAKE UP AS A PRINCIPAL POSITION ANY SHARES AND IN THAT CAPACITY MAY RETAIN, PURCHASE OR SELL FOR ITS OWN ACCOUNT SUCH SHARES. IN ADDITION, THE JOINT BOOKRUNNERS OR THEIR AFFILIATES MAY ENTER INTO FINANCING ARRANGEMENTS AND SWAPS WITH INVESTORS IN CONNECTION WITH WHICH THE JOINT BOOKRUNNERS (OR THEIR AFFILIATES) MAY FROM TIME TO TIME ACQUIRE, HOLD OR DISPOSE OF SHARES. THE JOINT BOOKRUNNERS DO NOT INTEND TO DISCLOSE THE EXTENT OF ANY SUCH INVESTMENT OR TRANSACTIONS OTHERWISE THAN IN ACCORDANCE WITH ANY LEGAL OR REGULATORY OBLIGATION TO DO SO. THE JOINT BOOKRUNNERS ARE ACTING ON BEHALF OF THE SELLERS AND NO ONE ELSE IN CONNECTION WITH THE PLACING AND WILL NOT BE RESPONSIBLE TO ANY OTHER PERSON FOR PROVIDING THE PROTECTIONS AFFORDED TO CLIENTS OF THE JOINT BOOKRUNNERS OR FOR PROVIDING ADVICE IN RELATION TO THE PLACING.

Q-FREE – FOURTH QUARTER AND PRELIMINARY FULL YEAR RESULTS 2016

Q4 2016 * 241 MNOK in revenues, up 23% from 197 MNOK in Q4-15 * 7 MNOK in EBITDA. Performance negatively impacted by 12 MNOK in inventory write-down and work in progress principle adjustments in Q-Free UK * 196 MNOK in order intake, 55 MNOK in announced and 141 MNOK in unannounced orders * 1.4 bn NOK in order backlog, 615 MNOK scheduled for delivery in 2017 * Cost savings program initiated in Q3-16 finalized with 50 MNOK in annual gross OPEX savings as promised * 134 MNOK in gross proceeds from private placement in October, cash flow further improved due to good cash management FY 2016 * 877 MNOK in revenues, up 14% from 767 MNOK in 2015 * 11 MNOK in EBITDA vs 69 MNOK in 2015 before restructuring charges * 1 575 MNOK in order intake due to signing of largest ever tolling contract in Slovenia (472 MNOK) and largest ever ATMS contract with Virginia Department of Transportation in USA (200 MNOK) POST Q4 2016 * The Security Division divested for a net consideration of 10 MNOK * Security business is reported as “Discontinued Operations” and excluded from 2015 and 2016 Profit and Loss, Balance sheet and Cash Flow statements. -In the fourth quarter of 2016, Q-Free has taken a number of actions to pave the way for profitable growth in 2017. We have built a record-high order backlog, the financial structure has been significantly improved, operational expenses have been reduced, and the business scope has been narrowed. Q-Free is now well positioned to generate double digit revenue growth and deliver attractive margins in 2017, comments CEO of Q-Free ASA, Håkon Volldal. Enclosures: Q4-16 report and presentation For further information, please contact: President & CEO, Håkon Volldal: +47 977 19 973 CFO, Roar Østbø: +47 932 45 175 About Q-Free Q-Free is a leading global supplier of ITS (Intelligent Transportation Systems) products and solutions. The company has approximately 420 employees, offices in 20 countries, and presence on all continents. Headquartered in Trondheim, Norway, Q-Free is listed on the Oslo Stock Exchange under the ticker QFR. www.q-free.com Twitter: @Q-FreeASA

Moberg Pharma AB Year-end report 2016

 PERIOD (FULL YEAR 2016) * · Net sales SEK 334.3 million (285.6) · EBITDA SEK 77.9 million (46.4) · EBITDA for Commercial Operations SEK 93.5 million (68.5) · Earnings before interest and taxes (EBIT) SEK 62.2 million (35.2) · Net profit after tax SEK 32.7 million (25.5) · Earnings per share SEK 2.25 (1.77) · Operating cash flow per share SEK -1.24 (2.12) · The Board of Directors proposes that no dividend be paid for the 2016 financial year FOURTH QUARTER (OCT-DEC 2016) · Net sales SEK 89.4 million (53.7) · EBITDA SEK 12.0 million (4.0) · EBITDA for Commercial Operations SEK 17.5 million (8.6) · Earnings before interest and taxes (EBIT) SEK 7.1 million (1.1) · Net profit after tax SEK -2.5 million (0.4)** · Loss per share SEK -0.17 (0.03) · Operating cash flow per share SEK 0.36 (0.16) *The results include a capital gain of SEK 41.1 million in the second quarter from the divestment of the Jointflex®, Fergon® and Vanquish® brands** Earnings before tax was positive. Additional tax bookings related to transactions resulted in a negative net profit after tax in Q4. However, please note that the company has deferred tax assets and corporate tax paid therefore is insignificant. SIGNIFICANT EVENTS DURING THE FOURTH QUARTER · The acquisition of Dermoplast® from Prestige Brands in the U.S. was completed on December 30, 2016. The purchase price was USD 47.6 million (SEK 433.2 million), plus inventory value, and the brand is expected to become the company’s second-largest product. The acquisition was financed through directed new share issues worth a total of SEK 148 million, a bond issue of SEK 215 million and available cash and cash equivalents. · Divestment of PediaCare® to Strides Arcolab International Limited, UK for a total consideration of USD 5.6 million, USD 0.6 million of which comprised inventory value. · European patent granted for BUPI. The patent is expected to remain in force until 2031. · Redemptions of stock option schemes increased the number of shares and votes by 279,150, while the new issues implemented in conjunction with the acquisition of Dermoplast® increased the number of shares and votes by 2,843,504, to a total of 17,411,842 shares. SIGNIFICANT EVENTS AFTER THE END OF THE QUARTERAdditional distribution secured for New Skin® Spray through Walmart and Walgreens. CEO COMMENTARY The acquisition of Dermoplast® in December finalized a transformative year for Moberg Pharma. Acquisitions totalled USD 88 million and significantly strengthened our brand portfolio. Furthermore, we increased the market share for our lead brand Kerasal Nail® to record-levels in the U.S. and progressed MOB-015 to gain regulatory approval to start Phase 3 as well as initiated patient enrolment. As for Q4, we delivered strong growth in sales and tripled EBITDA fueled by recent acquisitions. Recent acquisitions ensured continued profitable growthIn the fourth quarter, the company continued to deliver profitable growth with significant contribution from recently acquired brands, in particular New Skin®, increasing net sales by 67% to SEK 89 million with EBITDA tripling to SEK 12 million. In the U.S., Kerasal Nail grew market share in Q4 compared to last year, despite limited advertising during the low-season, and the market share for the full year grew to 27%, an increase with 4% compared to last year. We also secured important new distribution on New Skin® Spray in Walmart and Walgreens. These gains provide momentum as we head into 2017. Distributor sales, excluding divested brands, were up in volume in 2016 but down 6% in value due to volume discounts in key markets. The Asia-Pacific region represents a long-term growth opportunity and several of our markets have already performed very well. However, there are other markets in the region that need more time and will require refined strategies. Transformative acquisitions strengthened the brand portfolioWe completed successful acquisitions totaling USD 88 million in 2016 in line with our buy-and-build strategy for the commercial portfolio. Since the acquisitions were primarily debt-financed, the dilution to shareholders was limited. Dermoplast® is expected to become our second largest brand, contributing to sales and profitability from day one through our current sales channels in the U.S. Moreover, in addition to enabling further economies of scale, Dermoplast® offers an interesting direct sales channel to hospitals for us to develop. We were also pleased to complete the divestment of PediaCare®, releasing cash and resources for our core brands. The integration of New Skin and Fiber Choice® was finalized in Q4 and according to plan. Advancing our Phase 3 assetsWe are entering the year with two high potential pipeline assets in Phase 3. MOB-015 and BUPI both have the potential to become market leaders in their respective niches, taking Moberg Pharma to a whole new level. Following feedback from the FDA, we will include additional patients into the MOB-015 trial in North America. In total, our Phase 3 program is planned to include 750-800 patients. The increased sample size and a diligent screening process will reduce the risk of the Phase 3 program and, according to our revised timeline, we expect enrollment to be finalized during the second half of 2017. As for BUPI, we received patent approval in the EU and have been granted Scientific Advice meetings with two EU Health Authorities in March. The progress of both pipeline assets enables us to initiate discussions with potential commercialization partners. We expect the total investments in our Phase 3 assets to remain in line with previous estimates, approximately USD 20 million during 2016-2018. A significantly stronger companyOne year ago, we set high goals for 2016 and announced a plan of significant investments. I am proud to report that we delivered on these goals and that the results to date of these investments are meeting or exceeding our expectations. We start the New Year as a significantly stronger company than one year ago and I am excited about our prospects to create value. The transformative and immediately accretive acquisitions completed last year will more than double our U.S. sales, while the pipeline assets are progressing in line with our long-term growth strategy. Peter Wolpert, CEO Moberg Pharma TELEPHONE CONFERENCECEO Peter Wolpert will present the report in a conference call at 3 p.m. today,February 14, 2017. Phone +46 (0)8 566 426 95 ABOUT THIS INFORMATIONMoberg Pharma discloses the information provided herein pursuant to the Securities markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 8:00 am (CET) on February 14th, 2017.

Interim report fourth quarter and year-end report 1 january-31 december 2016

Fourth quarter 2016 ·Order intake rose 11% to SEK 3,434 million (3,086). For comparable units the increase was 1%. ·Net sales rose 9% to SEK 3,499 million (3,219). For comparable units, net sales decreased by 2%. ·Operating profit before amortisation of intangible non-current assets attributable to acquisitions (EBITA) decreased by 2% to SEK 391 million (398), corresponding to an EBITA margin of 11.2% (12.4%). ·Net profit decreased by 3% during the quarter, to SEK 249 million (258), corresponding to earnings per share of SEK 2.08 (2.14) 1). 1 January–31 December ·Order intake rose 9% to SEK 13,004 million (11,939). For comparable units the increase was 2%. ·Net sales rose 9% to SEK 12,955 million (11,881). For comparable units the increase was 2%. ·Operating profit before amortisation of intangible non-current assets attributable to acquisitions (EBITA) rose 4% to SEK 1,484 million (1,427), corresponding to an EBITA margin of 11.5% (12.0%). ·Net profit for the year rose 5% to SEK 936 million (894), corresponding to earnings per share of SEK 7.80 (7.44) 1). ·Cash flow from operating activities was SEK 1,207 million (1,076). ·The Board of Directors proposes a dividend of SEK 3.20 (3.00)1) per share for 2016. ·Bo Annvik was appointed as new President and CEO, and will take office at the Annual General Meeting on 26 April 2017. CEO'S MESSAGE With sales of SEK 13 billion and EBITA of SEK 1.5 billion, 2016 was once again a record year in the Group’s history. In a time of challenging market conditions in several segments, we have managed to continue generating profitable growth through acquisitions and development of existing companies, which shows the strength of Indutrade’s model. Fourth quarter After the third quarter’s weaker growth, both order intake and invoicing improved during the fourth quarter. Order intake increased by 11% and invoicing by 9%. In general, the trend in most markets has been stable. In Finland, much to our pleasure, we are seeing a clear improvement in the business situation following a long period of weak demand. In addition, most of the Group’s companies performed well during the quarter and delivered results that were well in line with expectations. During the quarter, lower order intake and outgoing deliveries as well as production disruptions of valves for power generation in the energy segment significantly affected comparisons with the preceding year in the Special Products business area. The investment in greater manufacturing capacity is resulting in greater opportunities for development of the valve programme in the long run. The total earnings impact compared with the fourth quarter a year ago was SEK -50 million, of which SEK -10 million pertains to costs for getting the new plant up and running. The challenging business situation, with soft demand and strong price pressure for companies in the marine segment, also continued during the fourth quarter. Lower invoicing together with restructuring costs had a significant negative earnings impact on the Flow Technology business area. AcquisitionsDuring the quarter the Scanmaskin Group, which makes surface finishing equipment, was acquired. A total of 11 acquisitions were made in 2016 with combined annual sales of SEK 1,130 million. Nine of the acquired companies have own products, which strengthens the long-term trend in the Group towards having a larger share of proprietary products. Our ambition since 2005 has been to increase the share of companies in measurement and sensor technology, so it is gratifying to note that four of the acquisitions carried out in 2016 are in this segment. In early 2017 three acquisitions have been carried out: RS Technics, which is active in measurement technology in the Netherlands; Sunflower Medical, which makes healthcare equipment in the UK; and Ellard, which manufactures control equipment for commercial doors in the UK. Outlook Since its stock market introduction in 2005 Indutrade has had a fantastic development. We have increased the share of companies with own products and own manufacturing. We have also expanded the business model outside of Sweden and the Nordic countries, and the number of companies during this time has grown from some 60 to more than 200 today. To enable this growth, the organisational structure has also developed, and today we have an organisation with six business areas that ensure that we can make full use of the experience and expertise that exists out in our companies. The cornerstones of Indutrade’s decentralised business model are firmly grounded, and I am convinced that Indutrade, through its ongoing evolution, has all the conditions needed for future profitable growth. Johnny Alvarsson President and CEO

Opus Group appointed Lothar Geilen as next CEO

“I am very pleased that Lothar Geilen has accepted his assignment as the new CEO”, says Katarina Bonde, Chairman of the board of directors for Opus Group. “Lothar has been with the company for nine years and knows the business inside out. During this period, he has been a key member of the senior management and has been instrumental in taking the company to a leading international vehicle inspection company. The world has a great need for our services and we have adopted a new five-year growth plan doubling the size of the company. I am convinced Lothar is the perfect candidate to take on this task.” “I am looking forward to taking on this new challenge of managing the company through the next growth period”, stated Lothar Geilen. “My focus will be on international expansion, on applying our leading technology position to market needs and on corporate sustainability”, Geilen continued. Lothar Geilen has been employed by Opus Group since 2008. He co-founded the U.S. company Systech International in 2000 and continued with Opus Group as head of the Vehicle Inspection Division after Systech was acquired by Opus Group in 2008. Lothar holds a Dipl.-Kfm. degree from Ludwig-Maximilian University in Munich, Germany. Magnus Greko will step down from the position as CEO of Opus Group to take on a newly established position in the Opus Group management team as Vice President Strategic Business Development. With Opus Group’s newly adopted five-year growth plan focused on entering new markets and finding acquisition targets, an increased emphasis on strategic business development is essential. “I am very pleased with Opus Group’s performance during the eleven years I have been CEO of Opus Group as a listed company. We have created a great platform for further expansion and I believe this is a good time to hand over the controls to Lothar Geilen while I will focus on strategic business development. I am convinced that Lothar will be a great CEO of Opus Group”, says Magnus Greko. Mölndal, February 14, 2017Opus Group AB (publ)

400/100/25: Opus Group’s new 5-year strategic plan

In a press conference at 10:00 CET on February 14 in Stockholm, Opus Group, one of the world’s leading vehicle inspection companies, will present its new five-year growth strategy. At the same time, Opus Group will introduce its new organization. The company plans to expand its business operations in Europe, Latin America and the U.S. & Rest of World to double its revenues by 2021. Growth in established markets will come primarily from U.S. emission inspection equipment revenues through the EaaS business model, and the introduction of the new technology offerings Remote Assisted Programming (RAP Service) and FASTLIGN®. The company expects that the revenues from the vehicle inspection business in Sweden and the U.S. will be flat at good EBITDA margins. Globally, the company expects significant growth to come from vehicle inspection programs in low and middle income countries. By 2021, Opus Group estimates revenues of USD 185 million in the U.S.; USD 120 million in Europe; USD 50 million in Latin America and USD 45 million primarily in Asia. In order to support the growth plan, Opus Group is strengthening its group management team (GMT) and organization. The GMT will be increased from four to eight members and will consist of: CEO, CFO, CTO, a VP Strategic Business Development, a Director of Corporate Communications and IR and the segment leaders for Europe, Latin America, U.S. & Rest of World. Mölndal, February 14, 2017Opus Group AB (publ)

Year-end report 2016

January  – December 2016 · Net sales amounted to SEK 1,697.2 million (1,650.2), a revenue growth of 2.8 percent before adjustments for acquired and divested businesses. Adjusted for the acquisition of Drew Tech and the divestment of Opus Equipment the FX adjusted organic revenue growth amounted to 5.7 percent. · Operating profit before depreciation and amortization (EBITDA) amounted to SEK 332.0 million (274.6), corresponding to an EBITDA margin of 19.5 percent (16.6), and an EBITDA growth of 20.9 percent. · Net financial income/expense includes net foreign exchange gain of SEK 53.4 million (26.1). · Profit for the period amounted to SEK 85.4 million (66.4). · Earnings per share after dilution amounted to SEK 0.29 (0.23). · Cash flow from operating activities amounted to SEK 204.2 million (201.2). · The Board proposes a dividend of SEK 0.12 (0.10) per share October – December 2016 · Net sales amounted to SEK 430.3 million (411.4), a revenue growth of 4.6 percent (0.5 percent FX adjusted). · Operating profit before depreciation and amortization (EBITDA) amounted to SEK 67.8 million (58.3), corresponding to an EBITDA margin of 15.7 percent (14.2) and an EBITDA growth of 16.3 percent. · Net financial income/expense includes net foreign exchange gain of SEK 33.6 million (-3.6). · Profit for the period amounted to SEK 21.4 million (3.0). · Earnings per share after dilution amounted to SEK 0.08 (0.01). · Cash flow from operating activities amounted to SEK 39.2 million (44.6). Mölndal, February 14, 2017Opus Group AB (publ)

Exercise of Thule Group Warrant Series 2014/2017

The Thule Group Warrant Series 2014/2017 has been completed and as a consequence hereof the number of shares in the company will increase by 1,036,455. The total number of shares in the company will thereafter amount to 102,072,910.All newly subscribed shares have been sold. The subscription price for the shares was SEK 105.70 per share and Thule Group AB (publ) has received total issue proceeds of approximately SEK 109.6m in connection with the exercise of the warrants.The warrants in Warrant Series 2014/2017 have been held by the CEO, other senior executives and the Chairman of the board (in total eight individuals). The terms for determining the exercise price for the warrants has led to that the ceiling for the highest realization value was reached at a share price of SEK 120.60.In connection with the exercise of the series, Thule AB repurchases 208,333 warrants from Frederic Clark and 12,940 warrants from Schuyler Horton, both American citizens, which for regulatory reasons have not been subject of the placement. These warrants will be canceled without being exercised. The purchase price for the repurchased warrants has been set to their market value, corresponding to SEK 8.1m.Following the transaction, the CEO, management and Chairman of the board remain as significant shareholders of the company and together hold approximately 1.5 percent of the shares in the company, corresponding to a value of approximately MSEK 214 based on the closing share price on Monday February 13, 2017.

YEAR-END REPORT, January–December 2016

Fourth quarter of 2016       · Consolidated net sales increased by 6 percent to SEK 440 m (415), of which organic growth amounted to 3 percent · Net sales for Product & Solutions amounted to SEK 298 m (293) and net sales for Installation Services amounted to SEK 158 m (139) · Operating profit (EBIT) before items affecting comparability increased by 8 percent and amounted to SEK 42 m (39) · Operating profit (EBIT) increased by 84 percent to SEK 39 m (21) · Operating cash flow amounted to SEK 125 m (118)[1] · Earnings per share before and after dilution were SEK 1.13 (0.31) January–December 2016 · Consolidated net sales increased by 5 percent to SEK 1,813 m (1,720), of which organic growth amounted to 5 percent · Net sales in Products & Solutions amounted to SEK 1,341 m (1,304) and net sales for Installation Services amounted to SEK 560 m (493) · Operating profit (EBIT) before items affecting comparability increased by 23 percent and amounted to SEK 224 m (182) · Operating profit (EBIT) increased by 45 percent to SEK 206 m (143) · Operating cash flow amounted to SEK 211 m (197) · Earnings per share before and after dilution were SEK 6.49 (3.40) · The Board proposes a dividend of SEK 3.75 per share [1] Note: the definition of Operating cash flow has been revised to reflect changes as of Q3 2015 in net working capital excluding items affecting comparability.Unless otherwise stated, figures within parentheses refer to the preceding year or the corresponding period in the preceding year in respect of income statement and/or cash flow items and the end of the preceding year or the corresponding period in the preceding year in respect of balance sheet items. For definitions of financial and alternative key performance indicators, please see page 21.    Message from the CEO Record results and delivering on external growth commitment I am proud to report our best year ever, in terms of both sales and financial results. Consolidated net sales for the fourth quarter rose by 6 percent, from SEK 415 m to SEK 440 m. EBIT before items affecting comparability for the fourth quarter increased by 8 percent compared with the corresponding period in 2015. For the full-year 2016, net sales increased by 5 percent, from SEK 1,720 m in 2015 to SEK 1,813 m in 2016. EBIT before items affecting comparability for the full-year increased by 23 percent and reached SEK 224 m (182), while the operating margin was 12.3 percent (10.6). Compared to our previously communicated expectations, the satisfying profit during the fourth quarter was helped by favorable weather conditions in all the Nordic countries. The good financial performance for the year was based on the combination of organic growth in most of our markets, and a favorable development of our cost position. In line with our strong operating result, our operating cash flow amounted to SEK 211 m (197). This has led to further significant strengthening of our financial position, and net debt decreased to SEK 25 m at the end of 2016. This will allow the Board to propose a dividend of SEK 3.75 per share, while leaving room for further acquisitions. In the beginning of 2017 we made two acquisitions, thus delivering on our commitment to developing our business through both internal and external growth. EPDM Systems is a Dutch prefabricator of EPDM based waterproofing solutions, with a business model similar to that of our Belgian operation. SPT-Painting is a Finnish provider of liquid waterproofing solutions for buildings, outdoor surfaces and ships. This latter acquisition represents an addition to our existing product and services portfolio, in a growing market segment. Nordic Waterproofing is one of Northern Europe’s leading producers and providers of products and related services for waterproofing, protecting and preserving buildings and infrastructure. Consolidated net sales in the fourth quarter of 2016 showed growth of 6 percent compared with the corresponding period in 2015, from SEK 415 m to SEK 440 m, with both of our operating segments contributing. While our Products & Solutions operating segment reported a sales increase of 2 percent, our Installation Services operating segment achieved an increase of 13 percent, based on improved demand in Finland. Denmark continued to see a very favorable demand trend. Our Swedish operations continued to be soft following weaker demand in both ROT- related DIY sales and sales of infrastructure project-related products. Sales in Norway in the fourth quarter increased 22 percent compared with corresponding period in 2015, primarily as a result of increased market share in direct sales to flat roofing customers. The Finnish market developed stably, mainly due to seasonal effects. The order inflow in the fourth quarter was slightly lower than the exceptionally strong corresponding quarter last year. Sales in the Product & Solutions operating segment increased despite weaker sales in Sweden. Earnings for the segment increased compared with the previous quarter, as well as compared with the corresponding quarter in 2015. The Installation Services operating segment also reported improved result as both the Finnish subsidiaries and the Danish franchise companies continued to perform well during the fourth quarter. Our total order book for Installation Services remains at an acceptable level compared with the corresponding period in 2015. The demand situation is in line with the seasonal variations. Earnings per share for the quarter were up, from SEK 0.31 to 1.13. Earnings per share for the full-year of 2016 were SEK 6.49 (3.40), an increase of 91 percent. I am pleased to welcome two new companies, EPDM Systems of the Netherlands and SPT-Painting of Finland, to Nordic Waterproofing. The acquisition of EPDM Systems, a leading Dutch prefabricator, highlights our strategy of strengthening our prefabrication footprint in those European countries where EPDM has significant market share. Prefabrication of EPDM-based waterproofing offers two important advantages versus on-site work: better efficiency through faster installation and better quality production in a controlled factory environment. We intend to continue developing both geographically and in terms of complementary prefabrication solutions for roofs and façades. Finnish company SPT-Painting, which operates in the growing floor coating market, has a strong market position. We expect to find synergies with it since SPT-Painting and our existing Installation Services serve overlapping customer groups. This acquisition is an important addition to our existing product categories. Good integration of the acquired companies is critical to success, and it is our view that the most determining factors for achieving such an integration are highly experienced and motivated management teams. I am pleased to report that bot EPDM Systems and SPT-Painting have such teams. Our growth strategy is based on organic growth and participating in trends towards systematic offerings and prefabrication. We continue to establish our brands in the Norwegian market using best practices developed in our other core markets. In addition to growing our EPDM platform in relevant European markets, we will continue to strengthen our market position by enhancing the product portfolio we offer our distribution channels. I take this opportunity to welcome Esa Mäki to Nordic Waterproofing, effective 1 April 2017. Esa has extensive experience in the markets we serve, and will be heading our Finnish business with the objective to realize the Group’s ambitions for further profitable expansion in both our Product & Solutions and Installation Services segments. I also want to thank Jaakko Tuominen for his considerable and longstanding efforts to the development of our Finnish business, and for having been an anchor through changing and challenging environments. I am very pleased that Jaakko has agreed to stay on as senior adviser in the Group. Vejen, 14 February 2017 Martin Ellis,President and CEO  Conference callA conference call for investors, analysts and media will be held today, 14 February 2017, at 10:00 a.m. CET and can be joined online at www.nordicwaterproofing.com (https://wonderland.videosync.fi/2016-11-15-nordic-waterproofing-holding-q3-report). Presentation material for the call will be available on the website one hour before the call. To participate, please dial:From the United Kingdom:      +44 20 3008 9801From Denmark:                        +45 82 33 31 78From Sweden:                        +46 8 566 426 92  Further information can be obtained fromMartin Ellis, President and CEO                             tel: +45 31 21 36 69Jonas Olin, CFO                                                  tel: +46 708 29 14 54Anders Antonsson, Investor Relations                    tel: +46 709 99 49 70 This information is information that Nordic Waterproofing Holding A/S is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 14 February 2017, 08:00 a.m. CET.

YIT to construct a terminal project for Posti in Vantaa, Finland

YIT has signed a contract with Posti to carry out a terminal project in Viinikkala, Vantaa, Finland. The construction of the terminal property of 26,000 square metres is intended to begin in March and it will be completed in summer 2018. The total value of the project for YIT is approximately EUR 29 million. The project is located in K3 Logistics business area, developed by YIT, between Ring III and Helsinki Airport. “The location of the terminal is ideal regarding material flows of Posti and our customers. The terminal meets the needs of Posti’s increasing freight volumes”, says Jaakko Kaidesoja, Head of Posti’s transport services. “The new generation logistics terminal designed by Posti and YIT together represents the cutting edge of the field both technically and functionally”, says Heikki Lähdesniemi, Project Development Manager for the project at YIT. “We will continue to construct both this significant terminal and at the same time the whole K3 business area in the logistic core of the capital region”, says Kalle Isometsä, Head of Unit at YIT. For further information, please contact: Hanna Jaakkola, Vice President, Investor Relations, YIT Corporation, tel. +358 40 5666 070, hanna.jaakkola@yit.fi    Kalle Isometsä, Head of Unit, YIT Construction Ltd., tel. +358 40 519 5967, kalle.isometsa@yit.fi YIT CORPORATION Hanna Jaakkola Vice President, Investor Relations Distribution: NASDAQ Helsinki, major media, www.yitgroup.com YIT creates better living environment by developing and constructing housing, business premises, infrastructure and entire areas. Our vision is to bring more life in sustainable cities. We want to focus on caring for customer, visionary urban development, passionate execution and inspiring leadership. Our growth engine is urban development involving partners. Our operating area covers Finland, Russia, the Baltic countries, the Czech Republic, Slovakia and Poland. In 2016, our revenue amounted to nearly EUR 1.8 billion, and we employ about 5,300 employees. Our share is listed on Nasdaq Helsinki. www.yitgroup.com

Probi appoints Jörn Andreas as new CFO

Probi AB (publ) has appointed Jörn Andreas as CFO. Andreas will replace Niklas Brandt who will remain in Probis leadership team as CIO with responsibility for IT infrastructure and Investor relations. Jörn Andreas comes from a role as CFO for the Pinova group within Symrise. He has also worked as CFO for the Diana Group, as Director of Corporate development and M&A at Symrise as well as a consultant of the Boston consulting group.  He has also served as a director on Probis board since 2014. “Jörn Andreas has a proven international track record as CFO and in complex M&A projects, his skills and experience is a perfect match for the next stage of development at Probi which is combining strong organic growth with acquisition growth. Jörn also knows the company very well from his time on the board which will give him a flying start.” says Peter Nählstedt, CEO of Probi. “I would like to thank Niklas Brandt for his excellent work and many years of service as Probi CFO and I am confident he and Jörn Andreas will be very successful in their new roles at Probi.” “Probi has made tremendous progress in developing into a global leading probiotics group. I very much look forward to my new role at Probi and to further building our growth platform driven by world-class innovation, strong financials and a passionate team,” says Jörn Andreas. Jörn Andreas will assume his new position on March 1st2017 and will as a result resign from Probis board of Directors. FOR FURTHER INFORMATION, CONTACT:Peter Nählstedt, CEO, Probi, tel +46 46 286 89 23, e-mail: peter.nahlstedt@probi.se ABOUT PROBIProbi AB is a Swedish publicly traded bioengineering company that develops effective and well-documented probiotics. Through its world-leading research, Probi has created a strong product portfolio in the gastrointestinal health and immune system niches. Probi’s products are available to consumers in more than 30 countries worldwide. Probi’s customers are leading food, health-product and pharmaceutical companies in the Functional Food and Consumer Healthcare segments. In 2016, Probi generated sales of MSEK 444. Probi’s shares are listed on Nasdaq Stockholm, Mid Cap. Probi has about 4,700 shareholders. For more information, please visit www.probi.se.

The Nomination Committee at Probi AB proposes new Board members

The Nomination Committee of Probi AB proposes to the AGM 2017 the election of Anna Malm Bernsten, Charlotte Hansson and Scott Bush as new members of the Board. Furthermore, the Nomination Committee proposes the re-election of the Chairman of the Board Jean-Yves Parisot, as well as the Board members Jan Nilsson and Jonny Olsson. Eva Redhe and Benedicte Fossum have declined re-election. Jörn Andreas has stepped down from the Board with immediate effect as he will take up the position of CFO at Probi on 1 March 2017, which has been previously communicated by the company. “I would like to take this opportunity to express our thanks to Eva Redhe and Benedicte Fossum for their efforts and contribution to the fantastic growth and development of Probi during the many years they have served as board members.”, says Jean-Yves Parisot, Chairman of the Board. Anna Malm Bernsten runs a consultancy business in the area of international business development, strategy, management and brand management issues. Anna has long and in-depth experience of Life Science including as President and CEO at Carmeda AB, as well as having held senior positions at Pharmacia, ASSA ABLOY AB and GE Healthcare. She has extensive experience of Board work, including as Chairman of the Board of Medivir and Board member of Cellavision AB, Arcam AB and Neurovive AB. Up until year-end 2016, Anna was Chairman of Oatly AB. She has a Masters degree in chemical engineering from the Royal Institute of Technology in Stockholm. Charlotte Hansson is CEO of MTD; Morgontidig Distribution KB. Charlotte has extensive experience of Board work in listed and state-owned companies, including B&B Tools AB, BE Group AB and Orio AB. Charlotte has more than 20 years’ commercial experience of Transport/Logistics as well as from the Life Science sector and has held a number of leading positions, including that of CEO for Jetpak Sweden. Charlotte has a Bachelor of Science in Biochemistry from Copenhagen University and holds a diploma in marketing from IHM.  Scott Bush has more than 20 years’ experience in leading positions in the probiotic industry, serving most recently as Global Director in the probiotics segment at DuPont. Scott has also held leading, global positions at Danisco and Rhodia. Scott, who is American and resident in the US, is a Board member of the International Probiotics Association and runs his own consultancy company through Probiotic Consulting LLC. Scott has a Bachelor of Science in food science, and an MBA, Finance from the University of Wisconsin. The Nomination Committee has conducted an assessment of the proposed Board to verify that it is appropriately composed and fulfils the requirements that can be made of the Board based on the company’s current and future situation. The Nomination Committee is of the opinion that the Board members, based on their experiences and personal attributes, possess the skills and knowledge required to contribute to continued profitable growth and share performance at Probi. Other proposals from the Nomination Committee will be presented in the notice of the Annual General Meeting, which will be held in Lund on Thursday, 4 May 2017 at 3:00 p.m. at the Elite Hotel, Ideon Gateway, Scheelevägen 27, Lund, Sweden. FOR FURTHER INFORMATION, CONTACT:Jannis Kitsakis, 4e AP-fonden, member of the Nomination Committee, jannis.kitsakis@ap4.se, tel: +46 706 03 80 23 ABOUT PROBIProbi AB is a Swedish publicly traded bioengineering company that develops effective and well-documented probiotics. Through its world-leading research, Probi has created a strong product portfolio in the gastrointestinal health and immune system niches. Probi’s products are available to consumers in more than 30 countries worldwide. Probi’s customers are leading food, health-product and pharmaceutical companies in the Functional Food and Consumer Healthcare segments. In 2016, Probi generated sales of MSEK 444. Probi’s shares are listed on Nasdaq Stockholm, Mid Cap. Probi has about 4,700 shareholders. For more information, please visit www.probi.se.

MINING ASSOCIATES’ SUBSIDIARY EUROMIN LIMITED, HAS SUBSCRIBED FOR 1 351 533 SHARES AT THE SECOND SUBSCRIPTION

Mining Associates, a highly respected, independent, international mining Consulting- and Investment firm, has by a directed share issue, through its 100% owned subsidiary EuroMin Limited subscribed for the Second Subscription of 1,351,533. The Directed Share IssueThe Board of Directors resolved, under an authorization granted by the Annual General Meeting on March 17th 2016 to issue 2,750,105 shares to EuroMin Limited. The right to subscribe for the shares shall, with derogation from the shareholders’ pre-emption rights, only vest in EuroMin Limited. EuroMin Limited has in 2 tranches subscribed shares for about 2,6 % of outstanding shares and votes. The subscription price was SEK 3.50 per share at both tranches, totally SEK 9,625,367.50 (about 1 million euro).  -  First Subscription: EuroMin Limited subscribed for 1,398,572 shares at a total price of SEK 4,895,002 paid in December and registered in January 2nd 2017 at Swedish Companies Registration Office. -  Second Subscription: EuroMin Limited subscribed for 1,351,533 shares at a total price of SEK 4,730,365.50, paid but not yet registered. Both EuroMin Limited, and its parent company Mining Associates Limited, are registered in Hong Kong, where Mining Associates is headquartered. The main motivation for the Investment is that it is deemed important and in the Company's interest to bring a new shareholder with extensive global mining knowledge into the Company and to secure financing, necessary for the development of the Silver Mine. The Board of Directors and Mining Associates believe that the subscription price corresponds to the shares market value at the time for signed agreement.  Stockholm, February 14th 2017 Timo Lindborg, CEO  Sotkamo Silver AB discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The official Stock Exchange Releases are given in Swedish and there may be differences in the translated versions.  About Mining Associates:Mining Associates is a leading global geological, resource and mining consultancy, headquartered in Hong Kong, with offices in Australia, United Kingdom and Canada. Our Consulting Business provides expert technical advice across a wide range of mineral commodities, geological settings and mining methods on a diverse range of projects globally. Our technical skills range from exploration to full feasibility studies, mine development, mining operations and closure. Mining Associates capital arm seeks projects where we see capital value growth opportunities or short paths to production and cash flow. Mining Associates unlocks value in mineral assets by expanding resources, merging assets, solving technical roadblocks or revising development concepts. About Sotkamo Silver AB:Sotkamo Silver AB´s business concept is to exploit mineral deposits in the Nordic countries with positive social and environmental benefits. Sotkamo Silver owns mineral deposits, which contain silver and gold in Finland as well as zinc and gold in Norway. The Company’s main development project is the Silver Mine project in the municipality of Sotkamo. Sotkamo Silver applies SveMin’s & FinnMin’s respective rules of reporting for public mining & exploration companies. Sotkamo Silver has chosen to report mineral resources and ore reserves according to the internationally accepted JORC or NI 43-101 code. The company applies International Financial Reporting Standards (IFRS) as approved by the European Union. Number of shares and votes are 103,215,990 before the registration of this issue at the Swedish Companies Registration Office. Number of shares and votes after the registration of this issue is 113,527,267. The ticker symbol is SOSI in NGM Equity in Stockholm and SOSI1 in NASDAQ OMX Helsinki. ISIN-code for Sotkamo Silver shares is SE0001057910. ISIN- code for share warrants series 2016/2017 are SE0008373880 Legal Entity Identifier (LEI): 213800R2TQW1OZGYDX93  Read more about Sotkamo Silver on www.sotkamosilver.com or www.silver.fi  Read more about Mining Associates on www.miningassociates.com

ABB strengthens digital offering by acquiring leading pioneer in 3D inspection technology

The acquisition expands the group’s portfolio of ABB Ability™ solutions that connect customers to the industrial Internet of Things. ABB Ability builds on the intelligent cloud, using connected devices to generate actionable digital information for a broad range of customers. The two companies have agreed not to disclose the value of the transaction. NUB3D is a privately owned company headquartered in Barcelona. It supplies 3D white-light scanning sensor technologies, using digital scans to optimize inspection and quality assurance in manufacturing. The sensors can detect defects on a manufactured part with an extremely high level of accuracy. By combining NUB3D’s proven world-class competence in 3D vision and metrology with ABB’s brand, worldwide reach, and offering and customer support, ABB will be able to create automated turnkey inspection and quality-control systems for automotive original equipment manufacturers, aerospace companies and customers in other sectors such as metals and plastics. The technology represents the future of flexible manufacturing, enabling a high level of automation with advanced data analysis that can be used to optimize production processes. NUB3D will become part of the Robotics business of ABB’s Robotics and Motion division and the new global application center for 3D metrology in ABB. “With this acquisition we are moving a step closer to the factory of the future. As our customers’ automation processes become more advanced and production cycles shorten, the ability to efficiently automate quality inspections becomes a compelling competitive advantage,” said Sami Atiya, President of ABB’s Robotics and Motion division. “Combining robotics and software is pivotal in implementing digitalization and expanding ABB Ability as a key driver of our Next Level strategy.” Manufacturers increasingly have to improve quality and productivity while accommodating greater product variation and customization in smaller lots. NUB3D’s 3D sensor technology rapidly records and compares highly detailed geometric and surface data with digital CAD models, enabling the automation of inspection of manufactured parts and pieces, helping factories to reduce cycle times while raising quality and reducing the risk of quality control errors. Jorge Rodriguez, CEO of NUB3D, added, “This is the perfect time and ABB is the perfect partner for us to accelerate our expansion into the growing 3D metrology market. The ABB Ability platform perfectly complements our use of cutting-edge digital solutions, and ABB’s leading robotics portfolio and vast global footprint will ensure that we can make the most of our early-mover advantage in integrated robotic inspection solutions.” ABB and NUB3D have already successfully introduced two fully robotized state-of-the-art automatic quality inspection solutions for off- and in-line inspection using NUB3D’s 3D white-light sensors. They are marketed under the names FlexInspect and InspectPack.

TROAX: YEAR-END REPORT 2016

OCTOBER – DECEMBER 2016 · Order intake increased by 21 per cent, or 26 per cent adjusted for acquisition and currency. · Sales increased 14 per cent to 31,9 (27,9) MEUR, or 19 per cent adjusted for acquisition and currency. · Operating profit increased to 9,4 (6,6) MEUR. Redemption of bond has influenced the operating result positively in the period 0,6 (0,0) MEUR. · Operating margin increased to 29,5 (23,7) per cent. · Profit after tax increased to 6,4 (4,3) MEUR. · Earnings per share was 0,32 (0,22) EUR. · Acquisition of Folding Guard, one of the market leading businesses in the North American market. JANUARY – DECEMBER 2016 · Order intake increased by 15 per cent, or 16 per cent adjusted for acquisition and currency. · Sales increased 12 per cent to 115,8 (103,7) MEUR, or 13 per cent adjusted for acquisition and currency. · Operating profit increased to 25,3 (22,4) MEUR. Result has been influenced by cost for starting up the new paint line and increased market investments. · Operating margin increased to 21,8 (21,6) per cent. · Profit after tax was 16,3 (13,7) MEUR. · Earnings per share was 0,82 (0,69) EUR. · The board suggest a dividend of 3,75 (3,00) SEK (Swedish Krona) per share. CEO COMMENTS During the fourth Quarter 2016, Troax showed an increased strength in the development of orders received. This increased by 21 per cent (26 per cent excluding currency and acquisitions). The development in continental Europe and UK are especially positive. We have not seen any effect of Brexit in the UK so far. In the Nordic areas the finish of the year was strong. New Markets have seen an acceptable increase, albeit these markets still have relatively low absolute figures. At the year end, the order book remains on a good and healthy level. One of the market leading producers on the American market, Folding Guard was acquired end of 2016. Sales invoiced increased in the quarter by 14 per cent, compared with the same period last year (excluding acquisition and currency the increase is 19 per cent). The progress was positive in all markets. Totally, the Group has increased to an order intake level of approximately 119 MEUR on a rolling 12 months’ basis, excluding Folding Guard in USA which was acquired in late December 2016. Folding Guard’s turnover in 2016 was approximately 18 MEURO. The result has improved during the quarter, mainly because of good sales volumes, but also due to the fact that the main extra costs for the new paint line in its inauguration phase are now over. The market investments are continuing according to plan. The operating result therefore becomes 9,4 (6,6) MEUR, which corresponds to a profit margin of 29,5 per cent to be compared with 23,7 per cent last year. Redemption of bond has influenced the operating result positively in the period 0,6 (0,0) MEUR. The Net result has also developed in a positive way, and amounts to 6,4 MEUR for the quarter (4,3 MEUR). The result per share, after the third quarter is 0,82 EURO to be compared with 0,69 EURO last year. The Working Capital is on a similar level as last year. Work in Progress, has been reduced and is now at a normal level for the Group. We have continued with good cash generation during the quarter and the net debt is now 63,9 MEUR. Thomas Widstrand, President and CEO PHONE CONFERENCE Invitation to presentation of the fourth quarter result:Thomas Widstrand, CEO presents the result on a phone conference on the 14th of February 2017 at 16:30 CET.  The conference will be held in English.For more information please refer to www.troax.com. This information is information that Troax Group AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 12:30 CET on 14th of February, 2017.

Cinnober forms management team for new subsidiary, Patrick Tessier joins as COO

Cinnober (http://www.cinnober.com) recently announced the establishment of a new subsidiary that will provide real-time post-trade technology and services to investment banks. The new subsidiary will modernize client clearing operations, a business area tightly squeezed by new regulatory obligations, higher capital requirements, and high spending on legacy IT infrastructures. The first member of the management team to be announced is Patrick Tessier, who is joining the company as COO this week. Tessier’s most recent position was Global Head of Futures and OTC Clearing Operations at Citi. Before that, he was EMEA Head of ETD Operations at UBS Investment Bank. Previous positions include CEO London Northern Europe at GL Trade, and European Head of Listed Derivatives Operations at Credit Suisse. Tessier will be based in London together with a team of experts in bank clearing, back office, and risk management. Software development will be carried out primarily in Sweden, where Cinnober has its two main offices. I am very happy to welcome Patrick to the Cinnober family,” says Veronica Augustsson, CEO of Cinnober. “He brings very valuable experience with a background of top positions in global investment banks. We both agree that these institutions have an enormous potential to improve and to become more efficient with our modular, real-time solution.” Cinnober is the leading independent provider of financial technology to exchanges and clearinghouses. The subsidiary will adapt and bring Cinnober’s award-winning real-time clearing technology to global investment banks and brokers. The solution will enable its customers to get a real-time view of risk exposure across asset classes, clients, and CCPs. For the second consecutive year, the underlying technology was named as Post-Trade Initiative of the Year by Financial News. Cinnober’s customers include major exchanges with extreme demands on reliability and performance, such as the Australian Securities Exchange, BM&FBOVESPA, Dubai Gold & Commodities Exchange, Euronext, Japan Exchange Group, Johannesburg Stock Exchange, the London Metal Exchange, LME Clear, NYSE, and the Stock Exchange of Thailand. See also: Cinnober expands investment in real-time clearing for banks (https://www.cinnober.com/press-room/cinnober-expands-investment-in-real-time-clearing-for-banks) (Nov 9, 2016). For further information or discussion, please contact:Fredrik BacklundHead of Corporate CommunicationsCinnober Financial TechnologyTel. +46-73 403 12 39fredrik.backlund@cinnober.com About CinnoberCinnober provides solutions and services to leading trading and clearing venues, including exchanges, clearinghouses, banks and brokers. Cinnober’s solutions are largely based on the TRADExpress™ Platform, incorporating everything needed for mission-critical solutions in terms of performance, robustness and flexibility. The portfolio of offerings includes price discovery and matching, real-time risk management, clearing and settlement, index calculation, data distribution and surveillance. Cinnober’s customers include the Australian Securities Exchange, BM&FBOVESPA, Dubai Gold & Commodities Exchange, Euronext, Japan Exchange Group, Johannesburg Stock Exchange, the London Metal Exchange, LME Clear, NYSE and the Stock Exchange of Thailand. For additional information, please visit www.cinnober.com

Nuevolution Technology Progress: Nuevolution scales its compound collection to 40 trillion using its Chemetics™ drug discovery platform

Stockholm, 14 February 2017. Nuevolution AB (publ) (NUE.ST) today announced the successful production and validation of its new ultra-high complexity library of 40 trillion (40,000,000,000,000) compounds. This library is roughly 10,000 fold larger than Nuevolution’s previous libraries, and likely constitutes the largest synthetic compound collection in the world. The 40 trillion (40T) library was assembled from the use of tens of thousands of individual fragments (building blocks) introducing an unprecedented chemical diversity. This library was produced with a key focus on hit identification for the many important and very tough-to-drug therapeutic targets not easily addressed by other approaches. The first 40T screening against a small subset of such difficult targets have identified both novel compound scaffolds and compounds with picomolar potency (extreme and very unusual potency) for their target, directly from the library without any further optimization performed. “The result demonstrates the great power of our Chemetics™ drug discovery platform. It supports both the growing Nuevolution pipeline and discovery programs for current and future collaboration partners”, said Dr. Thomas Franch, CSO, and continued: “The 40T library has been in the making for about two years, and we are very pleased by now being able to bring this extraordinary library into service in our search for novel and innovative medicines”. For more information, please contact: Thomas Franch, CSO Phone: +45 7020 0987 Email: tf@nuevolution.com Henrik D. Simonsen, CFO Phone: +45 3913 0947 Email: hs@nuevolution.com About Chemetics™ The Nuevolution Chemetics™ platform technology comprises proprietary methods enabling DNA-encoding of compound libraries for fast and cost efficient screening of disease targets. Nuevolution annually produces up to eight Chemetics™ libraries. For further details see Nuevolution homepage: www.nuevolution.com. About Nuevolution Nuevolution AB (publ) is a leading small molecule drug discovery biotech company founded in 2001, headquartered in Copenhagen, Denmark. Nuevolution partners its proprietary discovery platform and programs with pharmaceutical and biotechnology companies to seek future benefit for patients in need of novel medical treatment options. Nuevolution’s internal programs are focused on therapeutically important targets within inflammation, oncology and immuno-oncology. This information is information that Nuevolution AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was sent for publication, through the agency of the contact persons set out above, on Tuesday 14 February 2017, 13:00 CET. Nuevolution AB (publ) is listed at Nasdaq First North Premier in Stockholm, Sweden (ticker: NUE.ST). Redeye AB acts as Certified Adviser to Nuevolution AB (publ). More information about Nuevolution can be found at: www.nuevolution.com.

IFS and The Marsden Group collaborate on IoT offering for the oil and gas sector

The Marsden Group is a global technology company specialized in developing advanced analytics in support of IoT solutions for the upstream oil and gas market. From its offices in the United States, Europe, and Australia, the company serves some of the largest companies in the oil and gas sector. The combination of the IFS IoT Business Connector (http://www.ifsworld.com/corp/solutions/ifs-applications/iot-business-connector/) and The Marsden Group’s platform for IoT data discovery, machine learning and advanced analytics, oil and gas companies are able to monitor, capture, and analyze relevant IoT data, enabling timely action and optimized decision making in critical areas such as maintenance and supply chain management. “We are excited to announce our partnership with The Marsden Group, which is a highly visible and well-respected brand in the oil and gas sector,” IFS Global Industry Director for Oil and Gas, Hege Wroldsen said. “The Marsden Group brings long and deep industry experience, which is evident in the comprehensive nature of its IoT offering. Together, we will be able to offer a solution that de-risks and accelerates IoT initiatives.” The Marsden Group President, Andrew J. Pratt said, “By working together, we will be able to bring to market a comprehensive solution based on industry best practices. This means empowering customers with the right data at the right time in order to trigger the right action. For the asset-intensive oil and gas sector, IoT brings invaluable benefits in areas such as predictive maintenance and supply chain management. We look forward to a long and mutually beneficial partnership with IFS.” More information about how IFS supports companies in the oil and gas industry can be found here: www.ifsworld.com/corp/industries/oilfield-service-software/.

The Marketing Group’s Australian Subsidiary Channelzero Completes Acquisition of The Content Agency

· Acquisition bolsters Channelzero’s video content generation service offering · Purchase consideration of €106,500 will result in share capital increase of 59,497 shares Stockholm, 14 February, 2017 – THE MARKETING GROUP PLC (“the Group”), the world’s first digital marketing and advertising agglomeration, announces that Channelzero Pty Ltd (“Channelzero”), its wholly-owned Australian creative branding subsidiary, has completed the acquisition of The Content Agency Pty Ltd (“The Content Agency”), a provider of premium video content and content strategies based in Sydney, Australia. The Content Agency team’s expertise lies in target demographic user data generation as well as strategies for audience engagement aligned to business goals, the addition of which meaningfully augments Channelzero’s current service offering. Clients of The Content Agency include leading brands such as Studio Canal, Study Adelaide, University of Technology Sydney, The University of Newcastle Australia, Universal Music Group, Transdev and BBC Worldwide.  Commenting on the acquisition, Mikey Taylor, Chief Executive Officer of Channelzero said, “The acquisition of The Content Agency expands our capabilities within the video content space and brings an impressive list of new and exciting clients to Channelzero. We have seen increasing demand from our existing clients for recurring video production work and with this acquisition we are now able to service this demand in-house, adding a capability of growing importance to our business.” This acquisition marks the continuation of the Group’s strategy of adding mature, profitable, debt-free and well-managed private businesses that strengthens its position in major markets and diversifies its service offering and client base. The transaction was completed at a consideration of €106,500 and at the strike price of €1.79 per share (based on a 10-day volume weighted average price). This will result in the creation of 59,497 new ordinary shares. 75% of the new ordinary shares issued are subject to a 360-day lockup period. Adam Graham, Chief Executive Officer of The Marketing Group added: “I would like to welcome The Content Agency into The Marketing Group. This strategic acquisition further strengthens the Group’s presence in Australia and demonstrates our continuing ability to expand our service offering in key markets.” TheContentAgencyPty LtdLocation Sydney, Australia2016 AUD333,333Turnover2016 AUD44,030EBITDAKey Studio Canal, Study Adelaide, University of Technology Sydney, TheClients University of Newcastle Australia, Universal Music Group, Transdev and BBC Worldwide Key Video content strategy, video content production, video contentSynergies management Key Luke Hardiman, DirectorExecutiveWebsite www.thecontentagency.com.au -END- This information is information that The Marketing Group plc is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 04:30pm CET on 14th February 2017. For more information, please contact Stella TanDirector of CommunicationsE-mail: ir@marketinggroupplc.comSwedenClaes Delin / Mikael WidellPhone: +46 703 11 9960E-mail: claes.delin@cordcom.se  SingaporeMalcolm Robertson / Tom EvrardPhone: +65 6831 7829 / 9850 1998E-mail: ftiunitygroup@fticonsulting.com  The Marketing Group in brief The Marketing Group plc is a global marketing and advertising agglomeration comprising a portfolio of successful and independent digital marketing subsidiary businesses brought together under a central, publically-listed operating platform. Each company within the Group provides specialist marketing or advertising services and together form a global network of companies offering clients a full suite of services. The central operating platform supports its subsidiary companies with management and coordinating activities as well as a common publicly-listed investment vehicle. The Marketing Group is listed on Nasdaq First North Stockholm. www.marketinggroupplc.com. Mangold Fondkommission AB, +46 8-5030 15 50, is the Group’s Certified Adviser and liquidity provider.

BillerudKorsnäs issues SEK 1 700 million in bonds

BillerudKorsnäs has today successfully issued two bonds with a total nominal value ofSEK 1 700 million. The bonds have a maturity of 5 years and fall due on 21 February 2022. The fixed rate tranche of SEK 250 million pays a fixed coupon of 1.625% and the floating rate tranche ofSEK 1 450 million pays a floating coupon of three months STIBOR + 1.30%. The issue was made under the Medium Term Note program established in 2013. The program, with a limit of SEK 5 000 million has a total outstanding volume of SEK 3 500 million after the new issue. The bond issue was made to support the largest investment in the history of BillerudKorsnäs, a new board machine at the Gruvön site. The new board machine will enable the company to serve the growing demand for sustainable packaging solutions for food and beverages globally. Handelsbanken Capital Markets and SEB were Joint Bookrunners on the transaction. The bonds will be listed on NASDAQ OMX Stockholm. For further information, please contact: Per Norman, Group Treasurer, +46 (0)8 553 335 41Susanne Lithander, CFO, +46 (0)8 553 335 00 This information constituted inside information before publication. This is information that BillerudKorsnäs AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 17.00 CET on 14 February 2017.

Notice to attend the Extraordinary General Meeting of DDM Holding AG

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, SINGAPORE, CANADA, AUSTRALIA, NEW ZEALAND, HONG KONG, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. A.  Agenda and Proposals 1. Election of the Independent Proxy The Board of Directors proposes to elect Dr. Florian S. Jörg, attorney-at-law, c/o Bratschi Wiederkehr & Buob AG, Zurich, Switzerland, as independent proxy for a term beginning at the end of this EGM and ending after completion of the next annual general meeting. Explanation: Shareholders may choose to be represented at general meetings by an independent proxy elected by the general meeting. The Board of Directors thus proposes to elect Dr. Florian S. Jörg to serve as independent proxy. 2. Ordinary Capital Increase The Board of Directors proposes to increase the share capital of the Company from currently CHF 9,040,298.00 by up to CHF 4,520,149.00 to up to CHF 13,560,447.00 by issuing up to 4,520,149 fully paid-in registered shares with a nominal value of CHF 1.00 at an issue price of SEK 23.00 each. The newly issued shares shall not be privileged over the existing shares and shall not carry special benefits, be entitled to dividends for all of the business year 2017 and be subject to transfer restrictions as set forth in the Company’s articles of association. The pre-emptive subscription rights of the current shareholders are warranted. The Board of Directors shall be authorized to assign not exercised pre-emptive subscription rights to shareholders and interested third parties. Contributions for subscribed shares are to be made in cash. The agio of all newly subscribed registered shares shall correspond to the difference in CHF between the paid-in capital in the amount in SEK according to the SEK/CHF exchange rate published by Sveriges Riksbank on http://www.riksbank.se at the date of the registration of the capital increase in the daily register of the commercial register of the Canton of Zug and the total nominal value of these registered shares. For the smooth execution of the capital increase the newly issued registered shares shall be formally subscribed for by Carnegie Investment Bank AB, acting in the name, on behalf and for account of the subscribers who subscribed and contributed for shares to be newly issued. Explanation: DDM Holding AG acquires performing and non-performing financial assets from banks and other financial institutions primarily in Central and Eastern Europe.  The proposed ordinary capital increase will strengthen the Company’s balance sheet and provide additional funding for planned investments in the near to mid-term future and for general corporate purposes. B.  Participation and Voting Rights Shareholders registered with voting rights in the share register as of the close of business on 27 February 2017, will be authorized to participate and to vote at the EGM. From close of business on 27 February 2017 up to and including 8 March 2017, no entries will be made in the share register which would create a right to vote at the EGM. Shareholders who sell part or all of their shares before the EGM are no longer entitled to vote to that extent. Such shareholders are required to exchange their admission card and voting material to reflect the change in their shareholding. Shareholders who wish to participate or be represented at the EGM may either download the registration form via our website http://ddm-group.ch/investors or request a physical copy by e-mail to ddm@computershare.ch. The registration form should be completed and returned by mail or e-mail to the following address: Computershare Schweiz AG, General meetings, P.O. Box, 4609 Olten, Switzerland; e-mail: ddm@computershare.ch as soon as possible and ideally no later than 27 February 2017. Upon receipt of their registration form shareholders will be provided with an admission card and voting material (including proxy form) for the EGM. Shareholders (i) whose shares are registered in accordance with the Articles of Association of the Company in a securities register in accordance with the Swedish Financial Instruments Accounts Act (1998:1479) or otherwise in accordance with Swedish law and (ii) who hold such shares through a nominee must, in order to be entitled to attend and vote (in person, representation by proxy or by the Independent Proxy) at the EGM, temporarily register the shares in their own name. For the shares to be re-registered in time, such shareholders should instruct the nominee that manages the shares well in advance of 27 February 2017 for temporary re-registration, so called voting registration. After such shares have been registered in the shareholder’s own name, the shareholder shall follow the instructions as set out above in this section B. C.  Representation Shareholders who do not intend to participate personally at the EGM may participate and vote at the meeting through the representation of: –  the independent proxy, or –  a third person who need not be a shareholder; Mr. Florian S. Jörg, attorney-at-law, c/o Bratschi Wiederkehr & Buob AG, Zurich, Switzerland, has been appointed by the Board of Directors as the independent proxy for the EGM. Shareholders opting to be represented by the independent proxy shall submit the original of the completed and signed power of attorney (incorporated in the voting material) with voting instructions to Computershare Schweiz AG, General meetings, P.O. Box, 4601 Olten, Switzerland, ideally by no later than 4 March 2017. Shareholders may also vote by issuing electronic proxy and voting instructions to the independent proxy by voting through the online proxy voting platform www.ecomm-portal.com/shrd (http://www.ecomm-portal.com/shrd) until 7 March 2017, 11:59 am CET. Further details can be found on our website http://ddm-group.ch/investors. To the extent that a shareholder opts to be represented by the independent proxy but does not give the independent proxy specific voting instructions, the independent proxy will vote as proposed by the Board of Directors. If shareholders opt to be represented by a third person, their completed and signed original power of attorney (incorporated in the voting material) as well as their admission card and voting material should be sent directly to the address of their designated representative. D.  Shares and votes As of the date hereof, the share capital of the Company amounts to CHF 9,040,298.00, divided into 9,040,298 fully paid-in registered shares with a nominal value of CHF 1.00 each and thus a total of 9,040,298 votes. As of the same date, the Company does not directly or indirectly hold treasury shares.   DDM Holding AGFebruary 2017, for the Board of Directors Kent HanssonChairman The information was submitted for publication, through the agency of the contact persons set out above, at 18:00 CET on 14 February 2017. IMPORTANT INFORMATION This announcement is not and does not form a part of any offer for sale of securities. Copies of this announcement are not being made and may not be distributed or sent into the United States, Singapore, Canada, Australia, New Zealand, Hong Kong, Japan, South Africa or any other jurisdiction in which such distribution would be unlawful or would require registration or other measures. The securities referred to in this announcement have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and accordingly may not be offered or sold in the United States absent registration or an exemption from the registration requirements of the Securities Act and in accordance with applicable U.S. state securities laws. The Company does not intend to register any offering in the United States or to conduct a public offering of securities in the United States. The Offering of securities referred to in this announcement will only be made by means of a prospectus which will be registered with the Swedish Financial Supervisory Authority and subsequently made public and available on the Company's website (www.ddm-group.ch). This announcement is not a prospectus for the purposes of EU Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive"). Investors should not invest in any securities referred to in this announcement except on the basis of information contained in the aforementioned prospectus. In any EEA Member State other than Sweden that has implemented the Prospectus Directive, this communication is only addressed to and is only directed at qualified investors in that EEA Member State within the meaning of the Prospectus Directive, i.e., only to investors who can receive the offer without an approved prospectus in such EEA Member State. In respect of the United Kingdom, this communication is only being distributed to and is only directed at persons in the United Kingdom that are (i) investment professionals falling within Article 19(5) of the UK Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) high net worth entities, and other persons to whom this announcement may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “Relevant Persons”). This communication must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this communication relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. Persons distributing this communication must satisfy themselves that it is lawful to do so. This announcement does not constitute an issue or exchange prospectus as such term is understood pursuant to article 652a or article 1156 of the Swiss Code of Obligations, the listing rules of the SIX Swiss Exchange or the Swiss Federal Act on Financial Market Infrastructures and Market Conduct in Securities and Derivatives Trading. Matters discussed in this announcement may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as “believe,” “expect,” “anticipate,” “intends,” “estimate,” “will,” “may,” "continue," “should” and similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although the Company believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The information, opinions and forward-looking statements contained in this announcement speak only as at its date, and are subject to change without notice.

Saab Offers World Class Sensor Package for Indian Tejas LCA

Saab, in partnership with Indian industry, offers a solution that will bring the required Active Electronically Scanned Array (AESA) Fighter radar and Electronic warfare capability to India and the Indian Air Force. Thanks to our extensive technology development Saab can offer the latest technology, on time for the LCA Mk 1A needs, at low risk. The AESA fighter radar is developed by Saab with antenna technology based on the latest technologies using Gallium Nitride (GaN) and Silicone Carbide (SiC) substrates in combination with the latest generation of exciter/receiver and processor technology, giving optimum installed performance in a dense signal environment. The radar has a complete mode suite which includes air-to-air, air-to-ground and air-to-sea capabilities. A built-in memory provides a tool to record a large amount of data from performed flights. Integration in the LCA Mk1A fighter aircraft is enabled by the limited space, power and cooling required. The EW suite consists of sensors and transmitters developed by Saab and is a highly capable and extremely compact solution that provides essential situational awareness and self-protection. The heart of the suite is an electronic warfare receiver which is connected to a front end receiver and fin tip antennas inside the aircraft. Included is also an external AESA jammer pod. The radar warning system is based on ultra-wideband digital receivers and has very high probability of intercept, very good sensitivity and very high selectivity for handling the complex signal environment of today. The AESA jammer pod is small in size, low on weight and drag. Self-protection is based on Wideband Digital RF Memory (DRFM) that provides advanced jamming techniques and arbitrary combination of jamming waveforms. Transmission is performed by using GaN-based AESA:s. The EW suite also includes ground support systems and recording capability for advanced mission planning and post flight analysis. Saab’s solutions are based on the latest state-of-the-art technologies and COTS (commercial-off-the-shelf) available. The AESA fighter radar and electronic warfare units have no ITAR-restricted (Internationally Traffic in Arms Regulations) components, due to the high degree of Saab in-house developed and manufactured building blocks. Using contemporary technology provides the adaptability and growth potential needed to stay ahead. Technologies are re-used between variants and platforms in order to minimize Life Cycle Cost (LCC). “In our partnership, the transfer of technology will secure an indigenous Indian capability for series production, maintenance, repair and overhaul capability. Testing and development of the fighter sensor package will have synergies with the systems developed for Gripen,” says Anders Carp, head of Saab business area Surveillance. Saab has a proven background in tailoring systems to customer needs. This brings extensive experience from having open relations with customers when adapting advanced systems to new platforms. “Saab is a world leading company in the sensor area and has equipped some 4500 fighter aircraft with radar and electronic warfare systems. This has given us wide experience of successful sensor system integration, testing, and evaluation of radar and EW systems on fighter aircraft,” says Anders Carp. For further information, please contact:Saab Press Centre,+46 (0)734 180 018presscentre@saabgroup.com Regional contactVineet Khunger+91 98710 17080 www.saabgroup.comwww.saabgroup.com/YouTubeFollow us on twitter: @saab (http://www.saabgroup.com/YouTube) Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. 

Catena Media Year-end report January–December 2016

Fourth quarter of 2016 · Revenues totalled EUR 12.29 million (5.90), an increase of 108 percent compared with the same quarter for the previous year. · Adjusted operating profit excluding non-recurring IPO and bond expenses amounted to EUR 6.18 million (3.62), corresponding to an adjusted operating margin of 50 percent (61). Operating profit increased to EUR 5.75 million (2.90), corresponding to an operating margin of 47 percent (49). · Adjusted profit before tax excluding non-recurring IPO and bond expenses totalled EUR 4.87 million (3.62), whilst profit before tax amounted to EUR 4.44 million (2.90). · New depositing customers (NDCs) totalled 67,023 (24,779), an increase of 170 percent compared with the same quarter for the previous year and an increase of 19 percent when compared to the previous quarter. · Earnings per share amounted to EUR 0.079 (0.063). Year 2016 · Revenues totalled EUR 40.05 million (14.94), an increase of 168 percent compared to the previous year. · Adjusted operating profit excluding non-recurring IPO and bond expenses amounted to EUR 21.03 million (10.15), corresponding to an adjusted operating margin of 53 percent (68). Operating profit increased to EUR 18.65 million (8.98), corresponding to an operating margin of 47 percent (60). · Adjusted profit before tax excluding non-recurring IPO and bond expenses totalled EUR 19.89 million (10.16), whilst profit before tax amounted to EUR 17.51 million (9.00). · NDCs totalled 204,633 (69,331), an increase of 195 percent compared with the previous year. · Earnings per share amounted to EUR 0.319 (0.199).  Comment from Robert Andersson, CEO Another year of success with strong growth and solid results 2016 was the most eventful and successful year to date for Catena Media with continued strong growth and solid results. Looking back at what we have accomplished over the last twelve months is rather impressive. We have completed and integrated seven strategic acquisitions, entered three new markets, and concurrently broadened our offering, reached over 204,000 NDCs and increased the number of employees from 70 to 190. Moreover, we achieved two important milestones with the successful listing of Catena Media´s shares on Nasdaq First North Premiere and the issue of a three-year secured bond loan. Another successful quarter The fourth quarter was the company´s strongest ever with a top line growth of 108 percent when compared to the same quarter last year, coupled with a solid operating margin of 50 percent. As a result of the heavy investment in Paid media, as well as our investments in technology and the recruitment of new employees, our margin declined slightly. This is a natural consequence of our current strategy, which is focused on growth and increase in market share. Given the pace at which Catena Media is growing, being at the forefront of technology is an absolute necessity. We have therefore decided to invest further in technical development by reinforcing our Technical department with two outsourced teams in Budapest. While making two strategic acquisitions in the UK, we further advanced our market presence in the biggest iGaming market in Europe. Through the acquisition of SBAT, Catena will strengthen its focus on sports, as well as its social media know-how, and through Casinouk.com we have the opportunity to expand our offering in Paid media and Search. In terms of new markets, we entered the US in January by acquiring regulated affiliate assets targeting the Poker and Casino markets in New Jersey and Nevada. Following the acquisition, Catena Media adds three new verticals to its business. In addition to Poker, we also acquired websites targeting eSports and Daily Fantasy Sports. We are very excited about this opportunity, which makes Catena Media the largest regulated casino affiliate in the US, and puts us in pole position to take advantage of further re-regulation in what has the potential to become the world’s largest iGaming market.  Following this acquisition, about 50 percent of Catena Media´s revenue will derive from regulated markets.  We are also very pleased to note continued growth in our acquired assets and in the Sportsbook segment that we entered earlier this year. In addition, during December, we reached a record of 24,000 NDCs in one single month on our different sites. Looking forward I am highly positive and confident as we enter 2017. Our move to the Nasdaq Mid Cap list is progressing as planned and we aim to finalize the transition within the first half of 2017. As previously, our focus remains on delivering in line with our financial targets and on continuing to grow in the same successful way both through organic growth and through acquisitions across existing and new geographic markets. To conclude, I am really proud of what we have achieved in 2016. Catena Media is an extraordinary company with extraordinary people and together we will continue this exciting journey towards becoming the world´s number one provider of high-value iGaming leads. This information is information that Catena Media PLC is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on 15 February 2017, at 07:00 a.m. CET. 

Notice to Stockmann’s Annual General Meeting

STOCKMANN plc, Notice to general meeting 15.2.2017 at 8:00 EET Notice is given to the shareholders of Stockmann plc to the Annual General Meeting to be held on Thursday 23 March 2017 at 14:00 at Finlandia Hall in Helsinki (address: Mannerheimintie 13). The reception of participants who have registered for the meeting and the distribution of voting tickets will commence at 12:30. A. At the General Meeting, the following matters will be considered: 1. Opening of the Meeting 2. Calling the Meeting to order 3. Election of persons to confirm the minutes and to supervise the counting of votes 4. Recording the legality of the Meeting 5. Recording the attendance at the Meeting and adoption of the list of votes 6. Presentation of the Annual Accounts, the report by the Board of Directors and the Auditor’s report for the year 2016Review by the CEO 7. Adoption of the Annual Accounts 8. Resolution on the use of the profit shown on the balance sheet and the payment of dividendThe Board of Directors proposes that no dividend be paid for the financial year 2016. 9. Resolution on the discharge from liability of the members of the Board of Directors and the CEO 10. Resolution on the remuneration of the members of the Board of DirectorsThe Shareholders’ Nomination Board proposes that the annual remuneration of the members of the Board of Directors remain at the present level and that the net amount of the remuneration after taxes be paid in shares. The Chairman of the Board of Directors is proposed to be compensated EUR 76 000, the Vice Chairman EUR 49 000 and other members EUR 38 000 each for the term of office ending at the closing of the 2018 Annual General Meeting. Additionally, it is proposed that the Chairman of the Board be paid EUR 1 000 and each Board member be paid EUR 500 as a meeting remuneration for each meeting of the Board of Directors, the Chairman of the Audit Committee be paid EUR 1 000 and each member be paid EUR 700 as a meeting remuneration for each meeting of the Audit Committee, and the Chairman and each member of the Compensation Committee be paid EUR 500 as a meeting remuneration for each meeting of the Compensation Committee. Stockmann plc is responsible for the statutory social security and pension costs of non-Finnish members of the Board in accordance with the applicable national law. 11. Resolution on the number of members of the Board of DirectorsThe Shareholders’ Nomination Board proposes that the number of members of the Board of Directors remains eight (8). 12. Election of members of the Board of DirectorsThe shareholders’ Nomination Board proposes that the present members of the Board of Directors, Kaj-Gustaf Bergh, Jukka Hienonen, Susanne Najafi, Leena Niemistö, Michael Rosenlew, Per Sjödell and Dag Wallgren, all having given their consents, be re-elected for the term of office continuing until the end of the next Annual General Meeting. Board member Torborg Chetkovich has informed that she will no longer be available as member of the company's Board of Directors. The Nomination Board proposes that LL.M, M.Sc.(Econ.) Esa Lager with his consent, be elected new Board members for the term of office stated above. Esa Lager (b. 1959, Finnish citizen) is professional Board member and he has earlier had several management positions in the Outokumpu Group, e.g. as deputy to CEO and CFO. Biographical details of Esa Lager, as well as an evaluation regarding his independence, are available on the company’s website www.stockmanngoup.com. 13. Resolution on the remuneration of the auditorThe Audit Committee of the Board of Directors proposes that the auditors to be elected be reimbursed as per invoice approved by the Board of Directors. 14. Election of auditorThe Audit Committee of the Board of Directors proposes that Henrik Holmbom, Authorized Public Accountant and Marcus Tötterman, Authorized Public Accountant, be elected as auditors, both having given their consents. It is proposed that KPMG Oy Ab, a firm of Authorized Public Accountants, be elected as deputy auditor. 15. Appointment of the Shareholders’ Nomination BoardThe Board of Directors proposes that the Annual General Meeting resolves to appoint a permanent Shareholders’ Nomination Board to yearly prepare proposals on the composition and remuneration of the Board of Directors to the Annual General Meeting, and if necessary to an Extraordinary General Meeting, in accordance with the following. The Shareholders’ Nomination Board would consist of representatives appointed by each of the four largest shareholders. In addition, the Chairman of the Board of Directors would serve as an expert member. The right to appoint a representative belongs to the four shareholders who hold the largest share of voting rights in the company based on their shareholdings registered in the shareholders’ register maintained by Euroclear Finland Ltd on the first working day of September preceding the Annual General Meeting. Should a shareholder not wish to exercise his/her nomination right, the right shall be transferred to the next largest shareholder who otherwise would not be entitled to nominate a member. The Shareholders’ Nomination Board will be convened by the Chairman of the Board of Directors and it will elect a chairman from among its members. The Nomination Board is established to exist and serve until the Annual General Meeting decides otherwise. The members shall be nominated annually and their term of office shall end when new members are nominated to replace them. 16. Closing of the Meeting B. Documents of the General Meeting The proposals for the decisions on the matters on the agenda of the General Meeting as well as this notice are available on Stockmann plc’s website at www.stockmanngroup.com. The Annual Report, the report of the Board of Directors and the Auditor’s report of Stockmann plc, will be available on the above-mentioned website no later than 2 March 2017. The proposals for decisions and other documents mentioned above will also be available at the Meeting. Copies of these documents and of this notice will be sent to shareholders upon request. The minutes of the Meeting will be available on the above-mentioned website as from 6 April 2017. C. Instructions for the participants in the General Meeting 1. Shareholders registered in the shareholders’ registerEach shareholder who is registered on 13 March 2017 in the shareholders’ register of the company kept by Euroclear Finland Ltd is entitled to participate in the General Meeting. A shareholder whose shares are registered in his/her personal Finnish book-entry account is registered in the shareholders’ register of the company. A shareholder, who is registered in the shareholders’ register of the company and who wants to participate in the General Meeting, shall register for the Meeting no later than 17 March 2017 at 16:00 by giving a prior notice of participation to be received by the company no later than on the above-mentioned date. Such notice can be given: a) on the company’s website www.stockmanngroup.com;b) by telephone + 358 20 770 6891 (Euroclear Finland Ltd); orc) by regular mail to the following address: Stockmann plc, Annual General Meeting, P.O. Box 220, 00101 Helsinki, Finland. In connection with the registration, a shareholder shall state his/her name, personal identification number, address, telephone number and the name of a possible assistant or proxy representative and the personal identification number of a proxy representative. The personal data provided to Stockmann plc is used only in connection with the General Meeting and the processing of related registrations. 2. Holders of nominee registered sharesA holder of nominee registered shares has the right to participate in the General Meeting by virtue of such shares, based on which he/she, on the record date of the General Meeting, i.e. on 13 March 2017, would be entitled to be registered in the shareholders’ register of the company kept by Euroclear Finland Ltd. The right to participate in the General Meeting requires, in addition, that the shareholder on the basis of such shares has been registered in the temporary shareholders’ register kept by Euroclear Finland Ltd no later than on 20 March 2017 at 10:00 am. As regards nominee registered shares this constitutes due registration for the General Meeting. A holder of nominee registered shares is advised to request, without delay, necessary instructions regarding the registration in the temporary shareholder’s register of the company, the issuing of proxy documents and registration for the General Meeting from his/her custodian bank. The account management organization of the custodian bank will register a holder of nominee registered shares, who wants to participate in the General Meeting, in the temporary shareholders’ register of the company at the latest by the time stated above. 3. Proxy representative and powers of attorneyA shareholder may participate in the General Meeting and exercise his/her rights at the Meeting by way of proxy representation. A proxy representative shall produce a dated proxy document or otherwise in a reliable manner demonstrate his/her right to represent the shareholder at the General Meeting. When a shareholder participates in the General Meeting by means of several proxy representatives representing the shareholder with shares in different securities accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the General Meeting. Possible proxy documents should be delivered in originals to Stockmann plc, Annual General Meeting, P.O. Box 220, 00101 Helsinki, Finland before the last date of registration. 4. Other instructions and informationPursuant to chapter 5, section 25 of the Companies Act, a shareholder who is present at the General Meeting has the right to request information with respect to the matters to be considered at the Meeting. On the date of this notice to the General Meeting, 15 February 2017, Stockmann plc has a total of 30 530 868 Series A shares and 41 517 815 Series B shares representing 305 308 680 votes attached to Series A shares and 41 517 815 votes attached to Series B shares. Free parking is available in Q-Park Finlandia for participants in the Annual General Meeting. The venue’s doors will open at 12:30. Helsinki, 15 February 2017 STOCKMANN PLCThe Board of Directors Further information:Jukka Naulapää, Director, Legal Affairs, tel. +358 9 121 3850 www.stockmanngroup.com STOCKMANN plc Lauri VeijalainenCEO Distribution:Nasdaq HelsinkiPrincipal media

Stockmann Group's Financial Statement Bulletin 2016

STOCKMANN plc, Financial Statement Release 15.2.2017 at 8:00 EET October-December 2016:- Consolidated revenue was EUR 388.4 million (EUR 420.0 million).- Revenue in continuing product areas and businesses was down by 6.5 per cent.- Gross margin was up, to 53.5 per cent (51.0 per cent).- Adjusted operating profit was EUR 36.5 million (EUR 18.5 million).- Reported operating profit was EUR 33.8 million (EUR 4.3 million). January-December 2016:- Consolidated revenue was EUR 1 303.2 million (EUR 1 434.8 million).- Revenue in continuing product areas and businesses was down by 4.1 per cent.- Gross margin was up, to 53.4 per cent (50.6 per cent).- Adjusted operating profit was EUR 20.2 million (EUR -28.5 million).- Reported operating profit was EUR 17.6 million (EUR -52.5 million).- Reported earnings per share were EUR -0.33 (EUR -1.24). - Hobby Hall, which was divested on 31 December 2016, is included in the 2016 income statement in the Stockmann Retail segment.- Department store operations in Russia have been classified as discontinued operations. The comments in the report refer only to continuing operations. The Board of Directors will propose no dividend to be paid on the 2016 result. Outlook for 2017:Stockmann expects the Group’s revenue for 2017 to decline due to changes in the store network and product mix. Adjusted operating profit is expected to improve, compared with 2016. Due to normal seasonal variation, the first-quarter operating result will be negative. CEO Lauri VeijalainenI’m encouraged by the financial development achieved in 2016. The Group’s adjusted operating result improved by nearly EUR 50 million, producing a positive operating result after two years of heavy losses. Our improved profitability has reinforced our confidence that we are on the right path. The department stores’ offering is now focused on fashion, beauty, food and home products, and complemented by cafés, products and services from numerous attractive partners. Lindex continued to be the Group’s most profitable division in 2016. Its operating profit was up by EUR 10 million to EUR 55 million and it achieved its best ever sales for the first half of the year. Real Estate continued its positive development and increased its operating profit and also the fair value of Stockmann’s properties improved. Also, Stockmann Retail’s operating result improved significantly, by around EUR 20 million, but was still negative. The department stores improved their results, particularly in the last quarter of the year which ended up with a solid operating profit of EUR 14 million. Operating costs were down significantly due to the efficiency programme, and the improved gross margin. There is still a lot of work to be done to make the department store business profitable by the end of 2018, but I am confident that this target can be reached as planned. Stockmann will open a totally new department store in Tapiola in March. We will focus on offering inspirational customer experiences, appealing high-quality selections with dozens of new brands and excellent customer service. The speed will be increased further to achieve the turnaround and to redeem our promises to our customers, as well as to provide more reasons to visit our stores. Key figures Continuing operations 10-12/ 10-12/ 1-12/ 1-12/ 2016 2015 2016 2015Revenue, EUR mill. 388.4 420.0 1 303.2 1 434.8Gross margin, per cent 53.5 51.0 53.4 50.6Operating result, EUR mill. 33.8 4.3 17.6 -52.5Adjustments to operating 2.6 14.2 2.6 24.0result*, EUR mill.Adjusted operating result 36.5 18.5 20.2 -28.5(EBIT), EUR mill.Adjusted operating result before 51.9 37.9 79.4 43.4depreciation (EBITDA), EUR mill.Net financial costs, EUR mill. 9.1 7.2 23.1 21.2Result before tax, EUR mill. 24.7 -2.9 -5.5 -73.7Result for the period, EUR mill. 22.4 -19.1 -18.2 -88.9Earnings per share, undiluted, 0.29 -0.27 -0.33 -1.24EURPersonnel, average 8 422 10 151 9 006 10 763 Continuing and discontinued 1-12/operations 2015Net earnings per share, 0.36 -1.26 -0.12 -2.43undiluted, EURCash flow from operating 96.1 97.0 41.5 17.2activities, EUR mill.Capital expenditure, EUR mill. 14.7 16.5 44.2 53.4Equity per share, EUR 14.99 14.53Net gearing, per cent 68.3 72.1Equity ratio, per cent 48.3 46.1Number of shares, undiluted, 72 049 72 049weighted average, 1 000 pcReturn on capital employed, 1.8 -7.6rolling 12 months, per cent * Adjustments affecting operating result were EUR 2.6 million in 2016 and they were mostly related to ICT outsourcing (2015: EUR 24.0 million, relating to Academic Bookstore, Seppälä, Oulu store closing and other restructuring costs). Adjustments affecting tax and financial costs were EUR 9.7 million (EUR 21.8 million). Stockmann has revised the terminology used in its reporting due to the new guidelines of the European Securities and Market Authority (ESMA). Alternative Performance Measures are used to better reflect the operational business performance and to facilitate comparisons between financial periods. Starting from the second quarter of 2016, the previously used term “excluding non-recurring items” has been replaced with the term “adjusted”, and, as a consequence, “operating profit (EBIT) excluding non-recurring items” has been replaced with the term “adjusted operating profit (EBIT)”. Correspondingly, “adjusted EBITDA” is calculated from adjusted operating profit excluding depreciation. Stockmann uses the term “continuing product areas and businesses” which refers to operations excluding Russian retail operations (Stockmann and Lindex), Seppälä, Hobby Hall, Stockmann Beauty, the airport store and the product areas the company has withdrawn from in department stores (electronics, books, sports equipment, toys and pet supplies). Gross profit and gross margin are also used as alternative performance measures. Gross profit is calculated by deducting the costs of goods sold from the revenue, and gross margin is calculated by dividing gross profit by the revenue as a percentage. StrategyThe Stockmann Group is focusing on developing retail operations and real estate business in its department store properties in Finland and the Baltic countries, as well as the development and expansion of the Lindex fashion chain. The Stockmann Retail and Real Estate divisions cooperate closely, while Lindex is being developed as an independent part of the Group. In line with its strategy, Stockmann withdrew from several unprofitable business operations and merchandise areas during 2016 and reduced its department store network and retail space. The divestment of the Russian department store business was completed in February and Hobby Hall at year-end. Stockmann is considering divesting the Nevsky Centre shopping centre in St Petersburg. Investigation of this possibility is in progress. Stockmann is updating its selection that is focused on fashion, beauty, food and home products, improving services and investing in the renewal of its department store premises, in order to offer an improved customer experience. A new department store in rental premises in Tapiola, Finland, will be opened in March 2017. The new Stockmann online store was launched in the fourth quarter of 2016. The online store operates on a new platform and will gradually gain several new features, such as online availability of the goods in the brick-and-mortar stores and new delivery points. A new Crazy Days online store was launched in October 2016 when the campaign was taking place. Transition to more digital marketing based on customer data and development of digital services to support omnichannel shopping continued during the year. Risk factorsStockmann is exposed to risks that arise from the operating environment, risks related to the company’s own operations and financial risks. The general economic situation is affecting consumers’ purchasing behaviour and purchasing power in all of the Group’s market areas. Consumers’ purchasing behaviour is also influenced by digitalisation, increasing competition and changing purchasing trends. Rapid and unexpected movements in markets may influence the behaviour of both the financial markets and consumers. Uncertainties related to purchasing power and behaviour are considered to be the principal risks that could affect Stockmann during 2017. The operating environment may also affect the operations of Stockmann’s tenants and consequently may have a negative impact on rental income and the occupancy rate of Stockmann’s properties. These, particularly if related to the biggest tenants of the properties, may have an effect on the fair value of the real estate Fashion accounts for over two thirds of the Group’s revenue. An inherent feature of the fashion trade is the short lifecycle of products and their dependence on trends, the seasonality of sales and the susceptibility to abnormal changes in weather conditions. Responsible management of the supply chain is important for the Group’s brands in order to retain customer confidence in Stockmann. The Group addresses these factors as part of its day-to-day management of operations. The Group’s operations are based on flexible logistics and efficient flows of goods and information. Delays and disturbances in logistic and information systems as well as uncertainties related to the logistics partners can have an adverse effect on operations. Every effort is made to manage these operational risks by developing appropriate back-up systems and alternative ways of operating, and by seeking to minimise disturbances to information systems. Operational risks are also met by taking out insurance cover. The Group’s revenue, earnings and balance sheet are affected by changes in exchange rates between the Group’s reporting currency, which is the euro, and the Swedish krona, the Norwegian krone, the US dollar, the Russian rouble and certain other currencies. Currency fluctuations may have an effect on the Group’s business operations. Financial risks, mainly risks arising from interest rate fluctuations due to the Group’s high level of debt may have an effect on the financial costs and the financial position. Interest rate fluctuations may also impact the yield related to the properties owned by the Group, and thus to the fair value of these assets. Financial risks are managed in accordance with the risk policy confirmed by the Board of Directors. Outlook for 2017In the Stockmann Group’s largest operating country, Finland, the economy has slowly begun to recover. GDP and retail market are expected to grow slightly in 2017. Consumers’ purchasing power is, however, not expected to increase and purchasing behaviour is changing due to digitalisation and increasing competition. The Swedish economy remained stable in 2016 and the GDP growth estimate for 2017 remains on a higher level than in Finland. The steady growth in the fashion market stagnated in 2016, and the growth rate is expected to remain at the same level in 2017. In the Baltic countries, GDP growth is estimated to continue. The outlook for these countries is expected to be better than that for the Stockmann Group’s other market areas. The Russian economy is expected to recover gradually, but purchasing power of Russian consumers remains low. Stockmann will continue its turnaround by improving the Group’s long-term competitiveness and profitability. The efficiency programmes, launched in 2015 and continued in 2016, will be fully visible in the 2017 operating costs. Improvements in the operating result in 2017 are estimated to come mainly from the Stockmann Retail division, which is still loss-making, while Lindex and Real Estate are expected to continue their stable performance. Capital expenditure for 2017 is estimated to be approximately EUR 45-50 million, which is less than the estimated depreciation for the year. Stockmann expects the Group’s revenue for 2017 to decline due to changes in the store network and product mix. Adjusted operating profit is expected to improve, compared with 2016. Due to normal seasonal variation, the first-quarter operating result will be negative. Financial Statements Bulletin 2016This company announcement is a summary of the Stockmann Financial Statements Bulletin 2016 and includes the most relevant information of the bulletin. The complete bulletin is attached to this release as a pdf file and is also available on the company's website at stockmanngroup.com (http://www.stockmanngroup.com). Annual General Meeting 2017The Annual General Meeting of Stockmann plc will be held on Thursday 23 March 2016 at 2 p.m. at Finlandia Hall in Helsinki, Finland (address: Mannerheimintie 13). Notice of the Annual General Meeting which includes proposals to the meeting is published as a separate stock exchange release on 15 February 2017. Financial releases in 2017Stockmann's report by the Board of Directors, financial statements, audit report, CSR review, Corporate Governance Statement and an electronic version of the Annual Review will be published in the week starting on 27 February 2017. The 2017 interim reports will be released on 28 April 2017, 16 August 2017, and 27 October 2017. Stockmann will not publish monthly sales releases of its merchandise sales in 2017. Press and analyst briefingA press and analyst briefing in Finnish will be held today, on 15 February 2017 at 9:15 a.m. in Fazer’s À la Carte restaurant on the 8th floor of Stockmann's Helsinki city centre department store, Aleksanterinkatu 52. WebcastCEO Lauri Veijalainen will host a webcast in English today, on 15 February 2017, at 11:00 a.m. EET presenting the financial statements. To participate in the webcast, please dial one of the numbers below 5–10 minutes before the webcast begins. The presentation can be followed by this link (https://stockmann.videosync.fi/2017-02-15-q4/register) or on the address stockmanngroup.com. (http://www.stockmanngroup.com) The recording and presentation material are available on the company's website after the event. Finland: +358 9 7479 0361Sweden: +46 8 5033 6574United Kingdom: +44 330 336 9105United States of America: +1 719 457 1036 Confirmation code: 9962578 Further information:Lauri Veijalainen, CFO, tel. +358 9 121 5062Nora Malin, Director, Corporate Communications, tel. +358 9 121 3558 www.stockmanngroup.com STOCKMANN plc Lauri VeijalainenCEO Distribution:Nasdaq HelsinkiPrincipal media

Clas Ohlson increase sales in January 2017

Sales increase by 4 per cent in January to 578 MSEK (558). In local currencies, sales is unchanged versus previous year. Compared with the same month previous year, the net store portfolio was expanded by 8 stores. At the end of the period, the total number of stores was 213. Sales in January were distributed as follows: +-------------------------+-------+-------+-----------------+------------------+|Countries, MSEK |January|January|Percentage change|Percentage change,|| |2016/17|2015/16| |local currency |+-------------------------+-------+-------+-----------------+------------------+|Sweden |253 |259 |-2 |-2 |+-------------------------+-------+-------+-----------------+------------------+|Norway |235 |209 |+13 |+3 |+-------------------------+-------+-------+-----------------+------------------+|Finland |67 |63 |+6 |+4 |+-------------------------+-------+-------+-----------------+------------------+|Outside Nordic countries*|22 |27 |-19 |-12 |+-------------------------+-------+-------+-----------------+------------------+| |578 |558 |+4 |0 |+-------------------------+-------+-------+-----------------+------------------+ *Effected by store optimization in the UK.  Total sales during the first nine months of the fiscal year (May 2016 to January 2017) increased by 5 per cent to 6,415 MSEK (6,098). In local currencies, sales increased by 4 per cent. The third quarter interim report 2016/17 will be published at 07:00 CET on Wednesday 15 March 2017. The report will be presented on the same day at 08:30 CET in Clas Ohlson’s store at Drottninggatan 53 in Stockholm, Sweden. For more information, please contact:Sara Kraft Westrell, Director of Information and Investor Relations, phone +46 247 649 13  This is information that Clas Ohlson AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 7:00 am CET on 15 February 2017.

Nel ASA: Fourth quarter 2016 results

(Oslo, 15 February 2017) Nel ASA (Nel) reported revenues in the fourth quarter 2016 of NOK 50.6 million, compared to NOK 35.6 million in the same quarter in 2015. The company is on-track and well-positioned for the Californian market, both related to fueling stations and renewable hydrogen production. ”The fourth quarter was a strong period for Nel, with record high revenue growth, cash preservation and high business development activity in different key markets. We see increased interest in the field of hydrogen from multiple markets far outside our home base, and believe we are well positioned to take advantage of these opportunities”, says Jon Andrè Løkke, Chief Executive Officer of Nel. In the fourth quarter of 2016, Nel reported revenues of NOK 50.6 million, up from NOK 35.5 million in the same quarter in 2015, representing the strongest quarterly performance in 2016. The operating earnings were impacted by the full 2016 non-cash costs related to the company ́s stock option- and share incentive program of NOK 10.2 million, resulting in a negative EBIT of NOK 16.0 million (-5.4). The cash balanced increased NOK 1.8 million to NOK 225.5 million during the quarter.  “The underlying project-development pipeline is strong, and the company continues to experience a high activity level for its prospects and ongoing tender processes. We are well-positioned for the Californian market, both related to fueling stations and renewable hydrogen production”, says Løkke. The Energy Commission in California is expected to announce the Grant Funding Opportunity (GFO) in the first quarter of 2017. The full GFO award is likely to cover around 20 stations, to be installed and developed in 2017 and 2018. “Nel has both a direct and indirect market penetration strategy for California, were our US subsidiary Everfuel has applied directly for funding. In addition, we are offering our H2Station technology to other GFO applicants which have included our equipment into their proposals. California also represents an opportunity within hydrogen production, as 33 percent of the hydrogen must be renewable, compared with today’s situation with no TRUE renewable hydrogen available in this market”, says Løkke. Within renewable hydrogen production, Nel and SunPower Corp. have entered into a framework agreement to develop solar based renewable hydrogen facilities in California, US. The parties are exploring an initial facility in Davis, California, but are also looking at other locations. The target is to market low cost renewable hydrogen from the site at a price of around 4 USD/kg. The presentation will be broadcast live at www.nelhydrogen.com/webcast and can also be viewed at http://webtv.hegnar.no/presentation.php?webcastId=45446527 The fourth quarter 2016 report and presentation will be made available through www.newsweb.no and www.nelhydrogen.com. ENDS Further information: Jon André Løkke, CEO, +47 9074 4949 Bent Skisaker, CFO, +47 4682 1693 About Nel ASA | www.nelhydrogen.com       Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today.

SSAB Results for 2016: Lower cost level and stronger financial position lay foundation for profitable growth

Comments by the CEO SSAB posted a full year operating profit of SEK 1,213 million, up by SEK 1,456 million compared with full year 2015. Improved earnings were driven primarily by the cost reduction program, including synergies from the acquisition of Rautaruukki. Cost reductions were achieved faster than planned and amount to a full annual run rate of SEK 3 billion. Higher volumes and better capacity utilization also contributed to improved earnings for the full year. Our strategic growth initiatives in SSAB Special Steels and Automotive resulted in increased volumes and we continued launching new products at a high pace. Operating profit for the fourth quarter of 2016 was SEK 107 million, down by SEK 600 million compared with the third quarter of 2016. This was largely attributable to SSAB Special Steels, where there was a scheduled maintenance outage in Oxelösund and a production breakdown occurring when restarting the rolling mill in Oxelösund after the outage. The production breakdown was related to a faulty design in the newly installed control system resulting in damaged transformers. The rolling mill is up and running since the beginning of February and discussions have been initiated with the insurance company regarding potential compensation. Lower prices and lower margins in North America also impacted negatively on the fourth quarter. Global demand for high-strength steel remained stable during the fourth quarter. SSAB Special Steels’ shipments for the full year were up by 8% at 1 million tonnes. SSAB Special Steels is growing structurally in the market as a result of customers’ needs for increasingly lighter and stronger products. For SSAB Europe, underlying demand was stable. Market prices rose during the quarter and realized prices for SSAB Europe improved. Import restrictions on Chinese steel have resulted in lower imports and better pricing in Europe. In North America the fourth quarter was adversely affected by lower realized prices. Market prices, however, rose during the quarter, which is expected to impact positively on SSAB’s realized prices and margins from the first quarter of 2017 onwards. SSAB aims to reduce net debt by SEK 10 billion between the start of the first quarter of 2016 and the end of 2017. The rights issue during the second quarter of 2016 raised SEK 4.9 billion net and the net cash flow during the second, third and fourth quarters amounted to approximately SEK 2.2 billion. The remaining amount will be achieved through cash flow generated from operations, a structural reduction in working capital and through possible divestment of non-core assets. The integration between SSAB and Rautaruukki has been completed and the cost reduction program has ended, which resulted in savings of over SEK 3.0 billion and a reduction of over 2,500 employees. Together with our improved financial position, we have created a platform to continue to execute our “Taking the Lead” strategy with the goal to reach industry-leading profitability. We will do this by continuing to drive efficiency through continuous improvement in all our operations, by driving growth within chosen initiatives and by increased focus on the aftermarket. Against this background, I am convinced that we will continue to strengthen our position during 2017. Invitation to SSAB’s year-end report 2016 results briefing SSAB invites you to a presentation of the year-end report 2016 at 09.30am CET on Wednesday February 15, 2017. The press conference will be held in English and webcast live on www.ssab.com. It is also possible to participate in the briefing via telephone. Venue and time of briefing: World Trade Center (WTC) Stockholm, Kungsbron 1, Conference room Manhattan, 09.30am CET. Telephone numbers:+46 8 505 564 74 (Sweden),+44 203 364 5374 (UK),+1 855 753 2230 (USA). Link to webcast: Go to webcast (http://edge.media-server.com/m/p/4ke5hvo8)  For further information, please contact:  Investor Relations: Per Hillström, Head of IR,per.hillstrom@ssab.com, +46 70 2952 912 Media: Viktoria Karsberg, Head of Corporate Communications,viktoria.karsberg@ssab.com, +46 8 454 5734 This information is information that SSAB AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 7.30 am CET on February 15, 2017. 

Finnair Group financial statement release 1 January–31 December 2016

Finnair Plc        Financial Statement Release      15 February 2017 at 9:00 am Comparable full-year operating result more than doubled year on year; positive in Q4 October–December 2016  ·  Revenue increased by 0.4% year-on-year to 569.9 million euros (567.7)*. Excluding the sold travel agencies, revenue growth was 1.2% ·  Available seat kilometres (ASK) grew by 3.5%. ·  Comparable operating result was 1.6 million euros (0.8). ·  Operating result was 18.2 million euros (85.0). The items affecting comparability were mainly related to foreign exchange gains. ·  Comparable EBITDAR was 59.4 million euros (59.5). ·  Net cash flow from operating activities totalled 30.5 million euros (7.1), and net cash flow from investing activities amounted to -264.7 million euros (-7.8).** ·  Unit revenue (RASK) decreased by 3.0% year-on-year.*** ·  Unit cost (CASK) decreased by 3.2% and unit cost at constant currency excluding fuel decreased by 1.6% year-on-year. ·  Ancillary and retail revenue per passenger grew by 10.3% year-on-year to 12.2 euros. ·  Earnings per share were 0.08 euros (0.44). January–December 2016  ·  Revenue increased by 2.8% year-on-year to 2,316.8 million euros (2,254.5) with 6.5% ASK growth. Excluding the sold travel agencies, revenue growth was 3.2%. ·  Comparable operating result was 55.2 million euros (23.7). ·  Operating result was 116.2 million euros (121.7) including the sales gain on one Airbus A350 widebody aircraft (two were sold and leased back in 2015). ·  Comparable EBITDAR was 270.4 million euros (231.2). ·  Net cash flow from operating activities stood at 219.7 million euros (171.0), and net cash flow from investing activities totalled -499.6 million euros (78.6).** ·  Unit revenue (RASK) decreased by 3.5% year-on-year.*** ·  Unit cost (CASK) decreased by 4.8% and unit cost excluding fuel at constant currency increased by 0.3% year-on-year. ·  Ancillary and retail revenue per passenger grew by 15.2% year-on-year to 11.6 euros. ·  Earnings per share were 0.55 euros (0.57). ·  Outlook: Finnair estimates that, in 2017, its capacity will grow 8–10 per cent, weighted towards the second half of 2017. Revenue is expected to grow more slowly than capacity, reflecting both the increasing capacity in the markets and on the other hand Finnair's efforts to grow the ancillary sales. ·  The Board of Directors proposes to the Annual General Meeting that a dividend of 0.10 euros per share be distributed for 2016. * Unless otherwise stated, figures in parentheses refer to the comparison period, i.e. the same period last year.** Net cash flow from investing activities includes 168 million euro investments in money market funds and other financial assets maturing after more than three months. These investments are part of the Group’s liquidity management*** 2015 revenue includes sales from divested subsidiaries; Estravel was sold in December 2015 and SMT in October 2016. Outlook   The demand outlook for passenger and cargo traffic in Finnair’s main markets continues to involve uncertainty. Finnair estimates that, in 2017, due to the fleet renewal and introduction of new aircraft, its capacity will grow 8–10 per cent, weighted strongly towards the second half of 2017. Revenue is expected to grow more slowly than our capacity, reflecting increasing capacity in the relevant markets. In keeping with its disclosure policy, Finnair will issue guidance for its expected full-year operational result in connection with the half-year report in July. CEO Pekka Vauramo: As a whole, 2016 was a year of growth for Finnair. We successfully launched several new destinations, including Fukuoka and Guangzhou, and added frequencies to key routes. We took delivery of four Airbus A350 widebody aircraft and carried half a million more passengers than a year earlier. Considerable progress was made for example in the digitalisation of our technical processes. Due to the growth, we have also recruited and trained considerable numbers of new personnel, mainly pilots and cabin crew, as previously anticipated. We are building a culture of growth. In the last quarter, our comparable result was approximately 2 million euros positive, exceeding last year’s result by one million euros; hence, we achieved our ninth consecutive quarterly result improvement. The front-loaded training and other expenses resulting from the accelerated growth programme amounted to over 20 million euros in 2016. During the last quarter, we had over 100 pilots tied up in trainings. Considering the seasonality of our business and the headwinds we faced towards the end of the year, we can be fairly content with our result. Due to delays in some of the A350 deliveries, the training schedule of our pilots for the new aircraft type was interrupted, which forced us to wetlease additional capacity during the quarter in order to ensure the least amount of inconvenience to our customers. This caused additional expenses during the quarter. In addition, we were forced to cancel some flights towards the end of the year. Finnair’s revenue divided by the capacity, or RASK, showed more resilience than that of some of our peers. Ancillary sales continued healthy growth, and our plan to deploy more tourist capacity to Lapland was a success. As an example, Ivalo and Rovaniemi combined are currently the largest destination for our Chinese passengers. We have specified a target to boost our revenues by 500 million euros by the end of 2019. Ancillary sales, with new revenues streams, will play a key role in achieving this target. We are also expecting the new cargo hub to be completed in 2017, which will enable increased revenue, particularly by providing better facilities for premium services for specialty goods. This year will be an important leap of growth for us. There will be a tangible increase in capacity, four new A350s and active recruitments. At the same time, we are taking serious efforts to develop the customer experience and the internal people experience. I believe this will lay a solid foundation to launch into the year. Financial reporting  The publication dates of Finnair’s financial reports for 2017 are as follows: Interim Report 1 January – 31 March 2017:                               28 April 2017  Half-Year Report 1 January – 30 June 2017:                               20 July 2017  Interim Report 1 January – 31 September 2017:                           25 October 2017  FINNAIR PLC Board of Directors  Briefings  Finnair will hold a result press conference on 15 February 2017 at 11:00 a.m. and an analyst briefing at 12:30 p.m. at its office at Tietotie 9. An English-language telephone conference and webcast will begin at 2:30 p.m. Finnish time. The conference may be attended by dialling your local access number 0800 915 597 (Finland), 0850 510 036 (Sweden), 020 3059 8125 (UK) or +44 20 3059 8125 (all other countries) and quoting “Finnair” to the operator. To join the live webcast, please register at: http://www.investis-live.com/finnair/5889c7ff04323f1100d219ce/7y2ua For further information, please contact:  Chief Financial Officer Pekka Vähähyyppä, tel. +358 9 818 8550, pekka.vahahyyppa@finnair.com  Financial Communications Manager Ilkka Korhonen, tel. +358 9 818 4705, ilkka.korhonen@finnair.com  IRO Kati Kaksonen, tel. +358 9 818 2780, kati.kaksonen@finnair.com  Financial Statement Bulletin 2016 (http://mbpublicbinaryproxy/Public/3718/2189239/b8f3b10c495e9e54.pdf)

Sweco to continue feasibility study of Helsinki-Tallinn tunnel project

The Helsinki-Tallinn tunnel project is advancing to the next phase: a feasibility study focused on preparing an implementation plan to support the project’s decision-making process. This study is a continuation of the pre-feasibility study conducted by Sweco in 2015, which resolved various aspects of project execution, traffic structure and potential socioeconomic impact. In addition to investigating technical solutions, the study will evaluate the project’s economic impact. A fixed link between Helsinki and Tallinn is expected to enhance business opportunities for both capital cities. “New sustainable solutions are needed to improve the flow of freight and passenger traffic across the Gulf of Finland. The Helsinki-Tallinn tunnel would create an important link between Scandinavia and Central Europe. We are investigating the various technical solutions at hand, such as station location, train types and operational solutions for traffic flow. The strategic environmental impact assessment is also now part of the study. Sweco was also involved in the initial pre-feasibility study phase, so we can utilise our previous knowledge of the project’s impact and requirements”, says Sweco Environment Director Juho Siipo. The project team comprises multidisciplinary experts: Sweco Finland and Estonia are joining a consortium with WSP Finland and Sweden and Amberg Engingeering from Switzerland. Amberg Engineering has collaborated with Sweco in several international transport projects, including the Brussels and Paris metros and a high-speed railway line in Sweden. '’Amberg Engineering Ltd is expert in planning, design and site supervision of ultra-long tunnels such as the Gibraltar Strait Tunnel and the Gotthard Base Tunnel. This accumulated knowledge of the specific characteristics of such infrastructures will be very conducive for this feasibility study’’, says the president of the Amberg Group Felix Amberg. The contracting authorities for the project are the Finnish Ministry of Transport and Communications, the Estonian Ministry of Economic Affairs and Communications, the Helsinki-Uusimaa Regional Council, the Harju County Government of Estonia, and the cities of Helsinki and Tallinn. The results of the pre-feasibility study will be available at the end of 2017.

Tobii AB Year-End Report 2016

Tobii AB today reported its results for the fourth quarter and full year 2016. Tobii exceeded SEK 1 billion in annual sales and strengthened its cash position for increased investments in VR and smartphones. Comment by Tobii’s CEO Henrik Eskilsson: “2016 was another exciting and eventful year for Tobii. Tobii Tech passed key milestones in computer gaming, which also contributed to a significant rise in sales for the business unit for the fourth quarter. Together with Huawei, we also took our first step into the smartphone market. The rights issue that we recently carried out provides us with the muscle to further increase the pace of investment and address more areas simultaneously within Tobii Tech. We also continued to invest in market and product development in Tobii Dynavox and Tobii Pro to further grow and increase profitability over the long-term. Adjusted for currency effects and one-off effects, the Group’s net sales increased by 10% compared with the fourth quarter of 2015 and for the full year we exceeded SEK 1 billion in sales.” October – December · The Group’s sales totaled SEK 306 million (287), an increase of 6%. Adjusted for currency effects and one-off effects, the increase was 2% and 10%, respectively. · The gross margin was 71% (76%). · The Group’s operating loss amounted to SEK -10 million (-3). Tobii Dynavox made a positive contribution of SEK 41 million (45) and Tobii Pro of SEK 12 million (11), while investments in Tobii Tech had a negative impact of SEK -64 million (-59) on the Group’s earnings. · Earnings per share amounted to SEK -0.02 (-0.08). January – December · The Group’s sales totaled SEK 1,053 million (967), an increase of 9%. Adjusted for currency effects, the increase was also 9%. · The gross margin was 72% (75%). · The Group’s operating loss amounted to SEK -67 million (-36). Tobii Dynavox made a positive contribution of SEK 125 million (119) and Tobii Pro of SEK 15 million (21), while investments in Tobii Tech had a negative impact of SEK -207 million (-176) on the Group’s earnings. · Earnings per share amounted to SEK -0.57 (-0.30). Events during the third quarter · Tobii carried out a rights issue to finance increased investments in virtual reality and smartphones, which was heavily oversubscribed and generated proceeds of SEK 449 million for the company after issue costs. · Tobii Pro launched the company’s most powerful and advanced eye tracker to date, Tobii Pro Spectrum, and the analytics platform, Tobii Pro Lab. · Tobii announced its first design win in the smartphone area with the launch of Huawei Honor Magic. · Acer announced yet another monitor to come featuring integrated eye tracking from Tobii. Conference call Today at 10:00 a.m. Tobii will arrange a conference call with web cast presentation for media, analyst and investors. Please find dial-in details on Tobii’s website under Year-End Report, Q4 2016 (http://www.tobii.com/group/investors/calendar/year-end-report-q4-2016/). This information is information that Tobii AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, on February 15, 2017, at 8:00 a.m. CET.

Atlas Copco awards recognize innovative breaker and compressor monitoring technology

The John Munck Award for technical innovations is presented to Olof Ostensson and Thomas Lilja, who work in technical development for the Construction Tools division in Kalmar, Sweden. They developed the handheld pneumatic breaker RTEX, which cuts energy consumption by half, while being lighter and highly ergonomic. The RTEX has been embraced by customers, who benefit from lower fuel costs, reduced emissions, higher productivity and an improved operator environment. See a three-minute video (https://www.youtube.com/watch?v=TNlPjgfPlAM&t=13s) on the RTEX. The Peter Wallenberg Award goes to a team in the Compressor Technique Service division: Pieter Colen, Bob Rigouts, Louis De Jaegher and Damien Hoyen. They played key roles in advancing and promoting the groundbreaking SMARTLINK data monitoring system for compressors. The system lets Atlas Copco remotely measure the equipment performance and see exactly when service is needed. This gives customers peace of mind, allowing them to focus on their business instead of on the compressors. Thousands of customers globally have benefited from SMARTLINK since its launch in 2013. See a five-minute video (http://www.atlascopco.com/videogallery/detail/fbe7961e-1fd0-4334-a00c-6b424eb15e95) on SMARTLINK. “Our constant focus on increasing customers’ productivity lies behind the development of both the RTEX breaker and the SMARTLINK monitoring system,” said Ronnie Leten, Atlas Copco’s President and CEO. The John Munck Award, established in 1991, is presented each year to a product developer, designer or a team for outstanding contributions to the overall quality of an Atlas Copco product. The Peter Wallenberg Marketing and Sales Award -- named after Atlas Copco’s former Honorary Chair -- recognizes the most innovative successfully implemented method in the field of sales and marketing. The award was established in 1996. The awards will be presented to the winners at the Annual General Meeting on April 26, 2017.  For information on past award winners, please see http://www.atlascopcogroup.com/en/innovation/awards/internal-awards.

Sivers IMA launches new 60 GHz RFIC chip for WiGig

The continued 10x growth in mobile data traffic until 2022* is pushing the boundaries for new and innovative wireless solutions. WiGig, millimeter wave and beamforming will be vital technologies to support this tremendous growth.  “With this new RFIC, Sivers IMA will take a crucial step in becoming a leading supplier of millimeter wave RFICs for data and telecommunication infrastructure solutions. With the state of the art technical performance and very high level of integration, Sivers IMA offers unique value to our customers.” says Anders Storm, CEO of Sivers IMA. TRX-BF01 has 16 Tx +16 Rx digitally controlled beamforming channels, all in one chip. It includes all building blocks in Silicon Germanium, in a small 12,5x12,5 mm eWLB capsule. The built in full PLL and VCO have excellent phase noise and hence offer best in class EVM performance and can be used with the 64 QAM single carrier modulation, compliant to the 802.11ad standard, allowing for speeds up to 7 Gbps in the air. Silicon Germanium offers state of the art performance compared to many CMOS RFICs for millimeter wave, in some cases more than 100 times higher output power per Tx channel.   Prototypes of this new chip will be available to key customers and partners during Q2 2017. For more information:   Anders Storm, CEO Phone: +46 70 262 6390 E-mail: anders.storm@siversima.com  * Ericsson Mobility report (Nov 2016)   Sivers IMA is a leading manufacturer of micro- and millimeter wave products for connecting and quantifying a networked world. Sivers IMA has a long history and is internationally renown as a reliable supplier of high quality components used in telecommunications links, RADAR sensors and test & measurement equipment. Headquarters is located north of Stockholm in Kista, Sweden. Learn more at http://siversima.com.  

SMART WINDSCREEN WIPERS REDUCE ANXIETY WHEN OVERTAKING.

More than half of US drivers surveyed (Semcon/Inizio) stated that they feel anxious before overtaking a truck on a wet road. 50% of those indicated loss of sight as one of the reasons why. ProActive Wipers (PAW) is new software that identifies where other vehicles are and combines this with knowledge about wet roads. The system knows when nearby large vehicles present a risk of sudden water splashes, and activates the wipers. At the same time as the water hits the windscreen, it’s wiped away, giving the driver a clear view. “ProActive Wipers is a good example of how we can use technology that already exists in cars in new and creative ways. This solution uses the car’s camera, radar and rain sensor to make traditional technology, like windscreen wipers, smarter and driving safer for the user,” says Magnus Carlsson, responsible for safety and autonomous driving at Semcon. Information from PAW could also be used in different ways, for example to assess the risk of aquaplaning. Semcon also sees a big potential for the solution when autonomous cars come to market. “Driverless cars are dependant on cameras and other critical sensors behind the windscreen being kept free from dirt and water. The intelligence inside PAW could therefore be used to increase safety and reliability in self-driving cars,” says Magnus Carlsson. PAW is a proprietary and patent pending innovation from Semcon, which uses information from the car’s existing equipment. PAW has been evaluated in real conditions and the software could easily be implemented in today’s cars. See the film about PAW (https://www.youtube.com/watch?v=yFw6sMSgxwI) Download the complete press pack including the FAQs  (https://www.dropbox.com/sh/g9zl99wdomxa24c/AAD9gjMd809ejbuXZTid9VBEa?dl=0) www.semcon.com/paw

Nordea publishes its Annual Report and Sustainability Report

Today, Nordea publishes its Annual Report and Sustainability Report on nordea.com.The Annual Report describes operations in 2016 – an eventful year for Nordea. Besides macroeconomic and regulatory challenges for the sector, Nordea contended with substantial media attention, and commenced the implementation of a sweeping transformation agenda. Two important milestones during the year were the implementation of the new legal structure, and the launch of the first service on the new core banking platform.Despite the challenging market with sustained exceptionally low interest rates, we were pleased to report an improved net interest margin. Inflow to asset management was record-high, Euromoney awarded Nordea Private Banking for having the best Nordic Private Banking offering. We also further cemented our leading position in the Nordics in corporate advisory. However, earnings declined 1% over the full year.During the year, the operations of the former Retail Banking business area were streamlined and two new customer organisations were created – Personal Banking, which serves the household market, and Commercial and Business Banking, serving SMEs. This streamlining enables a sharper focus on improving the customer experience of Nordea, and puts us in a better position to keep working to strengthen the execution capacity in each customer group.The cost progression and credit quality were in line with our forecasts. The CET1 ratio improved by 190 bp in 2016 to 18.4%, and return on equity was 11.5%. Nordea’s board proposes a dividend of EUR 0.65 per share.We expect 2017 to be eventful too, and stand prepared to face the challenges. Our strategic focus is clear. Thanks to our strong balance sheet and robust business model, we can continue to invest in our platform and hence fundamentally change the bank. We continue to focus on creating a fully digital platform, improving customer satisfaction and transforming the organisation. In so doing, we will be best at compliance, with a strong ethics and value culture, and meet our commitments towards society and generate value for our customers and shareholders.In 2016 the bank embarked on a major transformation journey. In order to ensure a sustainable business model, environmental, ethical and social aspects must be integrated into all parts of our business. During the year we established a Business Ethics and Values Committee, chaired by the CEO, and appointed a new Head of Sustainability. We have also held dialogue meetings with a great number of stakeholders, and based on these have identified nine sustainability goals that we will work with in 2017. You can read about these in the Sustainability Report 2016. The Annual Report and Sustainability Report can be downloaded from nordea.com. The Capital and Risk Management (Pillar III) Report 2016 will also be available for downloading from nordea.com/ir. The Sustainability Report and Capital and Risk Management Report are available in English only.For further information:Claes Eliasson, Acting Head of External Communication, +46 72 141 67 12Rodney Alfvén, Head of Investor Relations, +46 72 235 05 15

Stena Line’s four new vessels planned for Belfast routes

-Introducing the world’s most fuel efficient RoPax vessels- Last year Stena announced a newbuild contract of four RoPax ferry vessels with a planned delivery schedule during 2019 and 2020.  The contract also contains an option for another four vessels to be ordered.  The four vessels are being built at the AVIC Shipyard in China and the plan is to locate the vessels on the Irish Sea, specifically on Stena Line’s routes to and from its expanding Belfast hub. “The routes to and from Belfast are strategically very important to Stena Line and during the last number of years we have made significant investments in ports and vessels to improve and develop our capacity offering a frequent high quality service for our customers to and from Belfast. Looking ahead, we intend to continue our ambitious development plan for our business in the region and the new vessels are a part of this strategic plan.   During the last few years we have seen a steady growth in freight and passenger volumes and we believe this will continue. Last year was a record year for us when we for the first time carried over 500,000 freight units through Belfast Port.  These new vessels will be the largest ferries ever to operate between Belfast and Great Britain”, said Stena Line’s CEO Niclas Mårtensson. Joe O’Neil, Commercial Director, Belfast Harbour commented: “We are delighted that Stena Line is planning for Belfast as the location for its next generation of RoPax vessels in what is a significant investment in and enhancement of Northern Ireland’s premier freight and tourism gateway.  Belfast Harbour has worked in close partnership with Stena Line over the last two decades to help it expand its Belfast routes into a flourishing hub and this very welcome investment news comes on the back of a record year for Stena Line’s freight business in Belfast Harbour.  We look forward to welcoming the new vessels and the associated benefits they will bring to Belfast Harbour and the economy of Northern Ireland.”  The new vessels are being constructed in line with Stena Line’s strategic focus on sustainability. “The new RoPax vessels will be among the most fuel efficient in the world with approximately 25% lower CO2 emissions per cargo unit than current RoPax tonnage.  Our aim is to lead the development of sustainability within the shipping industry and set a new industry standard when it comes to operational performance, emissions and cost competiveness.  The vessels will run on traditional fuel, but are designed to the class notation “gas ready” and are also prepared for scrubbers as well as catalytic converters, giving us flexibility for the future”, says Niclas Mårtensson. Stena Line, Gothenburg  15th February 2017

Studsvik’s Year-end Report for January – December 2016

· Sales in the quarter was SEK 246.3 (196.9) million. In local currencies sales increased by 23 per cent. · The operating profit for the quarter amounted to SEK 27.0 (11.4) million. Itemsaffecting comparability impacted earnings for the quarter by SEK –9.3 (0) million. · The free cash flow for the quarter was SEK –22.2 (8.5) million. · The full year net profit increased to SEK 63.0 (2.4) million. The Board of Directors proposes a dividend of SEK 1 per share. +---------------+-----------+-----------+-------------+-------------+| |Oct-Dec2016|Oct-Dec2015|Full year2016|Full year2015|+---------------+-----------+-----------+-------------+-------------+|Sales, SEK |246.3 |196.9 |758.8 |721.2 ||million  | | | | |+---------------+-----------+-----------+-------------+-------------+|Operating |27.0 |11.4  |24.7 |36.6 ||profit, SEK | | | | ||million  | | | | |+---------------+-----------+-----------+-------------+-------------+|Profit after |8.7 |2.8 |17.0 |14.6  ||tax, SEK | | | | ||million  | | | | |+---------------+-----------+-----------+-------------+-------------+|Free cash flow,|–22.2 |8.5 |129.6 |–29.8 ||SEK million* | | | | |+---------------+-----------+-----------+-------------+-------------+|Net debt, SEK |2.9 |134.3  |2.9 |134.3 ||million* | | | | |+---------------+-----------+-----------+-------------+-------------+|Net debt/equity|0.8 |45.0  |0.8 |45.0 ||ratio, %* | | | | |+---------------+-----------+-----------+-------------+-------------+|Profit per |1.06 |0.34 |2.07 |1.78 ||share after | | | | ||tax, SEK | | | | |+---------------+-----------+-----------+-------------+-------------+|Equity per |42.41 |36.30 |42.41 |36.30 ||share, SEK* | | | | |+---------------+-----------+-----------+-------------+-------------+|*Refers to | | | | ||total | | | | ||operations  | | | | |+---------------+-----------+-----------+-------------+-------------+ The interim report will be presented at a telephone conference call according to separate distributed invitation at 2:30 PM CEST today. Please read the full interim report in the attached file. For further information, please contact: Michael Mononen, CEO, +46 155 22 10 86 or, Pål Jarness, CFO, +46 155 22 10 09 Facts about Studsvik Studsvik offers a range of advanced technical services to the global nuclear power industry. Studsvik’s business focus areas are fuel and materials technology, reactor analysis software and consultancy services within waste treatment technology, decommissioning, NORM and solutions for final disposal. The company has 70 years nuclear technology and radiological service experience. Studsvik has 700 employees in 7 countries and the company’s shares are listed on the Nasdaq Stockholm. This information is information that Studsvik AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was released for public disclosure, through the agency of the contact persons above, on February 15, 2017, at 1:30 pm (CEST).  www.studsvik.com   

Update – JOSAB delivers purification technology to Indian infrastructure for water supply

· JOSAB supplies and finances 150-250 water kiosks including purification technology to Hyderabad in a BOO project. · HMWS&SB (Hyderabad Metropolitan Water Supply and Sewerage Board) is responsible for water supply with access to the Municipal water supply and assign appropriate locations. · Water kiosks are part of the state of Telangana’s regular water supply. · JOSAB estimates that the project generates a revenue over 7 years amounting to between MSEK 65 and 100. The project sum is an estimate based on local calculations and volumes. · Hyderabad is located in India and has 7 million inhabitants. Access to clean water is scarce as the water distributed in the normal municipal network is often contaminated. Since JOSAB has received many questions regarding the project, below is an in-depth information: As informed in a press release distributed November 30, 2016, JOSAB signed on November 29, 2016 a contract with a water treatment project in which JOSAB’s products will purify water in 150-250 water kiosks in Hyderabad, India. The project is a collaboration between JOSAB, the local company Natures Spring Eco Tap Pvt Ltd and the city of Hyderabad in the state of Telangana. Water kiosks will be placed at various locations in the city of Hyderabad. JOSAB is responsible for the  purification technology and production of water kiosks, while Natures Spring Eco Tap Pvt Ltd handles the marketing and public authorities as well as the daily operation of the units. Hyderabad city is responsible for water supply and provides sites with appropriate demographic conditions selected based on the city's internal statistics of previous consumed volumes of water kiosks and water needs. The project is based on a so-called BOO (Build Own Operate), where the payment is done via water tariffs, that is, JOSAB receives part of the revenues for a period of seven years. JOSAB gets paid based on purchased volume according to an integrated meter in each water kiosk. JOSAB owns the water kiosks throughout the project and beyond. The price is determined by the state to 1 rupee per liter of water and customers will fill the water in their own bottles. Bottled water costs 10-20 rupee per liter in stores. Payment is made with cash or a prepaid cards bought in kiosks. As a base of the previously announced sales revenues is the signed agreement, together with a volume assessment by the project partner and the city of Hyderabad. The calculated volume is estimated to be 4 m3 of water per day and machine, and hence no guarantee. The technology in water kiosk allows production of 24 m3 of fresh water per day. The city proposes placement of water kiosks based on the assessed needs in areas where demand is high, such as, for example, train stations, schools and shopping malls. The cost of, and access to, raw water is carried by the city of Hyderabad. JOSAB’s share of revenues under 7 years is estimated to be in the range of MSEK 65-100. JOSAB have been ready to supply the machines starting from December 2016, but delivery of the first machines have been postponed due to delays by the authorities in Hyderabad. The previously announced schedule is estimated to be kept, and according to the agreement all equipment will be deployed before the end of June 2017. Delays due to authority administration are common in India. The inauguration of the first machines will be done in the presence of a minister and is expected to occur shortly. JOSAB manufactures water kiosks using a subcontractor based on a long-term cooperation. Production of up to 250 water kiosks are procured and the units can be delivered within the agreed time schedule. Several Indian newspapers have written about JOSAB and the project. Water kiosks are part of the regular water supply in India and is attracting a lot of interest from the public. The publicity strengthens JOSAB’s brand. So far, two English-language newspapers reported about the project and also interviewed the Mayor who confirms that the project will be rolled out in the near future.1) 2) 1)            http://m.timesofindia.com/city/hyderabad/safe-drinking-water-at-drop-of-coin-250-dispensers-soon/articleshow/56675068.cms 2)            https://www.google.se/amp/telanganatoday.news/eco-friendly-water-purification-tech-for-water-atms/amp JOSAB in India JOSAB is established with its own subsidiary in Pune, India since 2012. JOSAB India has the task of establishing JOSAB’s technology in the Indian market for regular water supply. JOSAB has invested MSEK 5.8 in 2016 in India, of which MSEK 5.2 is financed through project financing from Prime World Ltd and Graceful Win Ltd. The authorities in Telangana announced in 2016 a contract to deploy between 150 and 250 water kiosks in and around the city of Hyderabad and with the requirement that JOSAB’s zeolite-based water treatment method should be used. JOSAB’s ecological purification method has been decisive for the choice of technology. JOSAB lacks tender license in Telangana and hence could not submit bids. In November JOSAB therefor signed a technical partnership with Natures Spring Eco Tap Pvt Ltd, a project company started for the purpose, and which has an agreement with the city of Hyderabad. The contract was signed on 29 November 2016. JOSAB supplies water kiosks containing JOSAB’s patented and ecological water treatment process. Water kiosks are part of the regular water supply in India and the agreement has a strategic value for JOSAB. After four years of testing of JOSAB’s products the state of Kerala introduced JOSAB’s technology as one of five approved water treatment technologies in public procurement in the state. JOSAB India received in March 2016 a tender licensed C that is valid in the state of Kerala and took its first order in the state in spring 2016. Tenders License C allows only participation in smaller projects, but with a number of additional orders in the state of Kerala qualify JOSAB India to apply for the higher bids license B. Offer B license will enable JOSAB to bid in India's states in their own name. Tender License B increases JOSAB’s opportunities to grow in India. Tenders totals in contracts that are made available with tender license B is also significantly greater than those available for holders of tender license C. In the state of Kerala, the World Bank in 2011 allocated MUSD 222 in a program for water and sanitation projects. The program is open to investment financing until 31 December 20183). With the State's approval of JOSAB’s technology and private tenders license in Kerala JOSAB India Pvt Ltd. can participate in procurements during 2017 and 2018, that is ongoing regarding this major project. 3)            http://projects.worldbank.org/P121774/second-kerala-rural-water-supply-sanitation-project-jalanidhi-ii?lang=en The potential in India is very large for JOSAB. Large areas of land, which includes the state of Kerala, has polluted rivers, which are important for the water supply, which is suited to be cleaned with JOSAB’s purification process. India seeks ecological solutions for water treatment and JOSAB’s green profile with ecological water treatment technology is a good fit. Stockholm 15th of February 2017 For more information, please contact: Johan Gillgren                                                               President/CEOJOSAB International AB       +46 (0)8 121 389 00                                                                                                                                                                     johan.gillgren@JOSAB.com  About JOSAB International ABJOSAB International AB manufactures and sells ecological water treatment solutions based on, by the company patented, unique filter material Aqualite™. JOSAB International AB has today four fully owned subsidiaries, JOSAB Hungary Kft, JOSAB India Pvt Ltd, JOSAB China Ecological Water Treatment Systems Co Ltd and JOSINT Financial Services AB.

Full year report 2016

Business highlights fourth quarter 2016  · Positive pivotal phase 3 trial results received for long-acting buprenorphine, CAM2038, for treatment of opioid addiction. · Start of Phase 1-trial of CAM2047, CAM2038 and CAM2058 for treatment of nausea and pain. · Stage 1 of the establishment of Camurus´ European commercial organization and operational structure completed. · Expansion of collaboration and license agreement with Braeburn Pharmaceuticals. · Preclinical development program for CAM2043 for treatment of pulmonary arterial hypertension completed. · Three presentations of long-acting buprenorphine, CAM2038, at ISAM annual meeting 2016 in Montreal. · Capital Markets and R&D Day held at the Royal Swedish Engineering Academy in Stockholm.  Financial summary fourth quarter 2016  · Revenues MSEK 37.1 (36.3). · Operating result before and after items affecting comparability MSEK -35.1 (-4.9) and MSEK -35.1 (‑40.4), respectively. · Result after tax MSEK -27.8 (-31.9). · Earnings per share SEK -0.75 (-1.05), before and after dilution. · Cash position MSEK 508.6 (716.1). Financial summary full year 2016  · Revenues MSEK 113.7 (154.8). · Operating result before and after items affecting comparability MSEK -102.5 (-30.5) and MSEK -102.5 (-204.1) respectively. · Result after tax MSEK -81.0 (-159.5) · Earnings per share SEK -2.17 (-6.02), before and after dilution. · Cash position MSEK 508.6 (716.1). CEO comments The final quarter of 2016 saw us achieve a major milestone for Camurus. Results from our completed Phase 3 study of CAM2038 in opioid dependence demonstrated significantly better treatment effect with our long-acting depots versus standard of care with daily sublingual tablets. With this achievement, we now initiated the work on the market approval applications for both the EMA and FDA. Our long-acting buprenorphine depots, CAM2038, for treatment of opioid dependence, clearly fulfilled efficacy primary endpoints agreed with the European Medicines Agency (EMA) as well as US Food and Drug Administration (FDA). Additionally, secondary analyses demonstrated superior efficacy versus daily sublingual buprenorphine/naloxone tablets. These clear-cut, positive Phase 3 results are particularly impressive in the light of the randomized, controlled double blind, double dummy design, and with regard to the complex patient population that was included directly from the active opioid misuse. Approximately 70% of the 428 study participants were using heroin and more than half of them were injection opioid users. Most of them also used other illicit drugs, including cocaine, amphetamine and marijuana. This group is representative of patients starting their treatment of opioid dependency both in EU and the US. Present daily treatment with buprenorphine or methadone has been clearly demonstrated to be effective in decreasing opioid misuse, reducing mortality and the spreading of infectious diseases. Unfortunately, these treatments have some significant limitations. These include poor treatment adherence, costs and stigma in connection to need of frequent clinic visits and supervised dosing, overdosing, as well as diversion and misuse. Using long-acting medications, these limitations can be significantly reduced, or even eliminated, as pointed out by Prof. Edward Nunes MD, PhD, Columbia University Medical School during his presentation at Camurus’ first Capital Markets and R&D Day in Stockholm, December 14, 2016. Combined with the documented treatment efficacy and favorable safety profile, our long-acting depot products have the potential to transform the treatment of opioid dependence and provide improvement to patients, healthcare providers and society. Process of filing market authorization and new drug applications for CAM2038 to the EMA and FDA mid 2017 are on track. During the period, important advances were also made regarding commercial manufacturing as well as establishment of our commercial organization and operational structure in front of the planned launching of CAM2038 in Europe during 2018. We have been working closely with experts and stakeholders within the various national health systems, as well as performing health economic analyses and modelling. Initial results will be presented at the AMCP Managed Care Specialty Pharmacy Annual Meeting i Denver, Colorado in March 2017. In our collaboration with Novartis, following the announcement of positive Phase 2 results for our subcutaneous long-acting octreotide depot, CAM2029, for treatment of acromegaly and neuroendocrine tumours (NET), a clinical study report has been completed during the quarter. Results will be presented at several conferences during the spring, including ENETS, Barcelona in March and at ENDO, Orlando in April. After completed preparations for GMP-manufacturing of the product during the quarter, GMP manufacturing is now initiated ahead of planned Phase 3 start later in the year. In the collaboration with Rhythm regarding weekly setmelanotide FluidCrystal® investigational product for treatment of genetic obesity disease, GMP-manufacturing was successfully completed and preparations of a clinical trial are ongoing ahead of the start during 2017. In our early development pipeline, we initiated a clinical pharmacokinetic study of new product candidates for treatment of pain as well as nausea and vomiting. Two of the programs are conducted with our US partner Braeburn Pharmaceuticals, after having expanded our license agreement during the period. A new exciting program in our pipeline is a subcutaneous depot of treprostinil, CAM2043, for treatment of pulmonary arterial hypertension. PAH is a rare progressive lung and heart disease with a poor life expectancy of less than 3 years, if left untreated. Based on our preclinical results, we believe that CAM2043 has potential to significantly improve treatment versus available treatments. Presently treprostinil is administrated using continuous infusion, a complex procedure associated with significant and treatment limiting side-effects such as pain and serious infections. The PAH market exceeded USD 4 billion 2015, with treprostinil representing about 25%. Our strong results delivered during the past year have resulted in an increased interest in Camurus and contributed to a positive development of the company value. Behind the success is our team of fantastic coworkers, dedicated partners and clinical investigators, as well as their study teams. Warm thanks to you all! Fredrik TibergPresident and CEO For more information: Fredrik Tiberg, CEO and Head of ResearchTel. +46 (0)46 286 46 92fredrik.tiberg@camurus.com    Rein Piir, VP Investor RelationsTel. +46 (0)70 853 72 92ir@camurus.com  This information is information that Camurus AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Markets Act. The information was submitted for publication, through the agency of the chief executive officer, 07.00 AM CET on 16 February 2017.

QT GROUP PLC FINANCIAL REPORTING 2017

Segment reporting Qt Group comprises of one reportable segment that offers software development tools to its customers. The chief operating decision maker of Qt Group is the CEO together with the Group’s management team. Due to the business model of Qt Group and the nature of its operations and governance structure, Qt Group forms one reportable operating segment, Qt Group. The figures of the reportable segment form the figures of Qt Group. Revenue from products and services Qt Group has previously reported its revenue as one consolidated revenue figure for the Group.   In 2017, Qt Group reports revenue from products and services as follows: license sales and consulting, as well as support and maintenance. License sales and consulting comprises of developer licenses, distribution licenses (runtimes) and consulting. Support and maintenance comprises of maintenance fees. Comparison figures 2016 Revenue by 1-3/2 4-6/2 7-9/2016 10-12/2016 1-12/2016products 016 016andservices ThousandEURLicense 4 435 6 215 4 567 5 855 21 073sales andconsultingSupport and 2 713 2 720 2 900 2 989 11 322maintenance Revenue 7 148 8 935 7 467 8 845 32 395total Revenue from geographical locations In financial statements, Qt Group reports revenue from geographical locations by the location of assets as follows: North America and rest of the world. Qt Group PLC Board of Directors FURTHER INFORMATION CFO Mika Harjuaho, +358 9 8861 8040 Qt Group Plc Qt Group Plc is responsible for Qt development, productization and licensing under commercial and open source licenses. The Qt offering includes a development environment that enables the reuse of software code across numerous different operating systems, platforms and screen types, ranging from desktops and embedded systems to wearables and mobile devices. Qt is used by approximately 1 million developers worldwide and is the leading independent technology behind millions of devices and applications. Qt is the platform of choice for in-vehicle systems, industrial automation devices and other business critical applications manufacturers, and is used by leading global players in 70+ industries. The Qt Company operates in China, Finland, Germany, Japan, Korea, Norway, Russia and USA with about 200 employees worldwide. The Qt Group is headquartered in Espoo, Finland and is listed on Nasdaq Helsinki Stock Exchange. The company’s net sales in year 2015 was 27 MEUR. To learn more visit http://qt.io

Year-end report 2016 and quarterly report October – December 2016

Fourth quarter 2016:  · Revenues for the fourth quarter increased by 23.9% to SEK 400 (323) million · Operating profit amounted to SEK 156 (122) million, an increase of 28.1% · Operating margin was 39.0 (37.7)%  · Profit after tax amounted to SEK 150 (116) million, an increase of 29.6% · Earnings per share amounted to SEK 0.62 (0.48) after dilution  · 13 new customer agreements were signed, 12 new customers’ casinos were launched Full year 2016: · Revenues for the full year increased by 28.5% to SEK 1,455 (1,132) million · Operating profit amounted to SEK 536 (402) million, an increase of 33.4% · Operating margin was 36.8 (35.5)% · Profit after tax amounted to SEK 504 (374) million, an increase of 34.9% · Earnings per share amounted to SEK 2.10 (1.56) after dilution · 45 new customer agreements were signed and 34 new customers’ casinos were launched · Proposed cash distribution to shareholders of SEK 2.25 (1.33) per share · At the end of 2016, NetEnt had 31 signed customers that had not yet been launched Important events in the fourth quarter:  · Retail deal signed with Gauselmann for gaming machines market in Italy  · Retail agreement entered with Paddy Power for gaming machines in Great Britain · NetEnt games launched on the regulated markets in Bulgaria and Portugal  · Contract signed with Codere regarding online games distribution in Mexico Comments by Per Eriksson, President and CEO: Another record year for NetEnt2016 was another exciting year for NetEnt with new record levels in revenues, earnings and cash flow. The year featured many new customers, new regulated market entries and successful game launches for NetEnt. Revenues for the full year increased by 28.5 percent to 1,455 SEKm. Operating profit and profit before taxes amounted to SEKm 536 and SEKm 546 respectively, and the operating margin improved to 36.8 percent. We believe in corporate social responsibility as a condition for long-term sustainability of our business, and focus on growing on regulated markets. During the year, we became members of the World Lottery Association (WLA), a member-based organization that promotes the interests of state-authorized lotteries around the world. Following new licenses and certifications, our games were launched on the regulated markets in Romania, Bulgaria and Portugal. We signed a total of 45 new customer agreements, the highest number ever, and we launched our games with 34 new customers. During the year, we made several larger investments – we continued to enhance our platform and developed a mobile solution for Live Casino Roulette, which we think will support future growth for us in this segment. The game trilogy NetEnt Rocks was very successful and Guns N’ Roses was named best game of the year at the EGR Operator Awards in London. We also launched a range of other innovative, best-in-class games such as Aloha, Drive, Warlords and Little Red Riding Hood, all of which became great successes among customers and players. In addition to offering the best games in the industry, we also manage all gaming transactions for our customers through so-called hosting. Our games are available 24/7, all year around. In 2016, we managed almost 36 billion transactions in our systems, which is 19 times more than the total number of transactions on the New York Stock Exchange during the same period. High growth and good profitability in the fourth quarterThe fourth quarter developed well, revenues increased by 23.9 percent in SEK and by 18.5 percent in EUR compared to the very strong fourth quarter of 2015. The operating margin improved to 39.0 percent, mainly due to better scalability in the business. Great Britain continues to offer great growth potential for us and in December, it became our largest geographical market for the first time. Mobile games continue to be an important growth driver and accounted for 43 percent of revenues in the quarter. We signed new retail deals for gaming machines with Gauselmann in Italy and Paddy Power in the UK. We also took our first step into Latin America by extending our partnership with Codere to include the regulated online casino market in Mexico. Future outlookFor the first quarter of 2017, we expect revenues to be in line with the fourth quarter of 2016. For the rest of 2017, we see conditions for continued solid growth supported by a strong pipeline of new games, growing market shares in the UK, mobile growth, new customers to launch, as well as our expansion in North America. We increase the number of employees, enhance our product offering and integrate more customers on new regulated markets. With this in mind, we foresee higher costs and an ongoing need to invest during 2017. These are all projects that will enable continued solid growth for NetEnt going forward. Presentation of earnings reportOn Thursday, February 16, 2017, at 9.00 a.m. the earnings report will be presented by CEO Per Eriksson live via webcast. The presentation can be followed in real-time on NetEnt’s website at https://www.netent.com/en/section/invest/. For additional information please contact:Per ErikssonPresident and CEOPhone: +46 8 5785 4500per.eriksson@netent.com This information is information that NetEnt AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 7:30 CET on February 16, 2017.

Year-end Report January-December 2016

October – December 2016• Net sales decreased with 6 percent to SEK 579 million (613)• Operating profit before depreciation increased to SEK 28 million (25)• Non-recurring items amounted to SEK -11 million (-12)• Adjusted EBIT before depreciation increased to SEK 39 million (37)• Operating profit increased to SEK 15 million (1)• Earnings after tax amounted to SEK -1 million (-13)• Earnings per share amounted to SEK -0.01 (-0.08)• Cash flow after investing activities amounted to SEK 23 million (5) January – December 2016• Net sales decreased with 9 percent to SEK 2,135 million (2,345)• Operating profit before depreciation decreased to SEK 61 million (70)• Non-recurring items amounted to SEK -18 million (-36)• Adjusted EBIT before depreciation decreased to SEK 79 million (106)• Operating profit increased to SEK 9 million (-5)• Earnings after tax amounted to SEK 297 million (-64)• Earnings per share amounted to SEK 1.42 (-0.41)• Cash flow after investing activities amounted to SEK 30 million (-75) Bong is one of the leading providers of specialty packaging and envelope products in Europe and offers solutions for distribution and packaging of information, advertising materials and lightweight goods. Important growth areas in the Group are packaging within retail and e-commerce and the envelope market within Eastern Europe. The Group has annual sales of approximately SEK 2.1 billion and about 1,500 employees in 15 countries. Bong has strong market positions in most of the important markets in Europe and the Group sees interesting possibilities for continued development. Bong is a public limited company and its shares are listed on Nasdaq Stockholm (Small Cap). For further information, please contact Håkan Gunnarsson, CEO for Bong AB.  Tel (switchboard) 46 44-20 70 00   This information is information that Bong AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 8am CET on February 16 2017.   

Nexam Chemical Holding AB (publ) Year End Report 1 January – 31 December 2016

Fourth quarter at a glance Operational: · Receives order of SEK 5.3 million concerning the high performance product NEXIMID®. Largest order in the company history. · Signs supply agreement with Diab concerning the NEXAMITE®-technology for the production of PET-foam. Financials:                                                                                                            · Net sales for the fourth quarter totaled SEK 2,097,000 (2,513,000). · The operating loss for the fourth quarter SEK -6,431,000 (-4,923,000). · In comparison to the beginning of the year, cash and cash equivalents amounted to SEK 133,147,000 (36,305,000). · Cash flow from operating activities was SEK -5,210,000 (-2,936,000). Lund 16 February, 2017 The Board of Directors These financial statements have not been audited by the Company´s auditor. Note: This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. For further information please contact: Anders Spetz, CEO, +46-703 47 97 00, anders.spetz@nexamchemical.com This information is information that Nexam Chemical Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 08:00 CET on February 16, 2017. ____________________________________________________________________________ About Nexam Chemical Nexam Chemical develops technology and products that make it possible to significantly improve the production process and properties of most types of plastics in a cost-effective manner and with retained production technology. The improved properties include strength, toughness, temperature and chemical resistance as well as service life. The improvements in properties that can be achieved by using Nexam Chemical's technology make it possible to replace metals and other heavier or more expensive materials with plastics in a number of applications. In applications where plastic is already used, Nexam Chemicals products can improve the manufacturing process, reducing material use and enable more environmental friendly alternatives. Example of commercial applications: pipe manufacturing, foam production and high-performance plastics. More information about the business will be found on www.nexamchemical.com (http://file/////TELLUS/styrelsen/A.%20Pressmeddelanden%20och%20nyheter/Pressmeddelanden/Eng/www.nexamchemical.com). The company´s Certified Adviser is FNCA Sweden AB.

Evolution Gaming: Year-end report 2016

Fourth quarter of 2016 (Q4 2015) · Operating revenues increased by 53% to EUR 34.3m (22.4) · EBITDA increased by 39% to EUR 13.0m (9.3), corresponding to a margin of 38% (42) · Profit for the period was EUR 9.0m (6.9) · Earnings per share reached EUR 0.25 EUR (0.19) · Mobile penetration amounted to 46% (28) Full-year 2016 (2015) · Operating revenues increased by 51% to EUR 115.5m (76.4) · EBITDA increased 44% to EUR 44.6m (31.0), corresponding to a margin of 39% (41) · Profit for the period was 31.7 MEUR (20.0) · Earnings per share reached 0.88 EUR (0.56) · The Board of Directors proposes a dividend of EUR 0.45 per share (0.32) Events during the fourth quarter of 2016 · Demand remains strong for tables and environments Events following the balance sheet date · Cecilia Lager new Board Member · Launch of a new game category – Live Lucky Wheel CEO Martin Carlesund comments: 2016 marked Evolution Gaming’s 10thyear in business and I am happy to report that we wrapped up a very successful year with a strong quarter. Sales increased by 53 percent compared with the fourth quarter of 2015. Adjusted for expenses related to the upcoming move to the main market, EBITDA amounted to EUR 13.4 million, corresponding to a margin of 39 percent and an increase of 44% compared to the fourth quarter of 2015. Live Casino continues to strengthen its position among operators as well as players. Our focus on the quality of the user experience, offering the broadest product portfolio for all devices and delivering a leading service to our customers are some of the factors behind our strong results in 2016. The year ended with continued solid demand for our services and a very high pace of delivery. The fourth quarter is also seasonally positive with a high level of activity from our customers. In addition to several new customers, existing customers are continuing to expand their offerings. This quarter, new dedicated environments were launched for 888, Virgin Games and bwin, among others. Existing customers are also choosing to expand into more markets where, for example, the aforementioned bwin launched its offering in Denmark during the quarter. We have also expanded further in our latest studio at Grand Casino Bucharest. Another growth driver is the heavy increase in mobile gaming – in the fourth quarter, almost half of the gaming revenues generated via Evolution’s platform derived from mobile devices. The equivalent number is above 50% among our largest customers. Extensive development is also taking place on the product side. The roll-out of Live Ultimate Texas Hold’em to operators is continuing. We have also launched another derivative of our world leading Live Baccarat product, Baccarat Control Squeeze, where the player is given even more opportunity to actively participate in the course of the game. After the end of the quarter, we have also launched an entirely new game, Dream Catcher, inspired by popular entertainment shows. It is the world’s first game in the Live Lucky Wheel category, which reinforces our position as the market’s prime innovator in the Live segment. At the publishing of this report, this year’s ICE, Europe’s largest gaming trade fair, has just been held. As a temperature gauge on the industry, I can report that this was the most intense exhibition to date, with a very large interest in our services. Apart from premiering the above-mentioned Dream Catcher, Dual Play Baccarat was also one of our main attractions. This is our second Dual Play game, further strengthening our offer to the land-based segment.  2017 will be an exciting year for Evolution. We will continue to work according to our strategy where product innovation, regulated markets and land-based solutions are key areas. In addition to our commercial focus, we are also preparing the company for a move to Nasdaq Stockholm in the second quarter of the year. Together with my colleagues, I want to thank you for the past year. We look forward to Evolution’s continued success with confidence.

Sobi™ publishes its report for the fourth quarter and full year 2016

Swedish Orphan Biovitrum AB (publ) (http://www.sobi.com/) (Sobi™) today announces its results for the fourth quarter and full year 2016. Revenues for the full year totalled SEK 5,204 M, an increase of 61 per cent compared to 2015. Revenues for the quarter were SEK 1,292, an increase of 59 per cent. Product sales for the full year amounted to SEK 4,548 M, an increase of 77 per cent, based on strong performance across the portfolio and the launch of our new haemophilia products, Elocta® and Alprolix®. Business highlights Q4 2016 · European Commission approved the transfer of the marketing authorisation for Alprolix to Sobi · European Commission granted SOBI003 orphan designation for the treatment of MPS IIIA (Sanfilippo A Syndrome) · European study of real-life haemophilia treatment emphasises the need to improve standard of care · In collaboration with Bioverativ, data were presented reinforcing the long-term safety and efficacy of Elocta and Alprolix · Sobi entered into a distribution agreement with Horizon Pharma for Ravicti® and Ammonaps® Financial summary Q4 2016 (Q4 2015) · Total revenue of SEK 1,292 M (814), an increase of 59 per cent (54 per cent at CER) · Product revenue of SEK 1,144 M (698), an increase of 64 per cent (58 per cent at CER) · Gross margin of 67 per cent (64) · EBITA of SEK 210 M (90) · Earnings per share 0.37 SEK (-0.04) Financial summary FY 2016 (2015) · Total revenue of SEK 5,204 M (3,228), an increase of 61 per cent · Product revenue of SEK 4,548 M (2,568), an increase of 77 per cent · Gross margin of 70 per cent (62) · EBITA of SEK 1,543 M (433) · Ended the year with a cash position of SEK 786 M · Earnings per share 3.01 SEK (0.24) “2016 was a highly significant year for Sobi. We delivered strong financial performance across the portfolio, we established a platform for transformational growth through the launch of two innovative state-of-the-art treatments for haemophilia in Europe and the Middle East, and we took several important steps forward with our pipeline of innovative therapies for rare diseases”, says Sobi’s CEO and President Geoffrey McDonough. Financial summary Q4 Q4 Full Full year year Amounts in SEK 2016 2015 Change 2016 2015 Change M Total 1,292 814 59% 5,204 3,228 61% revenues(1) Gross profit 860 520 65% 3,651 2,007 82% Gross margin 67% 64% 70% 62% EBITA 210 90 1,543 433 EBIT 100 17 1,133 146 (Operating profit/loss) Profit/loss 100 -10 809 65 for the period (1)Full year 2016 revenues include a one time credit in Q1 of SEK 322 M relating to the first commercial sales of Elocta, and a one time credit in Q2 of SEK 386 M relating to first commercial sales of Alprolix. Outlook 2017* Sobi expects revenues for the full year to be in the range of SEK 5,800 to 6,000 M. Gross margin is expected to be in the range of 66 to 68 per cent. Sobi expects EBITA for the full year to be in the range of SEK 1,600 to 1,700 M. *At current exchange rates  --- Sobi's report for the fourth quarter and FY 2016 can be found on http://www.sobi.com/Investors--Media/Financial-Reports/ About Sobi™ Sobi™ is an international speciality healthcare company dedicated to rare diseases. Our mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on Haemophilia, Inflammation and Genetic diseases. We also market a portfolio of speciality and rare disease products across Europe, the Middle East, North Africa and Russia for partner companies. Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2016, Sobi had total revenues of SEK 5.2 billion (USD 608 M) and approximately 760 employees. The share (STO:SOBI) is listed on Nasdaq Stockholm. More information is available at www.sobi.com.  For more information please contact   Media relations Investor relations Linda Holmström, Senior Jörgen Winroth, ViceCommunications Manager President, Head of Investor Relations +46 70 873 40 95 +1 347-224-0819, +1 212-579 -0506, +46 8 697 2135 linda.holmstrom@sobi.com  jorgen.winroth@sobi.com  This information is information that Swedish Orphan Biovitrum AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of Linda Holmström, Senior Communications Manager, at 08:00 am CET on 16 February 2017. 

Sobi™ expands haemophilia B development portfolio by adding rFIXFc-XTEN to its collaboration agreement with Bioverativ

Swedish Orphan Biovitrum AB (publ) (http://www.sobi.com/) (Sobi™) today announces that it has elected to add a novel product candidate (rFIXFc-XTEN) for the potential treatment of haemophilia B to the company’s collaboration agreement with Bioverativ. Sobi has the right to include the rFIXFc-XTEN fusion molecule into its collaboration agreement with Bioverativ. By making a one-time payment to Bioverativ Sobi gains an opt-in right to participate in the final development and commercialisation of this product candidate. The opt-in right may be exercised by Sobi in connection with the submission of the marketing authorisation application for rFIXFc-XTEN with the European Medicines Agency. In September 2014, Sobi elected to add the rFVIIIFc-VWF-XTEN fusion molecule for the potential treatment of haemophilia A to its collaboration agreement with Bioverativ.  “Sobi is committed to help address the unmet needs for people affected by haemophilia and we are pleased to engage with this innovative product candidate which has been designed for the subcutaneous treatment of haemophilia B,” says Milan Zdravkovic, Senior Vice President, Chief Medical Officer, and Head of Research & Development at Sobi. “We are inspired by the collaboration we have with Bioverativ to support people living with haemophilia. We have a longstanding relationship and this decision further adds to our common aspirations.” - - - About haemophilia BHaemophilia B is caused by having substantially reduced or no factor IX activity, which is needed for normal blood clotting.[i] (https://teamsites.sobi.com/s/corporate-communications/Shared%20Documents/Press%20releases/012_XTEN/012e_XTEN_170216_1.docx#_edn1) The World Federation of Hemophilia estimates that approximately 28,000 people are currently diagnosed with haemophilia B worldwide.[ii] (https://teamsites.sobi.com/s/corporate-communications/Shared%20Documents/Press%20releases/012_XTEN/012e_XTEN_170216_1.docx#_edn2) People with haemophilia B may experience bleeding episodes in joints and muscles that cause pain, decreased mobility and irreversible joint damage. In the worst cases, these bleeding episodes can cause organ bleeds and life-threatening haemorrhages. Injections of factor IX temporarily replace clotting factors necessary to resolve bleeding and, when used prophylactically, to prevent new bleeding episodes.i About the Sobi™ and Bioverativ collaborationSobi and Bioverativ collaborate on the development and commercialisation of Alprolix and Elocta/ELOCTATE®. Bioverativ has final development and commercialisation rights in North America and all other regions in the world excluding the Sobi territory, and has manufacturing responsibility for ELOCTATE and Alprolix. Sobi has final development and commercialisation rights in the Sobi territory (essentially Europe, North Africa, Russia and most Middle Eastern markets). Bioverativ was created as a spin-off from Biogen’s haemophilia business and separated from Biogen effective February 1, 2017. Bioverativ is an independent, publicly-traded company, headquartered in Waltham, Massachusetts, USA. During a temporary transition period, which includes time to allow Bioverativ to establish certain licenses and consents related to ELOCTATE® and ALPROLIX, each of Bioverativ and Biogen will have a relationship to the products. About Sobi™Sobi is an international specialty healthcare company dedicated to rare diseases. Sobi’s mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on Haemophilia, Inflammation and Genetic diseases. Sobi also markets a portfolio of specialty and rare disease products across Europe, the Middle East, North Africa and Russia for partner companies. Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2016, Sobi had total revenues of SEK 5.2 billion (USD 608 M) and about 760 employees. The share (STO: SOBI) is listed on Nasdaq Stockholm. More information is available at www.sobi.com. For more informationplease contact  Media relations   Investor relationsLinda Holmström, Senior Jörgen Winroth, ViceCommunications Manager  President, Head of Investor Relations+ 46 708 73 40 95, + 46 +1 347-224-0819, +1 212-5798 697 31 74   -0506, +46 8 697 2135linda.holmstrom@sobi.com jorgen.winroth@sobi.com  This information is information that Swedish Orphan Biovitrum AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of Linda Holmström, Senior Communications Manager, at 08:15 am CET on 16 February 2017. ---------------------------------------------------------------------- [i] (https://teamsites.sobi.com/s/corporate-communications/Shared%20Documents/Press%20releases/012_XTEN/012e_XTEN_170216_1.docx#_ednref1) World Federation of Hemophilia. About Bleeding Disorders – Frequently Asked Questions. Available at: http://www.wfh.org/en/page.aspx?pid=637#Difference_A_B. Accessed on: January, 13, 2017. [ii] (https://teamsites.sobi.com/s/corporate-communications/Shared%20Documents/Press%20releases/012_XTEN/012e_XTEN_170216_1.docx#_ednref2) World Federation of Hemophilia. Report on the Annual Global Survey 2013. Available at: http://www1.wfh.org/publications/files/pdf-1591.pdf. Accessed on: January 13, 2017. 

Starbreeze AB (publ) Year-End Report 2016

The full year-end report in Swedish is available at www.starbreeze.com/investor-relations/. The English version of the report will be available within a week. Financial statements in English are available at the end of this document. CHANGED FISCAL YEAR  Note that in accordance with the decision taken on the Annual General Meeting in November 2015, this is the fourth quarterly report after changing the company’s fiscal year to calendar year. The comparative period Q4 2015 corresponds to October-December 2015, previously Q2 2015/2016.  FOURTH QUARTER (OCTOBER - DECEMBER 2016) · Net revenue amounted to SEK 99.4 million (SEK 48.9 million), representing a growth of 103 %. Sum of revenues and capitalized development amounted to SEK 165.5 million (SEK 73.6 million). · During the quarter, PAYDAY 2 represented SEK 37.2 million (SEK 47.7 million) of net revenue. · During the quarter, Dead by Daylight represented SEK 54.6 million (SEK 0.0 million) of net revenue. · Operating income before depreciation and amortization, EBITDA, amounted to SEK 38.8 million (SEK 15.2 million), implying a margin of 23.4 percent. · Income before tax amounted to SEK 32.3 million (SEK 14.0 million). · Net income for the period amounted to SEK 30.2 million (15.4 million). · Earnings per share before dilution were SEK 0.11 (SEK 0.07) and earnings per share after dilution were SEK 0.11 (SEK 0.07). · Cash flow from operating activities amounted to SEK 12.9 million (SEK -3.0 million). · As of December 31, cash and cash equivalents totaled SEK 669.4 million (SEK 85.4 million).  FISCAL YEAR (JANUARY – DECEMBER 2016) · Net revenue amounted to SEK 345.5 million (SEK 218.4 million), representing growth of 58 %. Sum of revenues and capitalized development amounted to SEK 523.0 million (SEK 299.6 million). · Operating income before depreciation and amortization, EBITDA, amounted to SEK 81.2 million (SEK 49.5 million) equivalent to an EBITDA margin of 15.5 %. · Income before tax amounted to SEK 55.9 million (SEK 43.1 million). · Net income for the period amounted to SEK 57.1 million (SEK 39.4 million). · Earnings per share before dilution were SEK 0.22 (SEK 0.20) and earnings per share after dilution were SEK 0.22 (SEK 0.20). KEY EVENTS DURING THE FOURTH QUARTER (OCTOBER – DECEMBER 2016) · In October, Starbreeze carried out a direct share issue to institutional investors, where Första AP-fonden, a major Swedish pension fund, subscribed for a majority of the shares issued. A total of 16,452,991 shares were issued at a price of SEK 23.40, equivalent to a total amount issued of   SEK 385 million. In connection with the new issue, Första AP-fonden also acquired 1,850,000 shares from Indian Nation AB, the company of Starbreeze Chairman Michael Hjorth. · In October, Starbreeze acquired Nozon, a Belgian Visual Effects (VFX) studio and the developer of the PresenZ technology. The PresenZ technology, which was released in 2015, makes it possible to convert 3D films to VR films, and thereby overcome the technical differences between film and game environments. This occurs through interactive parallax in virtual reality and delivers high quality blockbuster computer graphics with true immersive feeling. Since 1998, Nozon has steadily grown to become a well-known, and award winning VFX studio thanks to the company’s creative/artistic approach and technology development. The consideration amounted to EUR 7.1 million, of which EUR 4.6 million was in cash and EUR 2.5 million in newly issued Starbreeze B shares. In addition, the parties also agreed on a 10-year earnout period, based on revenue from the PrezenZ technology. After the acquisition, Starbreeze’s has deepened its analysis of the PresenZ technology, which has resulted in the decision to include all the potential earnout in the calculation of goodwill from the acquisition. The goodwill is estimated at SEK 257.5 million as of December 31, 2016. · In December, Starbreeze agreed to acquire 90.5 percent of the shares in the Indian production company Dhruva Interactive. The total consideration amounted to USD 8.5 million, of which    USD 7.0 million was in cash and USD 1.5 million in newly issued Starbreeze B shares. The deal is planned to be completed in 2017 and had no impact on earnings during 2016. Dhruva Interactive is a highly reputed and best-of-breed art production house, with whom Starbreeze has a long-standing relationship. Founded in 1997, Dhruva is India’s leading game developer with over 320 employees, providing art production services to the global games industry. Dhruva has three studios in India. · During the quarter, Carnegie Investment Bank was appointed as advisor for the company’s relisting to Nasdaq Stockholm’s main market. Starbreeze intends to complete the relisting during 2017. · In November, a new brand was announced in the Publishing division. The new label Starbreeze IndieLabs aims to help projects that are smaller in scope to reach the market. Together with the Croatian studio Lion Game Lion, Starbreeze has agreed that the company will invest USD 300,000 to bring the game AntiSphere to PC and other platforms. Per the agreement Starbreeze will receive 30 percent of revenues, after the initial investment has been fully recouped by Starbreeze. Lion Game Lion and Soap Interactive in turn will retain 100 percent of the IP rights. AntiSphere is a top-down competitive arena battle game in which players use their skills in order to catch each other, and win the match. · In November, Starbreeze entered its second IndieLabs project with the Dutch studio KeokeN Interactive to publish the title “Deliver Us The Moon”. Starbreeze will invest USD 500,000 to bring the game to PC and other platforms. Starbreeze will be able to recoup 120 % of its investment, and will subsequently retain 50 percent of the revenues after distribution fees. KeokeN will retain 100 % of the IP rights. Deliver Us The Moon is set in the near future where the earth’s resources are nearly depleted. A brave astronaut will take the great step and travel to the moon in a do-or-die secret mission to save humanity. AFTER THE QUARTER · In early January, Starbreeze announced that the first pilot center for IMAX VR Experience had opened in Los Angeles, in close proximity to the popular shopping area - The Grove and Farmers Market. In the center, visitors will be able to test high quality VR experiences in StarVR, which is produced in collaboration with Acer. Experiences available for StarVR include John Wick Chronicles: Arcade Edition and the range will be gradually extended as new VR experiences in both film and games become available. StarVR was positively received by visitors and along with John Wick Arcade Edition, is currently one of the most popular VR experiences in the center. · After the opening of the first IMAX VR Experience center in Los Angeles, Starbreeze announced that the company is negotiating with IMAX regarding the continuation of the agreement on premium experiences in IMAX VR Centers, which was announced in May 2016. In light of the decision of IMAX to broaden its offering to include widely available VR experiences during the launch of the center, Starbreeze anticipates that the form of collaboration will be adapted accordingly. · The VR game John Wick: Chronicles was released on Steam for HTC Vive on February 9, in connection with the premiere of the movie John Wick: Chapter 2. The game was available for pre-order for USD 19.99 via the platform from October 6, 2016. · In January, Starbreeze signed an agreement with Behaviour Digital regarding a digital version of Dead by Daylight for PlayStation 4 and Xbox One. To date, more than 1.8 million copies of the game’s PC version have been sold on Steam. The development costs for the modifications required for the console version will be shared equally between the parties. The revenue sharing model follows the existing agreement. In February, Starbreeze signed a distribution agreement with Digital Bros’ subsidiary 505 Games regarding physical distribution of Dead by Daylight for PlayStation 4 and Xbox One. Furthermore, this means that 505 Games will pay an advance royalty of USD 2.5 million, which will be shared between Starbreeze and Behaviour. The agreement does not cover the Asian and Nordic markets. The console version of the game is expected to be released during the second quarter of 2017. · In February, Starbreeze signed an agreement with Double Fine Productions to publish the game Psychonauts 2. Starbreeze will invest USD 8 million to bring the game to PC and console platforms together with Double Fine Productions. The release is expected to occur sometime during 2018. The development of the game was previously funded by Double Fine Productions and through equity crowdfunding via the Fig service. Starbreeze will be able to recoup 100 % of its full investment including marketing costs and will receive an initial revenue share of 85 % after distribution fees and Fig crowdfunding revenue share. Starbreeze share of revenues will become 60 % after the investment is recouped, after distribution fees and Fig crowdfunding revenue share. Psychonauts 2 is a third-person action/adventure game where players control Razputin Aquato   – a newly graduated Psychonaut with powerful psychic abilities. STARBREEZE KEEPS DELIVERING CEO BO ANDERSSON KLINT GIVES HIS COMMENT We’re proud to yet again show a triple digit growth for this quarter and the highest EBITDA since the launch of PAYDAY 2. It is a solid performance that shows our ability to deliver profitability while we are scaling our business to secure future growth. PAYDAY The PAYDAY franchise generated SEK 37.2 million (SEK 47.7 million) in total whereof SEK 0.0 million (SEK 14.4 million) in production support. As the sole owner of the PAYDAY IP, we no longer receive any production support revenues. We’re additionally still awaiting 505 to recoup USD 5 million on console, while we get 100% of the healthy PC sales. Moreover, we expect 505 to have reached their USD 5 million recoup in Q1 2017 as we see impressive PAYDAY performance through digital distribution on consoles following the lastest update. DEAD BY DAYLIGHT We’re over the moon with Dead by Daylight, a complete success both strategically and financially. The game has now sold over 1.8 million units on PC and contributes with SEK 54.6 million to Starbreeze net revenues in Q4, making it the best quarter through the game’s lifetime. An impressive trend that we, together with Behavior, will nurse carefully as we expand the product to consoles in Q2 2017. To date, the game has generated over 267 MSEK in gross sales on Steam. STARBREEZE FINANCES We’re also delighted to see that both our acquisitions, ePawn and Nozon, for the first time are contributing to top-line. Both businesses are now fully integrated and run at full speed within Starbreeze. As we continue our steady growth we need to invest in our key assets PAYDAY, OVERKILL's The Walking Dead, Valhalla engine, StarVR and in our very important publishing business. Consequently, our operating expenses, excluding royalties to publishing partners, have increased with SEK 46.7 million or 78 % compared to Q4 2015. The incremental spend is in all material aspects still derived from employee related expenses as we continue to ramp up the teams for delivering on our plans. Despite the increase in costs we show a remarkable profitability with an EBITDA margin reaching  23.4% underpinned by a strong development of our top line but also boosted by a stronger US dollar.   Boosted by successful financing activities during the third quarter, we’re ending the year with a cash position of SEK 669.4 million (SEK 85.4 million). To be clear, these funds will not be put in the bank to rest, they will continue to build our momentum. Hence we expect it to be reduced over time. Worth noting is also that we now have positive cash flow from our operating activities amounting to         SEK 12.9 million (SEK -3.0 million). When closing the fourth quarter we also close the financial year 2016 where net revenues reached SEK 345.5 MSEK (SEK 218.4 million) which is 62 % better than the financial year when we launched PAYDAY 2. EBITDA reached SEK 81.2 million (SEK 49.5 million) and net profit SEK 57.1 million (SEK 39.4 million). Our core business is doing very well. VR-CENTER IN LOS ANGELES As the first phase of building and operating a pilot VR center, mimicking our VR arcade concept StarCade, with IMAX is underway, we have entered into negotiations with IMAX about the future sale of content and StarVR-headsets into this business. At the VR center, we operate under our original agreement and have two pods equipped with the latest iteration of our StarVR HMD showcasing John Wick Chronicles Arcade Edition in collaboration with Lionsgate. Since January, we have thoroughly enjoyed having customers and potential partners visit the center to experience both the hardware as well as our content, something that has strengthened our view that location-based VR at this time is the best way for consumers to experience high-quality VR. Our goal is to sell StarVR systems to as many different location-based businesses, theme parks and B2B projects as possible. Our aim is to sell a broader range of headsets and systems through our joint venture with Acer under the brand StarVR. STARVR EVOLUTION While we, just as planned, have not yet started shipping larger volumes of StarVR, the current interest from multiple markets and from prominent brands and business sets us up well for the mass production phase beginning later in 2017. We focus on distributing and prioritizing the current development version of the headset to key partners, ensuring that we are compatible with leading industry systems and standards to fully enable us to lead the charge once we deliver the first full production unit. We estimate approximately two more development iterations during the year, where we trust that the third iteration will include Tobii’s proprietary eye tracking. Durability, field of view, hygiene, resolution, refresh rates and weight are all key aspects that we improve constantly and according to plan. The roadmap of StarVR is clear, we’re still targeting B2B partners as our primary business, and we keep delivering as planned at our decided phase. We aim to make the development of StarVR and sales of VR content a significant business for us down the line. We secure this through making early investments and strategic collaborations. This will educate us internally how to master the experience design and optimize our production. Once the market is mature, we’ll be in a pole position. For the fourth quarter StarVR with related activities account for less than 10% of Starbreeze operating expenses. NOZON’S PRESENZ While we’re integrating all of our recent acquisitions with Starbreeze vision to build future ecosystems, Nozon’s Presenz technology is generating quite the buzz in Hollywood. Nozon is now working hard together with our business development team to produce its first showcase VR short movie that we believe will build the foundation for a major cogwheel in our VR offering. Using PresenZ, movie studios can use their CG assets from feature films repurposing them easily for VR movies without losing visual fidelity. We strongly believe that together with the high-resolution of StarVR, this can be a groundbreaking technology for movie and entertainment production everywhere.   PAYDAY MOBILE, BCN STUDIO As a separate note to this report, we also just announced that we’ve opened a new office in Barcelona, Spain. The Barcelona Studio consists of a handful of very talented individuals that have been with us in Stockholm for quite some time. Together with old friends and now new colleagues joining us from a prominent mobile developer, they form our task force to steer our mobile projects with a 100% focus. The bulk of the development will mainly be outsourced but we require a dedicated team from Starbreeze to make sure we are on point and deliver with the same focus as our other products. Starbreeze Barcelona will closely monitor the wrap up of Geminose and also focus its efforts on PAYDAY: Crime War. After a due diligence of the progress on the mobile version of our beloved PAYDAY franchise, we found a lack of focus on our product. As we want to see this game realized as badly as many of our fans, we’ve moved production to another studio, BadFly Interactive. As part of a work-for-hire partnership, BadFly have hit the ground running and we look forward to sharing more from the game in the months to come. The project has already accelerated considerably and is now fully playable in multiplayer with the games backend in place. The following months will be dedicated to building more content and polishing the gameplay format to maximize the fun of the final product. In 2017 we also continue our full productions of RAID, OVERKILLS The Walking Dead, CROSSFIRE Co-Op and Geminose. Our lineup is strong and our teams dedicate their full energy in making the games as high-quality as recent products such as the PAYDAY and Dead by Daylight DLC releases. Our success is of course shared by and thanks to our partners. Lately we had the pleasure to work with Universal on our PAYDAY Scarface DLCs in December. Additionally, we’ve continued our extremely successful partnership with Lionsgate on two DLCs for PAYDAY and the release of the stand-alone VR game John Wick Chronicles on Steam and in the IMAX VR center. These collaborations are tremendously important to us as we establish Starbreeze as a trusted partner for top-tier brands as well as it gives us an ever-growing community of fans from near and far enjoying and talking about Starbreeze products. Our publishing portfolio has grown to secure a steady flow of products, big and small, for the upcoming year. We are proud to have signed up Double Fine with Tim Shafer leading the development of their new AAA game Psychonauts 2. We are constantly looking to attract leading teams to our publishing business and 2017 will see a number of these projects initiated by Starbreeze. It is with great satisfaction that we also can announce that PAYDAY 3 production is officially initiated and at a full design stage. I’d like to especially clarify, that this project will enjoy as much time as we deem needed. It will be done when it’s done. This is our single most important brand today and the cornerstone of our business and we will treat it accordingly. Updates in the near future might be scares and far between. You simply don’t rush PAYDAY 3. With a team of over 550 talented developers, post the acquisition of Dhruva, we are well staffed for the full productions going forward. With this strategic acquisition our capacity is very satisfying, meanwhile we keep recruiting more game developers to secure quality and talent for the future. Our AAA game productions and our innovative VR pipeline is providing our developers with real challenges and exciting careers. At Starbreeze, we look forward to keep delivering on our games, services and strategy for 2017 and beyond. Let’s do this!### This information is information that Starbreeze AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 08:30 a.m. CET on 16 February, 2017 For more information, please contact:Starbreeze Investor Relations Contact: Maeva Sponbergs, +46 (0)8 209 208 or ir@starbreeze.com  About Starbreeze  Starbreeze is an independent creator, publisher and distributor of high quality entertainment products. With studios in Stockholm, Paris, Los Angeles, Barcelona and Brussels, the company creates games and other virtual reality entertainment products, based on proprietary design and licensed content. Starbreeze's most recent games include PAYDAY 2®, John Wick VR shooter and upcoming survival co-op FPS OVERKILL’s The Walking Dead. Under its publishing initiative, Starbreeze has together with Canadian studio Behaviour Digital successfully launched horror thriller Dead by Daylight.x Starbreeze has set out to develop truly immersive virtual reality experiences, by integrating software and hardware in its StarVR® head mounted display, which is produced together with Acer, displaying a unique field of view and a mission to bring top-end VR to large audiences. Together with IMAX, Starbreeze aspires to dominate the location based VR market with the IMAX VR centers. The first IMAX VR center opened in Los Angeles in January 2017.  Headquartered in Stockholm, Sweden, Starbreeze's shares are listed on Nasdaq Stockholm First North Premier under the tickers STAR A and STAR B with the ISIN-codes SE0007158928 (A share) and SE0005992831 (B share).  Remium Nordic is the company's Certified Adviser. For more information, please visit http://www.starbreeze.com, http://www.starvr.com, http://www.overkillsoftware.com  

New White Wolf Games Arrive Today with new Vampire and Mage stories (in the World of Darkness)

STOCKHOLM, SWEDEN (16th of February 2017) White Wolf Publishing today releases Vampire The Masquerade: We Eat Blood and Mage The Ascension: Refuge, two all-new interactive fiction games for Android, iOS, and PC. These classic roleplaying games enter the digital age with two new titles inspired by choose your own adventure books, written and illustrated by award-winning authors and artists. In Vampire The Masquerade: We Eat Blood you’re a young artist who wakes up at night to find you’re no longer human…but exactly what are you and why are you so ravenously hungry for blood?!? Told entirely through an innovate mobile messaging perspective, We Eat Blood is a sharp, mature, and terrifying story about your first nights as unwilling predator and prey. Will you join ancient vampire conspiracies, or will you turn the tables on oppressive authority and seek your own future? The temptation is real. The game is written and illustrated by Zak Sabbath and Sarah Horrocks. In Mage The Ascension: Refuge you play a volunteer at a European camp for Syrian refugees, and suddenly you discover that magic is real, you can use it, and you’re in the middle of a secret magical war for the fate of the world. The game lets you experience today’s social and political upheavals while learning that you can shape reality itself through sheer force of belief. Your actions and choices will have profound consequences on the world and people around you. Safety or sacrifice? Let them in or build the wall? The choice is yours. The game is written by noted Swedish author Karin Tidbeck. “The World of Darkness has always been about mature, intelligent stories,” said White Wolf Creative Director Martin Ericsson. “These new games uphold that tradition, but we put a very modern twist on it: we see our games as a way not only to entertain, but to look closely at contemporary issues, and ask some of the big questions of our time.” “We are absolutely delighted to see the first games from the new White Wolf based on our most popular brands reach our fans on both mobile and Steam,” said White Wolf CEO Tobias Sjögren. “We know we can create great entertainment as well as serve the responsibility any content creators have helping the audience reflect on the world around them. These games show we are keen on trying new formats and that stories in World of Darkness doesn’t shy away from tough questions or contemporary issues.” These game releases are the first digital game releases in over a decade for this acclaimed story world, and this release marks the start of White Wolf’s emergence as a transmedia entertainment company. White Wolf are working on a 5th edition of the Vampire: The Masquerade tabletop RPG books and recently announced a video game adaptation of Werewolf: The Apocalypse. Learn more about Vampire the Masquerade: We Eat Blood and Mage the Ascension: Refuge at White Wolf’s website: www.white-wolf.com.

Public transport supplier Pilotfish Networks AB is acquiring Appello Technologies AB

Pilotfish supplies a combination of a standardised communication platform and a range of services which in various ways improve productivity within the public transport system. At present, public transport in Scandinavia and in Europe in general is undergoing a rapid transition, with major challenges in the form of increased competition, new technology, electric vehicles and new information technologies. Cloud-based applications and services, standardised platforms and efficient autonomous vehicles are important tools for meeting the rapid changes which are currently taking place within the public transport sector. Executive Director of Pilotfish, Tomas Gabinus, says that “Appello has a fantastic team, which with its expertise within the fields of application development, maps and navigation services - used by millions of end-users - is a perfect complement to Pilotfish’s current team”. Tomas adds that “we furthermore intend to continue to develop Appello’s navigation service Wisepilot, which is supplied internationally to a range of telecommunications operators”. Lars Szakaly, Executive Director of Appello, remarks that “we at Appello look forward to working together with Pilotfish on continuing our collective journey as suppliers of modern applications for public transport”. For more information please contact: Tomas Gabinus, Executive Director, Pilotfish Networks AB. Tel.: +46 (0)31 3396674. Email: tomas.gabinus@pilotfish.se Pilotfish’s ambition is to achieve a higher level of competitiveness for bus and train operators within the public transport sector. Pilotfish’s approach is centred on structured digitalisation based around an open communication platform which can be supplemented with various user-friendly applications for utilization via the implementation of strategies aimed at continuous improvements. Pilotfish’s tender is based upon standards and architectures which are administered by the European Committee for Standardization’s ITxPT (Information Technology for Public Transport).

Stora Enso plans to shut down one SC paper machine at Kvarnsveden Mill in Sweden

Stora Enso will start co-determination negotiations with employees at its Kvarnsveden Mill in Sweden regarding a plan to reorganise the mill, including a permanent closure of paper machine (PM) 8. The planned actions would affect a maximum of 140 employees. The paper machine has an annual capacity of 100 000 tonnes of super-calendered uncoated magazine paper (SC) and it is planned to be shut down by the end of the second quarter of 2017. The plan would result in annual cost savings of EUR 12 million. Stora Enso will book restructuring charges of approximately EUR 17 million as an item affecting comparability (IAC) in its Q1/2017 results, of which about EUR 14 million will be cash costs. The planned closure would not have material impact on Stora Enso’s sales or operational EBIT. “We plan to reorganise Kvarnsveden Mill to ensure its competitiveness in the structurally declining paper market. This plan includes the permanent shutdown of PM8, which, due to its small size and technical age, is unfortunately no longer competitive in the current market conditions. We appreciate the efforts taken by the employees, and regret that this plan would be necessary to support the competitiveness of Kvarnsveden Mill going forward,” says Kati ter Horst, EVP Paper division. The closure of PM8 at Kvarnsveden Mill would not impact Stora Enso’s SC paper offering. In Europe, Stora Enso continues to produce SC paper at Kvarnsveden Mill PM12 as well at Maxau Mill in Germany and Langerbrugge Mill in Belgium. The group also serves its SC customers from Dawang Mill in China. No decisions regarding the planned reorganisation or employee impact will be taken until the co-determination negotiations have been concluded. Production at Kvarnsveden Mill would continue on two lines, PM10 for improved newsprint paper and PM12 for SC papers. For further information, please contact:Ulrika Lilja, EVP, Communications, tel. +46 72 221 9228Liisa Nyyssönen, SVP Communications, Paper division, tel. +358 40 544 3491 Investor enquiries:Ulla Paajanen-Sainio, SVP, Investor Relations, tel. +358 40 763 8767Stora Enso is a leading provider of renewable solutions in packaging, biomaterials, wooden constructions and paper on global markets. Our aim is to replace fossil based materials by innovating and developing new products and services based on wood and other renewable materials. We employ some 25 000 people in more than 35 countries, and our sales in 2016 were EUR 9.8 billion. Stora Enso shares are listed on Nasdaq Helsinki (STEAV, STERV) and Nasdaq Stockholm (STE A, STE R). In addition, the shares are traded in the USA as ADRs (SEOAY). storaenso.com (http://www.storaenso.com/)

Sectra Tiger approved for NATO SECRET

The ability to transfer information quickly and securely, without the risk of eavesdropping, can be vitally important for authorities, defense organizations and critical societal functions. Sectra Tiger/S 7401 offers the highest level of protection against eavesdropping attacks, even from state actors, and is a unique solution that is approved for both mobile and fixed communication at the NATO SECRET security level. Sectra Tiger/S 7401 was developed by Sectra under guidance from the Netherlands National Communications Security Agency (NL-NCSA). This approval confirms that the long and fruitful cooperation between Sectra and NL-NCSA meets the highest requirement for communication security.  Thanks to cooperation with customers and national security authorities in numerous countries, Sectra’s various solutions for secure communications have now been delivered to more than half of the EU’s member states, for national use and within the context of the EU and NATO. Users include government officials, officials in the diplomatic corps, decision-makers in defense and critical infrastructure, and military personnel in the field. Common to these is that they use security-approved products to communicate securely and that they have high demands on flexibility and mobility.  About Sectra Tiger/S 7401The secure mobile phone Sectra Tiger/S 7401 is the top tier of an ecosystem of security-approved products for secure communications. The system also covers solutions for secure smartphone use and secure fixed telephony. By using Sectra Tiger Ecosystem, an organization can assign secure communication solutions based on an individual’s communication and security requirements. Sectra Tiger/S 7401 also enables secure communications between different security domains. This means a user can securely communicate with colleagues in NATO, the EU and their respective national networks, with a single telephone, which is unique in the crypto industry. Download press images: communications.sectra.com/news-and-media/image-bank 

Airport operator Avinor extends its investment in IFS Applications

By upgrading to IFS Applications 9, Avinor will be able to leverage its layered application architecture and new support model, which will ensure that the company is always benefitting from the latest updates and enhancements in a cost-efficient way. In addition, the upgrade will give Avinor extended capabilities to monitor and document that work processes are carried out in accordance with the industry’s stringent safety requirements. IFS Applications 9 will also empower Avinor employees with the role-based and customizable IFS Lobby™ interface. “We chose to upgrade to IFS Applications 9 because we see great benefit in running evergreen ERP in the future,” Avinor CIO Brede Nielsen said. “Our goal is to remain the leader in terms of service delivery, safety, quality, and cost efficiency. In an increasingly complex industry, a comprehensive ERP suite is one of the most important enablers for achieving operational excellence.” Glenn Arnesen, CEO of IFS in Scandinavia, added, “Avinor plays a pivotal role in ensuring Norway’s airports run smoothly, making process efficiency and safety of the utmost importance. IFS Applications 9 will give Avinor a solid platform for ensuring business transparency and control in an always-updated, flexible environment. We are proud of the renewed trust that Avinor has placed in our solutions and we look forward to continuing our mutually beneficial partnership.” The two companies’ business relationship dates back to 1996, when IFS Applications was chosen as the central maintenance system for Oslo Airport Gardermoen. In 2012 (http://www.ifsworld.com/corp/news-and-events/newsroom/2014/10/21/13/06/2012-12-20-avinor/), Avinor chose to deploy IFS Applications 8 as its central ERP solution to manage and control its varied business processes across a network of 46 airports all over Norway. In 2013 (http://www.ifsworld.com/corp/news-and-events/newsroom/2014/10/21/12/47/2013-07-09-avinor/), the company opted to expand its IFS portfolio with additional functionality for HSEQ (health, safety, environment, quality) reporting. Another area where Avinor already enjoys major benefits, thanks to IFS Applications, is within procurement. The procurement solution is used for achieving a more precise ordering of security personnel, something that used to be a major cost and was sometimes problematic because of the airports’ diverse needs. The solution, together with process improvement, has contributed to substantial savings. Learn more about how IFS supports business in the civil aviation sector: www.ifsworld.com/corp/industries/aerospace-and-defense/civil-aviation-sector/.

Deveo combines forces with a global cloud computing powerhouse

Helsinki, Finland, February 2017: Code hosting and collaboration platform, Deveo, has joined forces with Alibaba Cloud, the cloud computing arm of Alibaba Group, to become   the first repository platform within the Alibaba Cloud Marketplace. With free private repositories, support for Git, Mercurial, and Subversion version control systems, and WebDAV, for storing binary files, Deveo offers a unique private hosting environment. “We are glad to partner with Alibaba Cloud to deliver the best tools for the developers to use in the cloud.” explained Deveo CEO, Ilmari Kontulainen. “The first step was adding Deveo to Alibaba Cloud’s marketplace, but we look forward to discussing a more in-depth collaboration to offer the whole DevOps tool stack on the cloud with a click of a button.”Deveo has been creating proprietary software to assist high-profile enterprises for the last 10 years, as part of the leading Finnish DevOps organization, Eficode. In 2014, the team launched their code hosting and collaboration platform as a standalone application, and while retaining enterprise users, set their sights on the wider industry.“Deveo's sister company has already introduced disruptive innovation in the mobile payment sector.” said Kontulainen. “We are hoping to find disruptive innovations in the DevOps tool sector together with Alibaba Cloud.”   Contact: Ilmari Kontulainen, ilmari@deveo.com, +358 440 715518Deveo Pohjoinen rautatienkatu 25, 00100 Helsinki, FinlandMore about Deveo: https://deveo.comAssets available: http://bit.ly/2fcAhBT   About DeveoBefore Deveo was founded in 2014, the founding team were building custom-tailored software production solutions for customers, including some of the world's largest companies. The small team of 8 work in a fully distributed company, with employees all over Europe, from the UK to Romania. The team are united by 5 core values of simplicity, transparency, customer centricity, curiosity and initiative, and are on a mission to streamline software development.

ALE and Hoist Group Enter Partnership to Address the Hospitality and Healthcare Markets

“Hoist Group is focused on making fully integrated, reliable and competitive solutions available to our customers, ones which ensure high quality services along with end user satisfaction. Combining the knowhow and technology of both ALE and our business will allow us to offer a wider range of solutions, open new areas of development and reinforce our leadership as the one and only hospitality partner for hotels”, says Marc Valentin, CTO at Hoist Group. The partnership creates a full end-to-end solution for the hospitality and healthcare EMEA market combining the Hoist Group Fusion Platform capabilities (guest and internet access, video content, centralised management, TV services, Digital Signage, PMS for hospitality & healthcare) with the Alcatel-Lucent Enterprise network LAN and WiFi, communications phones and cloud offers. As well, the two companies will offer integration and customisation capabilities via an enhanced go-to-market and geographical coverage beyond the original scope of EMEA.  “The hospitality and healthcare markets are key verticals for ALE. We have over 20 years of success with customers in these industries. The partnership with Hoist Group is an essential step forward in further developing our market relevance as well as distribution coverage. It will allow us to create enhanced end-to-end solutions and services for customers in these key vertical markets”, concludes Thierry Bonnin, WW senior Vice President verticals & Strategic partnerships.

Alligator Bioscience AB Full Year 2016 Report

Summary · During the quarter were the company’s shares listed for trading on Nasdaq Stockholm Mid Cap. In connection with this were new shares issued that provided the company 350 000 TSEK before underwriting expenses. · The company's project portfolio has continued to develop according to plan including the start of dosing in a second phase I clinical trial that is done by Janssen Biotech. · The Board of Directors proposes that no dividend shall be paid for the year 2016. Conference call for investors, analysts and the mediaThe 2016 Financial Statement will be presented by Alligator’s CEO, Per Norlén and members of the management group on Friday February 17, 2017, at 10.00 (CET).Phone numbers for participants from:Europe: +44 (0) 2030089803, Sweden: +46 856642696, US: +1 8558315946The recorded conference call will be available on Alligators website after completion of the conference, www.alligatorbioscience.com Fourth quarter 2016 in summary  · During the quarter, the company's shares were listed on the Nasdaq Stockholm Mid Cap. · In connection with this, a new share issue which provided the company TSEK 350 000 before underwriting expenses was done. · In October began dosing in a second phase I clinical trial with ADC-1013. This second study includes intravenous dose escalation and is done by Janssen Research & Development LLC. · Net sales for the period amounted to TSEK 6 433 (512). · Result for the period amounted to TSEK -19 352 (-39 450) which corresponds to a result per share before and after dilution with SEK -0,31 (0,67). · Cash flow amounted to TSEK 310 886 (-28 690) and cash and cash equivalents at the end of the quarter amounted to TSEK 659 136 (365 605). January - December 2016 in summary · Alligator’s clinical study with ADC-1013 was expanded in the first quarter resulting in a milestone payment of 5 MUSD following the terms in the partnership agreement with Janssen Biotech Inc. · Janssen started in October a phase I clinical trial with ADC-1013. · Cell-line development for manufacturing of clinical materials for ATOR-1015 began in January. · Result for the period amounted to TSEK -48 356 (207 377), which is equivalent to earnings per share before and after dilution of SEK -0,80 (3,81 and 3,70 respectively). · Cash flow for the period amounted to TSEK 287 135 (326 232). · During the second quarter, the participation in the Biosynergy project was written down with TSEK 22 120. · During 2016 has Alligator increased the share of expenses invested in R&D to 64,3% (54,6%). · The number of employees has increased during 2016, mainly within R&D, and the company is well prepared for further development in 2017. Events after the end of the period · In January 2017 has 700 000 warrants been converted to an equal number of shares. Financial summary (Group)  +---------------------------+-------+--------+-------+--------+| |October-December|January-December|+---------------------------+-------+--------+-------+--------+| |   2016|   2015 |   2016|   2015 |+---------------------------+-------+--------+-------+--------+|Net sales, TSEK (SEK | 6 433| 512| 58 240| 289 797||thousand) | | | | |+---------------------------+-------+--------+-------+--------+|Profit/loss for the period,|-19 352| -39 450|-48 356| 207 377||TSEK | | | | |+---------------------------+-------+--------+-------+--------+|Cash flow for the period, |310 886| -28 690|287 135| 326 232||TSEK | | | | |+---------------------------+-------+--------+-------+--------+|Cash and cash equivalents, |659 136| 365 605|659 136| 365 605||TSEK | | | | |+---------------------------+-------+--------+-------+--------+|Equity ratio, % | 96%| 95%| 96%| 95%|+---------------------------+-------+--------+-------+--------+|R&D costs as % of operating| 68,5%| 47,3%| 64,3%| 54,6%||costs excluding impairments| | | | |+---------------------------+-------+--------+-------+--------+|Earnings per share before | -0,31| -0,67| -0,80| 3,81||dilution, SEK | | | | |+---------------------------+-------+--------+-------+--------+|Earnings per share after | -0,31| -0,67| -0,80| 3,70||dilution, SEK | | | | |+---------------------------+-------+--------+-------+--------+|Average number of employees| 35| 26| 31| 27|+---------------------------+-------+--------+-------+--------+  For further information, please contact:Rein Piir, VP IR, rein.piir@alligatorbioscience.com, +46 (0) 46 286 42 80Per Norlén, CEO, per.norlen@alligatorbioscience.com, +46 (0) 46 286 42 80Per-Olof Schrewelius, CFO, per-olof.schrewelius@alligatorbioscience.com, +46 (0) 46 286 42 85 This information is such information as Alligator Bioscience AB (publ) is obligated to disclose in accordance with EU market abuse regulation. The information was submitted, through the above contact persons, for publication on 17 February 2017 at 08:00 (CET)

Lynparza positive in metastatic BRCA breast cancer

This announcement contains inside information 17 February 2017, 07:00 GMT LYNPARZA MEETS PRIMARY ENDPOINT IN PHASE III TRIAL IN BRCA-MUTATED METASTATIC BREAST CANCER Lynparza provided a statistically-significant improvement in progression-free survival compared to chemotherapy First positive randomised trial to evaluate the efficacy and safety of a PARP inhibitor beyond ovarian cancer AstraZeneca today announced positive results from its Phase III OLYMPIAD trial comparing Lynparza (olaparib) tablets (300mg twice daily) to physician's choice of a standard of care chemotherapy in the treatment of patients with HER2-negative metastatic breast cancer harbouring germline BRCA1 or BRCA2 mutations. Patients treated with Lynparza showed a statistically-significant and clinically-meaningful improvement in progression-free survival (PFS) compared with those who received chemotherapy (capecitabine, vinorelbine or eribulin). Sean Bohen, Executive Vice President, Global Medicines Development and Chief Medical Officer at AstraZeneca, said: "These results are positive news for patients with BRCA-mutated metastatic breast cancer, a disease with a high unmet need, and are the first positive Phase III data for a PARP inhibitor beyond ovarian cancer. This is highly encouraging for the development of our broad portfolio which aims to treat multiple cancers by targeting DNA damage response pathways." Initial findings from the OLYMPIAD study indicate that the safety profile of Lynparza was consistent with previous studies.   A full evaluation of the OLYMPIAD data is ongoing and the results will be submitted for presentation at a forthcoming medical meeting. AstraZeneca will be working with regulatory authorities to make Lynparza available to patients with this type of breast cancer. About Metastatic Breast Cancer Approximately one in eight women are diagnosed with breast cancer. Of these patients, approximately one-third are either diagnosed with or progress to the metastatic stage of the disease.[i] Despite treatment options increasing during the past three decades there is currently no cure for patients diagnosed with metastatic breast cancer. Thus, the primary aim of treatment is to slow progression of the disease for as long as possible, improving or at least maintaining a patient's quality of life. About OLYMPIAD OLYMPIAD is a randomised, multi-center Phase III trial assessing the efficacy and safety of Lynparza (300 mg twice daily) to 'physician's choice' chemotherapy (capecitabine, vinorelbine, eribulin) in 302 patients with HER2-negative metastatic breast cancer with germline BRCA1 or BRCA2 mutations, which are predicted or suspected to be deleterious. The international study was conducted in 19 countries from across Europe, Asia, North America and South America. The primary endpoint of the trial was progression-free survival (PFS) as measured by a Blinded Independent Central Review (BICR). Secondary endpoints include overall survival (OS), time to second progression or death (PFS2), objective response rate (ORR), and effect on health-related quality of life (HRQoL). About Germline BRCA mutations BRCA1 and BRCA2 are human genes that produce proteins responsible for repairing damaged DNA and play an important role maintaining the genetic stability of cells. When either of these genes is mutated, or altered, such that its protein product either is not made or does not function correctly, DNA damage may not be repaired properly. As a result, cells are more likely to develop additional genetic alterations that can lead to cancer.[ii] Specific inherited mutations in BRCA1 and BRCA2 increase the risk of female breast and ovarian cancers, and they have been associated with increased risks of several additional types of cancer. Together, BRCA1 and BRCA2 mutations account for about 20 to 25 percent of hereditary breast cancers[iii] and about 5 to 10 percent of all breast cancers[iv]. In addition, mutations in BRCA1 and BRCA2 account for around 15 percent of ovarian cancers overall[v]. Breast and ovarian cancers associated with BRCA1 and BRCA2 mutations tend to develop at younger ages than their nonhereditary counterparts. About Lynparza Lynparza (olaparib) is an innovative, first-in-class oral poly ADP-ribose polymerase (PARP) inhibitor that may exploit tumour DNA damage response (DDR) pathway deficiencies to preferentially kill cancer cells. Lynparza is the foundation of AstraZeneca's industry-leading portfolio of compounds targeting DNA damage response (DDR) mechanisms in cancer cells. Lynparza is currently approved by regulatory health authorities in the EU for use as monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed BRCA-mutated (germline and/or somatic) high grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) to platinum-based chemotherapy. It is also approved in the US as monotherapy in patients with deleterious or suspected deleterious germline BRCA-mutated (as detected by an FDA- test) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy. Lynparza is currently being investigated in another separate non-metastatic breast cancer Phase III study called OLYMPIA. This study is still open and recruiting patients internationally. About AstraZeneca in Oncology AstraZeneca has a deep-rooted heritage in Oncology and offers a quickly growing portfolio of new medicines that have the potential to transform patients' lives and the Company's future. With at least 6 new medicines to be launched between 2014 and 2020 and a broad pipeline of small molecules and biologics in development, we are committed to advancing Oncology as one of AstraZeneca's six Growth Platforms focused on lung, ovarian, breast and blood cancers. In addition to our core capabilities, we actively pursue innovative partnerships and investments that accelerate the delivery of our strategy, as illustrated by our investment in Acerta Pharma in haematology. By harnessing the power of four scientific platforms -- immuno-oncology, the genetic drivers of cancer and resistance, DNA damage response and antibody drug conjugates -- and by championing the development of personalised combinations, AstraZeneca has the vision to redefine cancer treatment and one day eliminate cancer as a cause of death. About AstraZeneca AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca.com and follow us on Twitter @AstraZeneca. Media EnquiriesEsra Erkal-Paler UK/Global +44 203 749 5638Vanessa Rhodes UK/Global +44 203 749 5736Karen Birmingham UK/Global +44 203 749 5634Rob Skelding UK/Global +44 203 749 5821Jacob Lund Sweden +46 8 553 260 20Michele Meixell US +1 302 885 2677Investor RelationsThomas Kudsk Larsen +44 203 749 5712Craig Marks Finance, Fixed Income, M&A +44 7881 615 764Henry Wheeler Oncology +44 203 749 5797Mitchell Chan Oncology +1 240 477 3771Lindsey Trickett Cardiovascular & Metabolic Diseases +1 240 543 7970Nick Stone Respiratory +44 203 749 5716Christer Gruvris Autoimmunity, Neuroscience & Infection +44 203 749 5711US toll free +1 866 381 7277 Adrian Kemp Company Secretary, AstraZeneca PLC ---------------------------------------------------------------------- [i] Dr Joyce O'Shaughnessy; Extending Survival with Chemotherapy in MBC" The Oncologist 2005:10 [ii] NCI website - BRCA Fact-sheet … https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet Last accessed January 2017 [iii] Easton DF. How many more breast cancer predisposition genes are there? Breast Cancer Research 1999; 1(1):14-17. [iv] Campeau PM, Foulkes WD, Tischkowitz MD. Hereditary breast cancer: New genetic developments, new therapeutic avenues. Human Genetics 2008; 124(1):31-42. [v] Pal T, Permuth-Wey J, Betts JA, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 2005; 104(12):2807-16.

MEDIVIR AB – FINANCIAL STATEMENT, JANUARY – DECEMBER 2016

Significant events during the fourth quarter · Medivir focuses research and development operations exclusively on oncology and reorganises in order to achieve significant cost savings. As a result of the operative transformation a non-recurring sum of SEK 49.1 million was charged to the profit/loss for the period and of SEK 52.6 million for the full year. · Medivir divests its pharmaceutical company, BioPhausia (Nordic Brands), to Karo Pharma for SEK 908 million and reports a consolidated capital gain of SEK 534.8 million, thereby applying IFRS 5 (see p. 12). · Medivir strengthens its clinical pipeline by entering into an agreement on the acquisition of a portfolio of clinical phase oncology programmes, which has increased its intangible fixed assets by SEK 89 million and current receivables by SEK 22 million. October – December 2016 · Net turnover for the continuing operations totalled SEK 9.9 million (34.5 m), SEK 5.6 million (31.1 m) of which comprised royalties for simeprevir. · Revenues from Medivir’s continuing pharmaceutical sales totalled SEK 2.9 million (2.9 m), of which SEK 2.9 million (2.7 m) derived from sales of OLYSIO®. · The profit after tax for the continuing operations was SEK -121.3 million (-56.9 m). · Basic and diluted earnings per share totalled SEK -4.50 (-2.11) and SEK -4.50 (-2.11), respectively. · The cash flow from operating activities amounted to SEK -69.6 million (-37.6 m). January – December 2016 · Net turnover for the continuing operations totalled SEK 93.0 million (474.3 m), SEK 60.3 million (418.6 m) of which comprised full year royalties for simeprevir. · Revenues from Medivir’s continuing pharmaceutical sales totalled SEK 12.3 million (53.9 m), of which SEK 12.0 million (53.0 m) derived from sales of OLYSIO®. · The profit after tax for the continuing operations was SEK -294.9 million (31.7 m). · Basic and diluted earnings per share totalled SEK -10.94 (1.09) and SEK -10.94 (1.08), respectively. · The cash flow from operating activities amounted to SEK -180.1 million (307.4 m). +-------------------------------+--------+-------+-------+-------+|Summary of the Group’s figures | Q4 | Q1-Q4 ||(SEK m) | | |+-------------------------------+--------+-------+-------+-------+|Continuing operations | 2016| 2015| 2016| 2015|+-------------------------------+--------+-------+-------+-------+|Net turnover | 9.9| 34.5| 93.0| 474.3|+-------------------------------+--------+-------+-------+-------+|Gross profit | 7.7| 30.0| 77.1| 436.0|+-------------------------------+--------+-------+-------+-------+|Operating profit before | -120.7| -51.9| -278.9| 95.7||depreciation and amortisation | | | | ||(EBITDA) | | | | |+-------------------------------+--------+-------+-------+-------+|Operating profit (EBIT) | -128.9| -60.4| -312.4| 55.4|+-------------------------------+--------+-------+-------+-------+|Profit/loss before tax | -129.9| -67.8| -306.7| 46.2|+-------------------------------+--------+-------+-------+-------+|Profit/loss after tax | -121.3| -56.9| -294.9| 31.7|+-------------------------------+--------+-------+-------+-------+|Operating margin, % |-1,306.1| -175.3| -335.7| 11.7|+-------------------------------+--------+-------+-------+-------+|Basic earnings per share, SEK | -4.50| -2.12| -10.94| 1.09|+-------------------------------+--------+-------+-------+-------+|Diluted earnings per share, SEK| -4.50| -2.12| -10.94| 1.08|+-------------------------------+--------+-------+-------+-------+|Net worth per share, SEK | 64.38| 54.04| 64.38| 54.04|+-------------------------------+--------+-------+-------+-------+|Return on equity | -30.5| -15.5| -18.5| 1.8|+-------------------------------+--------+-------+-------+-------+|Cash flow from operating | -69.6| -37.6| -180.1| 307.4||activities | | | | |+-------------------------------+--------+-------+-------+-------+|Cash and cash equivalents at | 1,698.5|1,077.9|1,698.5|1,077.9||period end | | | | |+-------------------------------+--------+-------+-------+-------+|R&D spending/total opex, % | 65.9| 77.8| 78.8| 73.1|+-------------------------------+--------+-------+-------+-------+ Conference call for investors, analysts and the mediaThe financial statement for January – December 2016 will be presented by Medivir’s President & CEO, Niklas Prager.Time: Friday, 17 February 2017, at 14.00 (CET).Phone numbers for participants from:Sweden 08- 566 426 91Europe +44 20 3008 9804USA +1 855 753 2235The conference call will also be streamed via a link on the website: www.medivir.comThe presentation will be available on Medivir’s website after completion of the conference. CEO’s commentsWe took several significant steps in the restructuring of Medivir during the fourth quarter. In all essentials, we completed the transformation of the company that had been in progress throughout the year. A key part of this transformation was the focusing of the company’s operations exclusively onto research and development in the field of oncology. This focus was given extra emphasis with the acquisition of two oncology projects in late development phases, both of which have considerable potential. The acquisition strengthens and balances our research portfolio and gives us a wider range of projects in different phases, shifting the company’s primary focus from early stage research to clinical development.As a further step in this process, we also divested BioPhausia with its drug portfolio Nordic Brands. After having considered and prepared a separate stock exchange listing of BioPhausia, we judged that a sale to Karo Pharma AB was the best alternative for our shareholders. An Extraordinary General Meeting in early February 2017 endorsed the Board’s proposal that the net proceeds from the sale of SEK 870 million should be distributed to Medivir’s shareholders in the form of a voluntary redemption programme.We also reorganised the company’s early stage research and administrative functions during the quarter. It is estimated that this will give annual savings totalling approximately SEK 110 million.Furthermore, we continued to make progress in our research projects during the quarter, both in our internal portfolio and in partner projects. I would like to make particular mention of the fact that we selected two new candidate drugs from our own research portfolio that have now proceeded to preclinical development: MIV-323 for the treatment of RSV infections and MIV-818 for the treatment of liver cancer. In keeping with our new exclusive oncology focus, we will continue to pursue the development of MIV-818 in-house, while for that of MIV-323 we will be seeking a partner.Along with MIV-802 for the treatment of hepatitis C, which we licensed out to Trek Therapeutics in the third quarter of 2016, these projects are clear indications of the improved productivity of our early stage research operations and ability to continue to produce new, well-differentiated candidate drugs in areas of great unmet medical needs on the basis of our own technology platform.The osteoarthritis trial MIV-711 proceeded according to plan and is now fully enrolled. As before, we expect to report data from the study during the third quarter of 2017.In November our partner, Janssen Research & Development, announced that they are building on earlier interesting results by initiating a phase IIb study with the combination of simeprevir, odalasvir and AL-335 for the treatment of hepatitis C.Q4 royalties attributable to the hepatitis C drug OLYSIO® (simeprevir) amounted to SEK 5.6 million as a result of the decline in global net sales.The extensive transformation we have now achieved gives me great hope for the future. Our strong, balanced research and development portfolio with a focus on oncology, based on our exciting technology platforms for protease inhibitors and nucleosides/nucleotides, has considerable potential to create long-term value for the shareholders and will generate a continuous news flow in 2017 and the years to come. It is therefore with a sense of pride and great confidence that I feel spring 2017 is the right time to hand over the baton to a new CEO, Christine Lind. I would like to take this opportunity to thank all our engaged shareholders, the Board of Medivir, all our employees and business partners for the stimulating and intense years at the helm of Medivir and I wish the company every success in the future. As a shareholder, I will be following the progress with great interest! Niklas PragerPresident and CEO  Upcoming reporting dates:Interim Report (January – March 2017)28 April 20172017 Annual General Meeting3 May 2017Interim Report (January – June 2017)25 July 2017Interim Report (January – September 2017)26 October 2017 For further information, please contact:Niklas Prager, President & CEO, phone: +46 (0) 8 407 64 30Ola Burmark, CFO, mobile: +46 (0)725-480 580.This information is information that Medivir AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08.30 CET on 17 February 2017.About MedivirMedivir is a research-based pharmaceutical company with a focus on oncology. We have a leading competence within protease inhibitor design and nucleotide/nucleoside science and we are dedicated to develop innovative pharmaceuticals that meet great unmet medical needs. Medivir is listed on the Nasdaq Stockholm Mid Cap List.

Summa Equity’s first fund closes at SEK 4.5 billion

Summa Equity was founded in 2016 by five partners brought together by a shared vision of building a leading specialised private equity firm in the Nordic lower mid-market. The firm focuses on capturing the investment opportunity provided by thematic megatrends that are expected to drive long term growth. Reynir Indahl, Managing Partner, Summa Equity comments: “Our investment strategy is designed to address the challenges associated with generating long-term profitability in a volatile market underpinned by low economic growth. In the process we hope to be part of developing innovative solutions to some of the most pressing challenges of our time. The closing of our first fund brings us closer to realising this vision and marks the beginning of an exciting journey.” Summa Equity Fund I is backed by a broad investor base comprising endowments, foundations, pension funds, insurance firms and funds of funds across the Nordics, Europe and North America. The Fund’s strategy will focus on investments related to four themes: resource scarcity, energy efficiency, changing demographics and tech-enabled businesses. The firm has offices in Stockholm and Oslo and the partners are Reynir Indahl, Jenny Keisu, Johannes Lien, Christian Melby and Tommi Unkuri. Two deals, Sortera and eGain, have already been completed for the fund: · Sortera is the market leader in collection and recycling of building material waste in Sweden’s largest urban areas. · eGain is a leading Nordic technology/service provider of remote optimisation and climate-based control of heating in multi-apartment buildings. Jenny Keisu, Partner and COO of Summa Equity, continues: “Sortera and eGain are great examples of the investment opportunities we see. They both have megatrend driven, resilient business models uncoupled from GDP growth and we have already identified a number of value creation initiatives that are being implemented to stimulate their respective growth strategies. A third investment is finalised and will be announced shortly providing a solid foundation for the fund.” Summa Equity’s investment philosophy also contributes to a strong environmental, social and governance (ESG) profile with the goal to generate long-term sustainable growth and profitability. As part of this commitment the firm will be the first Nordic Private Equity firm to report towards the UN Sustainable Development Goals. Summa Equity was advised by London-based Rede Partners, an independent fund raising and secondary adviser to the private equity industry. The legal advisors in connection with the fund raising were Mannheimer Swartling and Ropes & Gray. The new fund is domiciled in Sweden and is regulated as an AIF (Alternative Investment Fund) by the Swedish Financial Supervisory Authority. Ends Notes to Editors For more information, please contact: Jenny Keisu, Partner and COO, +46 72 24 24 144 About Summa Equity Summa Equity was formed in 2016 by partners with a shared vision of building a leading specialised private equity firm in the Nordic lower mid-market, positioned to capture the investment opportunity provided by the thematic megatrends expected to drive growth over the long term. The Firm focuses on sectors related to four megatrend driven themes: resource scarcity, energy efficiency, changing demographics and tech-enabled businesses. Summa Equity closed its first fund in February 2017 with commitments of SEK 4.5 billion.

Cloetta acquires Candyking

”The acquisition of Candyking will significantly strengthen Cloetta’s position in Denmark, Norway and the United Kingdom. Cloetta will be able to develop the Candyking brand and product offering, in order to offer an attractive customer and consumer experience. The acquisition will also strengthen our position in natural snacks with the Parrot brand. In addition, there are substantial cost synergies that make the acquisition attractive,” says Danko Maras, CFO and outgoing CEO a.i., of Cloetta. Candyking offers stores a complete concept in pick and mix candy including products, displays and accompanying store and logistic services. Candyking itself does not manufacture any products, instead they purchases products from different suppliers. The company currently supplies approx. 8,000 retail outlets in seven countries. Sweden, the United Kingdom, Norway and Denmark are the largest markets. Other markets are Finland, Ireland and Poland. In total Candyking have approx. 370 employees. Candyking’s total sales (including Danish tax) amounted to approx. SEK 1,300m on a rolling twelve month basis per the third quarter of 2016. Underlying EBITDA was approx. SEK 70m and underlying EBIT approx. SEK 30m. Candyking’s trademarks in confectionary are Candyking, Karamellkungen and Candyking Favourites. The company is also a leading pick and mix supplier within natural snacks in Sweden and Finland under the Parrot brand. The acquisition is expected to create substantial synergies that will gradually be realized during the years 2017 – 2020. Synergies will be created within administration, procurement, logistics, sales and through insourcing of production. The final outcome of the synergies is dependent on volume development. Cloetta intends to, following completion of the transaction, revert with information regarding expected synergies and non-recurring costs. The Cloetta group’s target of an underlying EBIT margin of 14 per cent stands firm. The transactionCloetta has agreed to acquire 100 per cent of the shares in Candyking as well as 100 percent of Candyking’s outstanding bond and other debt. The initial purchase price amounts to SEK 325m on a cash and debt free basis with a potential additional purchase price of maximum SEK 225m based on the result of Cloetta’s and Candyking’s combined sales volume of pick and mix in confectionary and natural snacks in the Nordic countries, the United Kingdom and Poland during 2018. The seller of the shares is Candyking’s CEO, Dani Evanoff. The majority of the initial purchase price and the potential additional purchase price will be allocated to the holders of Candyking’s SEK 750m bond loan. In connection with closing of the acquisition, Candyking’s bonds will be delisted from Nasdaq Stockholm. At the same time Cloetta will issue an earn-out instrument to the current bondholders that entitles to the future potential additional purchase price. The instrument will be registered at Euroclear in order to facilitate the distribution of any additional purchase price to the current bondholders. The transaction is subject to approval from the Swedish Competition Authority. FinancingThe acquisition will be financed by Cloetta using cash and its existing credit facilities. AdvisorsHandelsbanken Capital Markets has been financial advisor to Cloetta and Advokatfirman Cederquist has been legal advisor. KPMG contributed with support regarding financial due diligence. Conference call and web presentationA conference call and web presentation with Danko Maras, CFO and outgoing CEO a.i., will be held today at 15.00 p.m. Those who wish to participate are invited to dial in on telephone numbers. Phone numbersSE: +46856642690DK: +4535445575FI: +358981710493UK: +44 2030089802NO: +4723500254  Web presentationLink to the live broadcast will be published on www.cloetta.com The presentation will be in English. Make sure that you are connected to the conference by dialling in and register a few minutes before the conference begins. An audio recording of the conference call will be published on www.cloetta.com This information is such that Cloetta AB (publ) is required to disclose pursuant to the EU Market Abuse Regulation. The information was submitted, through the agency of the contact person set out below, for publication at 13.30 CET on 17 February 2017.

UPDATE ON STATUS OF THE REFINANCING OF FINANCIAL OBLIGATIONS

The Board of Directors (the “Board”) of EMAS Offshore Limited (the “Company”, together with its subsidiaries, the “Group”) refers to the announcement released by the Company dated 13 December 2016 (the “Announcement”) where the Company announced that the Group has signed a term sheet with all its financial lenders to refinance its financial obligations (“Refinancing”) over a period of 5 years from 12 December 2016 and the Refinancing will be subject to documentation and conditions that would be set out in definitive agreements (the “Definitive Agreements”) to be entered into between the parties within sixty (60) days from 12 December 2016. Unless otherwise defined, capitalised terms used herein shall have the same meanings ascribed to them in the Announcement.  The Board wishes to announce that the Company and all its financial lenders are still in the process of negotiating and finalising the Definitive Agreements. The Company has requested its financial lenders to grant an extension of time to finalise the Definitive Agreements within sixty (60) days from 10 February 2017. The Company will make further announcements in compliance with the listing requirements of the Oslo Bors, upon the execution of the Definitive Agreements and/or when there are material developments in respect of the Ongoing Initiatives. Shareholders of the Company (the “Shareholders”) are advised to exercise caution when trading in the Company’s shares as there is no certainty or assurance as at the date of this Announcement that the Definitive Agreements will be entered into or the Ongoing Initiatives will be undertaken or completed at all. When in doubt as to the action they should take, shareholders and potential investors should consult their financial, tax or other advisers. By Order of the Board Shannon OngCompany Secretary17 February 2017